Content-Type: text/html

Reference sequence (query): batch____
Identities normalised by aligned length.
Colored by: property
HSP processing: ranked
Search cycle: 3
                                                                                                       1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :         .         .         .] 181
    batch____                                              bits   E-value  N 100.0%   1:181              MSEAPKKRWYVVQAFSGFEGRVATSLREHIKLHNMEDLFGEVMVPTEEVVEIRGGQRRKSERKFFPGYVLVQMVMNDASWHLVRSVPRVMGFIGGTSDRPAPISDKEVDAIMNRLQQVGDKPRPKTLFEPGEMVRVNDGPFADFNGVVEEVDYEKSRLKVSVSIFGRATPVELDFSQVEKA    
  1 UniRef50_P0AA01        Transcription antiterminati...   190     1e-47  1  99.4%   1:181    1:181     MSEAPKKRWYVVQAFSGFEGRVATSLREHIKLHNMEELFGEVMVPTEEVVEIRGGQRRKSERKFFPGYVLVQMVMNDASWHLVRSVPRVMGFIGGTSDRPAPISDKEVDAIMNRLQQVGDKPRPKTLFEPGEMVRVNDGPFADFNGVVEEVDYEKSRLKVSVSIFGRATPVELDFSQVEKA    
  2 UniRef50_Q01SW9        Transcription antiterminati...   189     4e-47  1  50.0%   2:181   61:239     -DESSAKKWYIIHTYSGFENKVQESLRTRADAFGFADKIGQILIPTEEVVELRNGKKVTSKRLVYPGYVLVEMEMNDALWHEVKNTPRVTGFVGG-GNSPVPLSADEVNSILYRQASSAERPRPKMTFEKNDSVRIIDGPFANFSGKVDEVNPERGTLRVMVTIFGRATPVELEFLQVEKV    
  3 UniRef50_Q9CK84        Transcription antiterminati...   185     6e-46  1  77.9%   1:181    1:182     MTETtkKRWYVLQAFSGFEGRVATTLREYIKLHQMEDQFGEVLVPTEEVVENVAGKRRKSERKFFPGYVLVQMEMNDETWHLVRSVPRVMGFIGGTADKPAPISQREADRILNRLQESSEKPRHRKEFQPGEEVRVTEGPFADFNGTVEEVDYEKGRLKVSVSIFGRATPVELEFSQVEKT    
  4 UniRef50_C7M2W0        Transcription antiterminati...   183     3e-45  1  46.6%   8:181   67:243     -------EWYVVHCYSGYENRVRQNLATRIRSLGLEDRIFEVEIPMEDVTELKNGRRVKVQRKVFPGYVLVRAEMDDEVWSAIRNTPGITSFVGS-GSKPVPLSRKEVEAMFSFATPEELRPQPqqEFEIGETVRVKEGPLADFVGEVAEVNADQLKLKVLFNIFGRETPVELDFTQVSKA    
  5 UniRef50_A5D5K3        Transcription antiterminati...   182     7e-45  1  48.0%   6:180    2:173     -----EKKWYVVHTYSGYENKVKANLEKRIDSMNMEDKIFRILVPMEDEVEIKDGKKKVSKRKIFPGYVLVEMIMTDDSWYVVRNTPGVTGFVGS-GSRPIPLNDAEARQIIRQM--GVEEPRTRVDFTVGENIRVISGPFENFIGQIEEINMEKSKVKVMISMFGRETPVELDFTQVEK-    
  6 UniRef50_D0LJE5        Transcription antiterminati...   181     1e-44  1  48.0%   3:181   13:189     --QNDKFKWYVVHTHAGYEQRVRETLQQRAVALGFKDNIGEILVPTLNVMEVVKGKRKTSTKKFFPGYIFVQMEFTDSVYHLIRNTPKVTGFVG--GNTPQPVPESEISVIHNTMSDNHSKPRPKVMFEQGDNVRVTDGPFASFTATVEEVKPDKQKLRVLVTIFGRATPVELDFTQVEKA    
  7 UniRef50_P57151        Transcription antiterminati...   180     1e-44  1  80.6%   1:180    1:180     MHESQKKRWYVLQAFSGFESRVAQSIREHVKLNQMEDLFGEVMVPSQEVVEIRGGQRRKSEYKFFPGYVLIQMKMTDSTWHLIRNVPKVLGFIGGKSDKPSPISDKEVEIIINRLRKIGNKPRPKTLFEPGEMIRVNDGPFADFNGVVEEVDYEKSRLKVSVSIFGRSTPVELDFRQVEK-    
  8 UniRef50_D1CD65        Transcription antiterminati...   176     3e-43  1  46.6%   5:180   26:198     ----DGFQWYVIHTYSGYEDKVKRDLQHRVETMGMSDRIRDIIVPTVEEIEIREGKRHKVQKKVFPGYVLVRMRMDDAAWNVVRYTPGVTGFVGS-GTKPTPLDEKEVEKILQRM--SEEPPKVKMSLRLGEAVRIVDGPFTDFEGTVDEINEEKGKVKVLISIFGRPTPVELDFLQVEK-    
  9 UniRef50_Q9KGE7        Transcription antiterminati...   175     4e-43  1  44.6%   6:180    2:177     -----EKNWYVVHTYSGYENKVKTNLEKRVESMDMTDKIFRVMVPVEEETEVKNGKSKQVSRKVFPGYVLVEMVMTDDSWYVVRNTPGVTGFVggAGSKPTPLLPEEVDAILRQMG-MQEERQVEIDFQLKESVKVKEGPFANFIGTIEEIQLDKRKLKVHVNMFGRETPVELEFTQIEK-    
 10 UniRef50_C8XBG0        Transcription antiterminati...   175     5e-43  1  46.2%   8:180  123:305     -------EWYVVHSYAGYENKVKTNLETRIKSLDMEDYIFQIEVPTEEVTEIKNGQRKQVQRKVYPGYILVRMDLTDQSWSAVRNTPGVTGFVGATAQKPSALTIDEVVKILTPTapGSAPVRTEVDFSIGESVTVMDGPFATLPATINEVNADAQKLKVLVSIFGRETPVELSFSQVAK-    
 11 UniRef50_Q5HRL6        Transcription antiterminati...   175     5e-43  1  38.9%   1:180    1:181     MSEegAKRWYAVHTYSGYENKVKKNLEKRVESMNMTEQIFRVVIPEEEETQVKDGKAKKLVKKTFPGYVLVELIMTDESWYVVRNTPGVTGFVggAGSKPNPLLPEEVRFILKQMGLKEKTID--VELDVGEQVRIQSGPFANQIGEVQEIEADKFKLTVLVDMFGRETPVEVEFDQIEK-    
 12 UniRef50_A6W3A4        Transcription antiterminati...   174     1e-42  1  69.3%   6:181    2:177     -----TKRWYVVQAYSGYEKHVMRSLIERVQVMGQEENFGDILVPTEEVVEIRDGKKRKSERKFYPGYVLVQMDMNDASWHLVKGTSRVLGFIGGTADKPSPITSREADAILQRVSDGVDKPRPKTLFEVGEVVRVNEGPFADFNGVVEEVDYDKSRIKVAVLIFGRSTPVDLEFSQVEKA    
 13 UniRef50_Q6A6K1        Transcription antiterminati...   174     1e-42  1  41.6%   8:180  117:302     -------EWYVLHTYSGMENKVKQNLDARVQNFNMEDYIFETVVPTEEVVEIRNGARRTITRVYLPGYVLVRMDLTDDSWGIVRHTPSVTGFVGQSTT-PIPLTFDEVVKMlkTSSPKAKPKVEVADYEVGESVQITDGPFAGVPAQITEINTNNQRIKALVEILGRSTPVDLEFNQIEK-    
 14 UniRef50_Q1WST1        Transcription antiterminati...   174     1e-42  1  38.8%   3:180    6:184     --ESVEKKWYVLHTYAGYENKVKENLESRATSMGMEDYIFRVVVPEEEKHEtkTGKEKVEKLKTFPGYVLVEMVMTDQSWYVVRNTPGVTGFVggSGSKPAPLLDEEINHILHELGISSR--HSNFDAEVGDAVTIIDGAFSGLVGKITEIDTEKMKLKVDIDMFGRETAAELNYDQVDK-    
 15 UniRef50_B4R8J9        Transcription antiterminati...   172     3e-42  1  54.2%   4:180   12:187     ---NPRHKWYIVHAYSNFEKKVAESIREQARTQGLEENFSEILVPTEDVVEIRRGRKVNSERKFFPGYVLVKMEMTDEAYHLIKNTPKVTGFLGS-GSKPIPVSEKEVERIVGAIEEGVERPKPTITFEIGEQVRVTDGPFASFNGSVEQVDEERARLRVTVSIFGRATPVELEYGQVEK-    
 16 UniRef50_A3EVT3        Transcription antiterminati...   172     4e-42  1  43.6%   2:180    6:183     -DSDSKKNWYVIHTYAGFENRVKTSIEERVVLKDLADIVGQVVVPIQNVTELKEGKKKVSSRKVFPGYVLVEMEPTEEAIQFILATPKVTGFLGN-GTTPIPMSSREVSELFDRIESGTAMPSPSQHFSESETVRITDGPFQGFSGMISEVDNDHGKLKVLVSIFGRQTPVELDFLQVER-    
 17 UniRef50_B9KYX2        Transcription antiterminati...   172     7e-42  1  45.8%   4:180   23:196     ---DQQGEWYVLHTYSGYENKVRQNLLHRVETMDVADKVFEVVIPMQEEIEIRGGQRHTVQRKVFPGYVLVRMILDDESWHVVRNTPGVTGFVG-VGNRPVPLDRAEAEAIIR--GAKAEQPKVRMTLLPGDVVRIIDGPFTDFRGVVDEVDNEKGKVRVLVSFFGRETPVTLDFLQVER-    
 18 UniRef50_P65591        Transcription antiterminati...   171     8e-42  1  61.5%   7:180    3:176     ------KKWYVVQAYSGFEKNVQRILEERIAREEMGDYFGQILVPVEKVVDIRNGRKTISERKSYPGYVLVEMEMTDDSWHLVKSTPRVSGFIGGRANRPTPISQREAEIILQQVQTGIEKPKPKVEFEVGQQVRVNEGPFADFNGVVEEVNYERNKLRVSVQIFGRETPVELEFSQVEK-    
 19 UniRef50_D1BP79        Transcription antiterminati...   171     1e-41  1  42.1%   4:181    2:177     ---EADKKWYVIHTYSGYENKVKTTLELKVQSMGLQDVISRILVPLEDEIDEKDGVKKVVKRKIFPGYVLVEMEVNDRSWYVVRNTPGVTGFVGSAT-KPVPLSDSEVEHILKSQGL-DKKPTINVDVEVGETVRITSGAFEDKLGVITELNPEKGTLKLSVEMFNRDTEVELEFSQVEKA    
 20 UniRef50_Q2LQ92        Transcription antiterminati...   171     1e-41  1  50.3%   8:178    4:173     -------KWYVVHTYSGFESKVKQSLQERIEAAGMQARFSDILIPEEDVVELVSGEKKTSKRKFFPGYILVKMELDDDTWHLVKDTPKVTGFIGSRE-KPSPIPDKDVELLKTRIDEGTLKPKPKFKFEVGDHVTIIDGPFTNFDGVIDEVKAEKGKLRVIVSIFGRPTPVELDFIQV---    
 21 UniRef50_B1I1L1        Transcription antiterminati...   170     2e-41  1  41.7%   7:181    3:177     ------KQWFVVHTYSGYENKVKANLEKRIESMSMEDKIFRIVVPVEDEIEVKGGKRKISKRKIFPGYVMVEMILDDDSYRVVRNTPGVTGFVggIGSKPIPLTDAEANQIISQMEGDE--PRIRIDLVPGEKVRVMAGPFENFIGTVDDVNYEKAKIRVMISMFGRETPIELEYFQIEKV    
 22 UniRef50_Q1AU17        Transcription antiterminati...   170     2e-41  1  40.8%   7:180    2:175     ------KKWYVVNTYSGHENKVRATLERRIESLGLQRYFGEIRIPTEQVIEIKNGKKVPTTHRQFPGYILVNVEMNDDTWRVIRQTPGVTQIVGS-GDKPTPLSRAEVERLLHPEeeKREKVKATVDFDIGETVRVVAGPLSDFTGTISDINVDQSKVKVLVSIFGRETPVELSFNQVAK-    
 23 UniRef50_Q0AUG6        Transcription antiterminati...   168     6e-41  1  42.4%   9:180   33:202     --------WYVVHTYSGYENKIKVDLSKRVESMNMQDKIFEVIIPEEQEVEYKNGKRKVTNKRIFPGYVIVNMIMDDDSWYVVRHTPGVTGFVGS-GSKPIPLHQEEIDKIRRQMGLM-EKKTMIIDIEIGESIRVKTGPFANFEGVVRELLPEKGKIRVNISMFGRETPVELDYEQIEK-    
 24 UniRef50_C4Z2Q9        Transcription antiterminati...   168     9e-41  1  36.6%   5:179    2:176     ----DDAKWYVVHTYSGYENKVKANIEKTVENRNLHDQILEVIVPLETVVEIKDGSKKAAQKKMFPGYVLVKMVMNDDSWYVVRNTRGVTGFVG-PGSKPVPLTPTEIKNliSLEEEQEVKPVIQFAGKVGDKVMILSGAWEDTVGEITNINEGKQCLTINVEMFGRETPVEIDFTDVK--    
 25 UniRef50_P35872        Transcription antiterminati...   167     2e-40  1  42.5%   8:181    4:184     -------EWYAVHTLVGQEEKAKANLEKRIKAFGLQDKIFQVLIPTEEVVerEGGKKEVVRKKLFPGYLFIQMDlpNEAWEVVRGTPGITGFVG-AGMRPVPLSPDEVRHILEvlLGKKEAPKAQVAFREGDQVRVVSGPFADFTGTVTEINPERGKVKVMVTIFGRETPVELDFSQVVKA    
 26 UniRef50_C4XIP4        Transcription antiterminati...   167     2e-40  1  52.8%   1:180    8:186     VDEQSNARWYIVHTYSGFENRVELTLREMMRTGQDGGSIKEVVVPTEKIIELVKGEKKTSTRKFYPGYVMVKMAMDDNSWHLVQSIPRVTGFIGGK-NQPTPMRDSEAQKILSLMVSRQEQPRPKYHFERGDDVRVIDGPFGGFNGVVEDVNYDKGKLRVSVSIFGRQTPVELDFVQVSK-    
 27 UniRef50_D1B6U2        Transcription antiterminati...   167     2e-40  1  41.3%   3:181    2:180     --KDDKRRWYIVQTYSGYENKVKANLEQRIATMGMEDRIFNVLVPVEEKVFVKEGRAKRVRRKVFPSYVLVEMIMDDQSWYVVRHTPGVTGFVGS-GNHPIPLTDREVAEVMGKIgpADRKPKVELDIEVGDTVRVKSGPFEGCVGPVVEVDPDKGRVRFSVTVFGRETVAEAGHEDLEKV    
 28 UniRef50_B0SAG6        Transcription antiterminati...   166     2e-40  1  39.1%   1:179    1:181     MGDSLDKKWYVLQTYSGHENKVKTNIEKMVQQQKLEDQIFSVKIPSMEVAEMKNGKKKVTKKKLMPGYVLVEMNMTDDLRFKIQNLPSVSTFVGGKGKGPEPLSLDEIKNLFSDVgeSEEVSRPRFLFKVGETLKIIDGPFANFTGLVDEIFPDKGRLRVRVEIFGRSTPVELDYLQVK--    
 29 UniRef50_D0WPF7        Transcription antiterminati...   166     3e-40  1  38.3%   6:180   86:272     -----DGRWYVLHTYSGYEKRVKQDLEVRMHSMNMEDYIFQIEVPMEEVFEIRRGQRKLVSRVRMPGYVLIRMDLTDDSWRVVQSTNGVTGFVGN-GRTPVALSENEVVSMLTPvkAASPTPATLSPYAVGDAVTLTSEPWAGMPATVSEVDAANQRLTVLMTLVGQETPVELSFNQVRK-    
 30 UniRef50_Q9CBK0        Transcription antiterminati...   166     3e-40  1  43.0%   9:180   39:227     --------WYVIHSYAGYENKVKANLETRVQNLDVGDCIFQVEVPTEEVTEIKNGQRRLVNRKVLPGYILVRMDLTDDSWAAVRNTPGVTGFVG-ATSRPSALALDDVVKFLLPSGSAKKDAkiEVDYEVGESVTVMDGPFATLPATISEVNAEQQKLKVLVSIFGRETPVELTFSQVSK-    
 31 UniRef50_B2KEU4        Transcription antiterminati...   166     4e-40  1  42.2%   1:180    1:176     MSEN--KAWYIVHTQTGHEDKVREKILLQVETQNFGDRIFQVLVPTEDVVEVKQNKKVQRKRKFFPSYVLVEMDLTSEAYWFIRNVSGVTGFLGDPN--PVPLPEEEIAAILDLTQPGSGKPKHVIEFEAGENVRITEGPFKHFIGVVQEVNNQKTKLKIMVNVFDRSTPVELDFLQVEK-    
 32 UniRef50_C1Z9H7        Transcription antiterminati...   165     6e-40  1  35.2%   2:180   24:203     -STENAMLWYVLKITSNREKSIRDNLLRRIRQEGLEQFFGEILIPTEKVVENKNGKKKVVEHKLYPGYLMVQMILNDDTWYIVRTTGGVGDFTGSAG-KPTPMQDHEIARMLQKQEQKQeaPAMKIEFAVGDIVKIKEGTFEGFEGPIDSIDEANGKINVLVEIFGRSTPVELEYWQAER-    
 33 UniRef50_P27309        Transcription antiterminati...   165     7e-40  1  36.4%   8:180  111:298     -------EWYVIHTYAGYEKRVKANLEQRAVSLNVEEFIYQAEVPEEEIVQIKNGERKNVRQNKLPGYVLVRMDLTNESWGVVRNTPGVTGFVGNAYD-PYPLTLDEIVKMLAPEapAVKRTIEVLDFEVGDSVTVTDGPFATLQATINEINPDSKKVKGLVEIFGRETPVELSFDQIQK-    
 34 UniRef50_A6LPP9        Transcription antiterminati...   164     1e-39  1  39.5%   4:180   10:179     ---SDRARWYVVHTYSGYENKVKANLEKAIENRNLEALIHDIQVPMEEVVEEKDGKQKVSLKKKFPGYVLVKMLMGDEAWYVVRNTRGVTGFVG-PGSKPVPLSDEEVESM------GVLEVPVEIDLEVGESIRIISGPLRDSVATIQEIIPDKRKVKALVEMFGRETLAELDFNQVEK-    
 35 UniRef50_B3T6R2        Putative transcription term...   164     1e-39  1  38.9%   2:181   91:270     -PQNPNVKWYILQAYSGYEGRVEQTIREKLRIKGIEHLVDEIFIPSEDIIRTKEGKKRKVNQKYFPGYVLIHMELTPELWHLLMNVNRVSGFIGGTQKKPLPLDEKELEEIRSQVNEGFQQKATEDEYSVGQKVTITEGSFGNFSGTIDEVNLERRKLKVLVSIFGRPTPVEVEFENVKHV    
 36 UniRef50_D1NBR2        Transcription antiterminati...   164     1e-39  1  39.8%   1:181    1:192     MNESAEtqWFVIHTLSGHENKVRDKILRQLQT-GDQVPVYEAFIPTEKVAEVRQGKKTTTTRKLFPGYIWVRMDlnEKAWYFIRSVQGVLGFLGGD-NKPTALTESEVEDIMRPAQAGAPEVKPKIAFEVGEVVRIKDGAFENFEGAIQEIDNERGKLKLMVSIFGRSTPVELEFWQVERT    
 37 UniRef50_B8DVU5        Transcription antiterminati...   164     1e-39  1  37.1%   6:180  142:327     -----EGKWYVLHTYSGYEKRVKSNIESRVQSFGLEDTIFQVEVPMEEVEKHTEKGKKVVTRVRVPGYVLIRMYPDENARRIVRETEGVTGFVG-PSREPAPLSRKEVVSMMAPmpAAAKKRTLEVSYKVGDQVTVTDGPFTSMSAVVSDVEPATQKLTVLVSIFGRDTPVELGFDQVQR-    
 38 UniRef50_Q6MJ02        Transcription antiterminati...   163     2e-39  1  49.7%   6:180    2:176     -----EKKWYIVNVQTSCENTAKKAIEEKIKSSKMEEFFGEILIPAESVVELVKGQKQTKSRKFFPGYIFVQMFLNDETWHLVRNSSKVTGFVGGTKTRPPEVPEAEVLRVTQQMAGVAEKPRPKVKFAVGENVTVIDGPFSNFQGTVEEINEDKAKLKVLVSIFGRPTPVELDYIQVEK-    
 39 UniRef50_D2MPP9        Transcription termination/a...   163     3e-39  1  30.7%   2:180   13:192     -DDENEVRWYVVNTYAGHENRVKDNLEKRLETMGIQESLFRIFVAEEEEIVIKKNNKSEVKknMFPGYIFVQMKMTDQAWYVVRNTPGVTGFIGSSGgkPFPVSEDEMESILRRMGHGDQKV--VVDFQVGDNVKILTGPFANMIGRISAMNDQTQIATVMTLLFGRETPNEISYGDLQK-    
 40 UniRef50_B3QYK9        Transcription antiterminati...   162     3e-39  1  38.4%   8:179   29:199     -------RWYTVRTYSGHERKVKEHLDKKIDDAGIRDKIPQVYIPYERFVEVKDGKKKSRVKNAFPGYVLIEAVLDKQTRYLVLDAPSVIGFLG-VGDEPTPLRPDEVKRLLEPEQEIERKMVTKAPFEVGGAVKIIDGPFNSLTGVIQEVNAEKMKVKVLINFFGRSTPTEVDFSQVK--    
 41 UniRef50_A4QBE9        Transcription antiterminati...   162     4e-39  1  39.1%   3:181  118:317     --KKQPGVWYIIQCYSGYENKVKANLDMRAQTLEVEDDIFEVVVPIEQVTEIRDGKRKLVKRKLLPGYVLVRMDMNDRVWSVVRDTPGVTSFVGNEGNA-TPVKHRDVAKFLMpmPTDTKKPQVAVDFTVGEAVTILTGAFASVSATISSIDPELQKLEVLVSIFGRETPVDLSFDQVEKV    
 42 UniRef50_C9M8Z2        Transcription antiterminati...   162     4e-39  1  36.9%   3:181    7:185     --EQANVQWFAVQTYSGYENKVKNNLEQRIASMNAEDKIFRVLVPMEDVVVVKDGKSKQMSRKLFPSYVLVEMIMDDQSWYVVRHTPGVTGFVG-AGAHPLPLSDEEVRDVLVKVGeeAETPQIVVECQVGDSVRVKSGPFVGAVGVVSDVNTSTGKVKFVLSVFGRETEAEVNHTELERV    
 43 UniRef50_A4XLK3        Transcription antiterminati...   161     1e-38  1  37.2%   1:180    1:174     MSDK-RAKWYVVHTYCGYENKVKANLEKIIENRNLSDKILDIRIPTELVTEIKDGKKIVKEKKKFPSYVLIKAVMDNDIWYTIRNVRGVTGFVGPE-SKPTPLTDEEIEAM----GIKEEEVVEVFDIEVGDNVKIVAGPFADFYGPVIDINKERKKVKVMLNLFGRETPVEFDYHQVEK-    
 44 UniRef50_D2R5P4        NusG antitermination factor...   161     1e-38  1  35.0%   2:181   85:267     -DKDLKFEWYILKVQVNREDSIKASLLRRINMNGLERFFKDVVVPTEDVAetKTGKRRVVKKKIYPGYILVNMVFNDETWFIVRETSGIGDF-TGAMGKPTPMDPKDVERIlkMLEEDTNQVRTAIPFKVGDRVRVKEGYFQNFEGDIDGIDQANGRVTVMINIFGRSTPVELEHWQIEAV    
 45 UniRef50_Q1UZH8        Transcription antiterminati...   160     2e-38  1  45.7%   7:181    2:175     ------KNWYIVQSHSNFENKVAGLIKEEAEKAKISDKIEEIVVPTHDVTEVKRGKRIQRKKKYFPGYVLIKSEMDNDLYHLIKNLKRVSGFLGSKG-IPVPVSDKEIEKILGQIKDGVAQPKSGIEYSIGEKVQVVDGPFASFSGMVEDIDEEKSRLKVSVSIFGRPTPVDLEYNQVEKA    
 46 UniRef50_B3E158        Transcription antiterminati...   160     2e-38  1  42.2%   2:181   16:200     -AKSQNMQWYALHVLSGQEEKVKKNLEKRIKTEEMQDLVGEVVIPVERVSEVRKGKRIEINRKLYPGYVFLQIQLRdrAWYFVRETSGVIGF--ADGDNPLPMPREQVEGMLRQIQERTSSALPKTVFSVGDRVKVGDGPFLNSEGVIEEVDLERGKLRVSVNIFGRSTPVELEYWQVEKA    
 47 UniRef50_Q87A27        Transcription antiterminati...   160     2e-38  1  63.4%   7:181    2:185     ------KRWYVVHAYSGFEKSVAQALRDRISRIEIQDRFGDVLVPAEEVVEMRSGQKRRSEHKFFPGYVLIQIeiDNECWHLVKETPKVMGFIGGTADRPLPISSDEADVILRRVQDGAEKPRPKVLFEPGQMVRVIDGPFNDFDGLVEEVNYEKNRLRVAVLIFGRPTPVDLDFGQVQKS    
 48 UniRef50_Q1RHC5        Transcription antiterminati...   160     2e-38  1  44.1%   2:180   13:188     -SEKDTKKWYVIHTASGAENRIKRIMLERISKQKMSDFFDDILVPVFGVSEVKRSKNVKVEKKLMPSYILIKMNMTDKSWHLVKNIPGVTGFLGSKTT-PKALTESEIQNIR--LETEAKEAKDAKLYEVGEIVTVTEGPFETFTGTVEEVDQEKARLKVSVSIFGKATPIELSFTQVKK-    
 49 UniRef50_Q14PQ9        Transcription antiterminati...   160     2e-38  1  34.1%   8:180   32:215     -------KWYVINCYSGHEDRVRDDLIQRVESLNMKDVVFDIRVIKETVSAKKGGKLIEKEKNLYPGYIFINMIMNDEAWYIVRNTTGVTGFIGSSGrkPFPLTDQEARTMLSKtqGKKVKKVFVANFEVNDYVRILSGTFTEMEGQVTKIDTSKGIAIVNLEMFGRLTPTEVEFDQCEK-    
 50 UniRef50_B2UQY7        Transcription antiterminati...   160     2e-38  1  38.1%   1:181    1:189     MPSTPEPhwYVLHVLSGQENSVRDRIIRKAKDAELSDFIYRVEVPTELISEVRNGKKTERHSKLFPGYVYANmtLNKDLWYFIQQIDGVISIAGSR-NAPLPMRKREVEDLLPLLDAEAVAARPKVEFAVGDPVRVCEGPFQSQEGTIEEIDPEKGKLRVSVSIFGRATPVDLEYWQVEKA    
 51 UniRef50_C8WBL1        Transcription antiterminati...   160     2e-38  1  48.0%   7:181    2:178     ------SRWYIIHAYSGFENKVKEAVAAEAERLGLQPLVEAIEVPTEQAVEVRRGKKVAVERKCFPGYVLAKLNMNEDVYHLVKNTPKVTGFLGFSG-KPQPISDAEAEHILNHKAEAekKAQIKVDFEIGDQVKVLEGPFASFNGVVEDLDFDRARVKVSVSIFGRATPVELEFEQVERA    
 52 UniRef50_D0MHN6        Transcription antiterminati...   160     3e-38  1  43.3%   1:180    1:184     MTEEKkrKWYVLRTFSGHEKKVKQYLEREIERLGLQDRVGQILIPTETVFELRGGKKRTRERTFFPGYILIEAVLDRELQHLIANMPSVVGFLGS-GDQPTPLRPDEVRRILGKVDEAREmeQPEIPFKPGDVVRIIEGPFNNFTGVVEEVYPDKLKLKVMVSIFGRKTPLEVDYLQVER-    
 53 UniRef50_Q6AP83        Transcription antiterminati...   159     4e-38  1  51.2%   7:178    3:174     ------KQWYILQAHSGFEEKVKLTLEDRIKKDGLEDFFGDILVPTEQVVEMVKGSRKTSSKKFFPGYMLINMELTDETWhvHENMPRVVGFVG-DDRNPMPLSDEEAAKIIGRIQEGSERPRPKVIFDVGENVRVIDGPFSNFQGVVDEVFPDKGRVRVMVSIFGRETPVELEFVQV---    
 54 UniRef50_D2RNN9        NusG antitermination factor...   159     4e-38  1  36.2%   4:180    2:189     ---ENQKHWYVIHTYSGYENKVKMNLESKIHSLGMEEQIFQVLVPMQNEVDAKDDKQKVVARKVFPGYVLIEMIVDDRTWYAVRNTPGVTGFVG-TGTKPIPLSDREVERILGAQPKEgeEPVVRMECPVgdTVRIKAPGFTDMVGTVAEINDEQQKIKVMVEMFGRETPIEVKFTQVEA-    
 55 UniRef50_A6CA55        Transcription antiterminati...   159     4e-38  1  37.1%   4:181   17:194     ---SEKRLWYVLKVQSNREKSIRDALLRGIKRDGLEEYFGEIIIPTEKVVETKGGKKRVFERKLYPGYLMIQVELNDDSWYLVRSTNGVGDFTGAAG-KPIPMQEHEIARMLGREESKEETpkIKLDFQVGDVVKVKDATFEGFEGTIDAVDEASGKVTVLIEIFSRPTPTELEYWQIEKV    
 56 UniRef50_B0RIR6        Transcription antiterminati...   159     4e-38  1  39.0%   4:180  153:344     ---SKPGKWYVIHSYAGFERRVKSNIENRMVSLNMEDDIYQIEVPMEDVVEIKNGQRKMVNRVRIPGYVLVRMALNEDSWSVVRHTPGVTGFVGNA-HNPTPLRFEEAFSMLKSlgQAQRVVAAEVDFEIGETITIKEGSFAGLPGSISEIKPESGKLTVLVSLFERETPVELSFDQVTK-    
 57 UniRef50_B1ZPC3        Transcription antiterminati...   158     6e-38  1  39.5%   4:180    8:189     ---PADAQWFALHTLSGQENKVKAYIDKFKKAEELDDSIFEVLLPTEIVSEVKGGKKSTKVRKLYPGYVFIQMRLynKPWYFVKEVAGVIGFVG--GDRPAALRQSEIDEIRARIEAANGKEVPKVQYSVGEEVKITDGAFASLTGRIDEIDPERGKLKVSVSIFGRFTPVELEYWQVQR-    
 58 UniRef50_B0S060        Transcription antiterminati...   158     8e-38  1  38.6%   5:180   21:192     ----KEGKWYVVHTYSGHEGKVKVNIEKMVENRGYIDDIFEVVVPTEEYVSEVGGAKKLKERKIFPGYVFVKMTITDVSWYLVRNTRGVTGFVGPE-SKPVAVSEKEIQKFALKNQSYSKK---EIDVNVGDNVNIVSGAFSDQVGIIEEINTEKAICKVLISLFGRDTSVEISFDDIEK-    
 59 UniRef50_B6G0A9        Transcription antiterminati...   158     9e-38  1  37.8%   1:180    1:179     MSELQEAKWYVVHTYSGHENKVKATIERAVITRGMENIITHVVVPTENVVEkpKGNEKIRQRKVYPSYVLIKMIITDESWYVVRNTKGVTGFVG-PGSKPVPLSEEEVIAM-GIELPAQEVVGGDVDFEPGDVVKIINGSFAGNVGTVEEVNAEKKEVKLLTEIFGRKSPVTIGIQSIEK-    
 60 UniRef50_A0Q872        Transcription antiterminati...   158     9e-38  1  54.7%   9:180    3:175     --------WYVVQVHSGYEKRVKAQLEENIEIAGLKNNFGRILVPTENVVEMKGGQKRKSERKYFPGYVLIEADLSTDAWNLVKSVPRVLTVVGSKG-KPIPLSKAEVDRILGFVekSTVEPRLRKSYHVGEVVRVLEGPFNDFTGVIEEVNYEKSRLRVAVSIFGRSTPVELEFSQVEK-    
 61 UniRef50_C0QWX1        Transcription antiterminati...   157     1e-37  1  39.4%   1:180    1:194     MSEekDYKWYIVHTQHGYENKVRERIEKRAKENGMTDLIVDIYIPSETVTSTKNGKKVSKEEFFYPGYVLVKMVMNDATQSMVRRTPGVAGFIGsgNIIPTPLSESDVARIFENREDKSKTGINEieFDIGEKVQVIDGPFNGLNGIIENINSDKGRVTVKIEIFGRSTPTELEFSKVKK-    
 62 UniRef50_P68893        Transcription antiterminati...   157     1e-37  1  33.7%   1:178    1:176     MLDSFDKGWFVLQTYSGYENKVKENLLQRAQTYNMLDNILRVEIPTQTVNVEKNGQTKEIEENRFPGYVLVEMVMTDEAWFVVRNTPNVTGFVGSHGnkPTPLLEEEIRAILLSM--GQTIDVFDTNIKEGDVVQIIDGAFMGQEGRVVEI--ENNKVKLMLNMFGSETVAEVELYQI---    
 63 UniRef50_Q9CDV7        Transcription antiterminati...   157     1e-37  1  35.8%   1:179    1:181     MEDNndQGWFVIQTYAGYERKVKEDLLERAELYNMADKILRVEIPTETIRTEVNGKMKEVEENLFPGYVLVEMNMTDEAWFIVRNTPNVTGFVGSHGnkPTPLFEQEIQDILVGM--GKVVREIDFDVFVGKRVRIVDGAFSGFEAPITEINGDK--LTLTVDMFGRATPVELDMHQIE--    
 64 UniRef50_C4LL90        Transcription antiterminati...   157     2e-37  1  40.6%   1:180  145:351     MRELKkgEWYIVQCYSGYENKVKTDLEVRSQTLGVDEQIHEVVVPIEEEVEVKDGKRKVVKHKLLPGYVLMRIELDDASWSVIRDTPGITSFVGNEGH-PTPVKIREVAKFLLPPETATQKAEQevDYEVGEAVTVLSGPFASVSATISEIDAENSKLKALVSIFGRETPVELDFDQVEK-    
 65 UniRef50_C8NX40        Transcription antiterminati...   157     2e-37  1  36.6%   9:180  146:340     --------WYIIQSYSGYENKVKTNLDMRIQTLEVEESIYDVVVPIEQVFEkkNGKKKIVKRKLLPGYVLVRMDLNDAAWSVVRETPGVTSFVGNEGNA-TPVKHRDVAKFLMpmPEQEEKPNVAHDFQVGEAVTILSGALASVSATINEIDPETGKIQALVSIFGRETPVELTADQIER-    
 66 UniRef50_P52852        Transcription antiterminati...   157     2e-37  1  37.6%   8:180  126:308     -------EWYVIHTYAGYENRVKTNLEPRAVSLNVEDYIFQAEVPQEEVVQIKNGDRKTIKQNKLPGYVLVRMDLTNESWGVVRNTPGVTGFVGNAYD-PYPLTLDEIVKMLAPEapQRKVEVQVLDFEVGASVTVTDGPFATLQ-TINEIKSDSKKVKGLVEIFGWETPVELSFDQIQK-    
 67 UniRef50_B9CLA2        Transcription antiterminati...   156     4e-37  1  39.0%   7:178    3:180     ------KRWYVLHTYSGYENKVMNDLEHRVEAYGLQDAVVDVQAPGEMVTEVKKRGEKDveVKFYPGYVLVRMELDDNTWSVVRNTPGVTGFLGVDG-KPSPLRREEFNKMMRRSgdATTLKRVTTDVEVGQSVHVLSGPLADFDGIVSEVNAESGKIKVMLTIFGRETPVELTLDQI---    
 68 UniRef50_C2KN14        Transcription antiterminati...   155     5e-37  1  39.9%   8:180   90:278     -------RWYVVHTYSSYEKRVKQNIEQRVANngMEEWIYQVEIPMEEHIEVKAKSRRKVLRPRIPGYVLVRMDMEENSWRLVKDTPAVTGFVGNQQD-PVPLTLQEVIDMLAPTAAQavSTQIVTDFEVGQGVTITSGPFETMTATIAEIYPDTSKLKVLVTIFERETPVELNFDQVEK-    
 69 UniRef50_B3EL56        Transcription antiterminati...   153     2e-36  1  37.7%   5:179   16:189     ----SRPRWYALRIYSGHERKVKEGIELEVERQALEDKILQVYVPYEKFVEVRNGKKRSLTKNAFPGYVLIEAILDKQTKNLIMDIPSVMGFLG-VNDIPTPLRPDEVEKILEPESTVEQRSVVEAPFRVGDTVKVIDGPFSSLTGVVHDVCVERMKVKVMISFFGRSTPTELDFSQVK--    
 70 UniRef50_C9LQP9        Transcription antiterminati...   153     2e-36  1  34.9%   3:177   30:200     --SEKDIRWYVIHTYSGYENKVKDTLTRKVHSMGMDDTIIQILLPMHDEEEVKDGEKKVVSRKVFPGYLLIQMEVNDRSWYVVRNTPGVTGFVG-TTTKPIPLSDEEAKRII---EGKDKKQTAKTDAKVGDTIKITRGPFADRSAVVLDVSDDRSKIKADISNFGTTTTIELEVGY----    
 71 UniRef50_A3ZLI3        Transcription antiterminati...   153     2e-36  1  35.8%   9:181  120:294     --------WYILKVQSNREKSICANLWRRVKMAGLEAYFDEVMVPTEDIVEFKNGKKKITKRKLYPGYIVVHMAINDDTWFLVRETGGIGDFTGAAG-RPTPMLAHEVERITKKVEdgEEPVKTNIRFKLGDHVRITEGTFENFEGDVEGIDETNGRVTVMINIFGRTTPVEMEHWQMEPV    
 72 UniRef50_C7GYQ7        Transcription antiterminati...   153     2e-36  1  36.2%   4:180   28:197     ---DNVARWYVVHTYSGHEQKVKDNILKIVESRGMGDLILKINIPTEEKVEIKNGQRKSRKVKQFIGYILIKMKVTNESWYVVRNTQGVTGFVG-QGKKPVPLTAEEVRRL------GIEKVIVNLKIKPGDTIKVINGPFEGHNGEVIEVDEEHETLRAKIFMFGRETPVDLEYEQIDK-    
 73 UniRef50_B8E0K4        Transcription antiterminati...   152     4e-36  1  35.6%   5:181    2:175     ----AEPKWFVVHTLAGHEHKVKAILERQVKLNHLEDKVFEIVVPEEKVMTVKGGKKRIQVKKVFPGYLFIRMIEDEDVIRMIRNTTGVTGFVGTPG-RPSTLNPQEEHWIRRFLEQKEIRPELKV--KKGDRVYIKSGPFMGYEGFVDEVYPEKGTVRVLLSIFGRETPTEIDHTQVEKT    
 74 UniRef50_Q83MQ7        Transcription antiterminati...   152     5e-36  1  40.5%   8:180   36:215     -------KWYVVHSPAGFERRAKANLETRVVSMNADQAIYQVEVPMEDVVGIRNGQRKMITRVRIPGYVLVRMDLNESSWAVVRNTPWITGFVGN-MHQPVPLSFEEVFDMLKTtrQKRSVTVSDVDLEVGETVVIKTGSFAGLPGTISEIKPENGRLTVLISLFERETPVELAFDQVEK-    
 75 UniRef50_C7RDB1        Transcription antiterminati...   152     5e-36  1  35.8%   4:179   36:205     ---KENARWYVVHTYTGYENRVNDKIQMMIDNEQNPD-ILEVTVPTEEYVEVKNDTKKVKTRKLFPGYVMVKMNITNKSWYIIRNTQGVTGFVGPDG-KPVALTPAEVRKF----GVKDEAPILNINVNVGDDVNIISGPFEGFVAKVEEVDKEKGSIKAFVDMFGRDTLIDLDFTDIE--    
 76 UniRef50_P36265        Transcription antiterminati...   152     6e-36  1  39.9%   3:180   17:203     --TPSEGHWFAVQVASGCEKRVKLNLEQRIHTLDVADRILQVEIPKTPIVkrKDGARVQGEEKIFPGYVLIRMIMDDDAWQVVKNTPHVINFVGSEQKrpMPLSHGEVERIFRHVDE--QEPVVKIDMEIGDHIMVLSGPFKDFEGDVIEVSPERSKLKALLSIFGRETPVELEFTQVEK-    
 77 UniRef50_C1A6N2        Transcription antiterminati...   151     1e-35  1  37.9%   6:179    3:179     -----EHRWYAIQTTSGHENKVQRLIQRKipAQPEDRLIRQALVPTQQVVEIKNGKKVTVERKIFPGYVLVEMVASQDTLHEINAIQGVIKFVG-KDKDPMPLRDDEVRRLLGQADPADETprEEIPFLVGQAVAITEGPFADFNGTVEEILPDKGKVRVSVSLFGRPTSVELDYLQLR--    
 78 UniRef50_Q2JTQ7        Transcription antiterminati...   151     1e-35  1  38.7%   8:180   40:221     -------RWYAVQVASGCENKVKSTLMQRAAALDVADQIVEVVIPKRTGFKlrSGKRQEQEEKIFPGYVLVRMDLNDDTWMVVKTTPNVINFVGTEERrpRPLSPSEVQRIFSSVE--VEEVPLKIDMAPGDRIEVLSGPFQGFYGEVVDVSPERGKLKALISIFGRDTPVELEFGQVRK-    
 79 UniRef50_B1VAN1        Transcription antiterminati...   148     7e-35  1  30.9%   2:179   24:201     -TEAPQFRWYIAQTYLGYENTVKQDLLRRVESLGIGELISNVLSPRETYYETrdGKKTSKERNLYPGYVFIEMIITDHSWFVVKNTPRITGFLGSSgsKPIPLSEKEINPVLFKMGIMS---KPNYDHLIGKKVEIISGSLANQQAKVSIIDNDREKIIVEVDLFGRTVPVEISFSDFK--    
 80 UniRef50_A6GCJ0        Transcription antiterminati...   148     1e-34  1  43.5%  12:179    1:171     -----------MNTFSGYENTVKKSLEDRIKKNELEECFEDILVPSEQVIEQRGKRQVKQTRKFFPGYIFVRMRLTKPAWHLVKNTPKVSGFL-SSGKTPKPVSQREMDRMLGKTEpeEEVVVPDIDYSVGDQVRVKSGAFANFSGEVEEVNTEKRKIKLSVSIFGRPTRVEVDFSEVE--    
 81 UniRef50_Q2S1Q0        Transcription antiterminati...   147     2e-34  1  39.1%   1:179    1:182     MAEDTETdwYVLRTFSNHEKKVRRYLESEIERIGLEDQVEEILIPTETVFEMKGGEKKTKEKTFFPGYILLNCTLTSDLRDLAEDLPSVIGFltGTGDEPTQLREEEIKRILGKMDRAEEmeQPEMPFKVGDPVKVVDGPFDSFNGIVEDVYPDQMKVKVMVSIFGRKTPVELDYLQVE--    
 82 UniRef50_A7BC06        Transcription antiterminati...   147     2e-34  1  40.7%   9:180   73:253     --------WYVIHTYSGHERKVKANLEQRITTQNMEDYIFAVEVPDEYVMEYRGNAKKRVRHVRIPGYAIVCMDFNEASYRVVKETPAVTGFVGDQ-HNPVPLSIDEVVMLLTPndQPAPVQAVQTQFEVGEIVTVTDGPFETMSATISEIMPEAQKLKVLVTIFERETPLELGFDQVEK-    
 83 UniRef50_Q9ZK20        Transcription antiterminati...   147     2e-34  1  40.7%   9:180    4:174     --------WYAIQTYSGSEQSVKKAIENLANDHDIRDRIQEIIVPTEDIIEvkKSKTKVMERSLYPGYVFIKVDLDTVLWHKIQSLPRVSRFIG-ENKKPTPLSEADIGHILEKM-NNRAAPKPKIFFEQGEVVRVVEGPFANFTATVEEYDVEHRKLKLNVSIFGRTTPIEILYSQVEK-    
 84 UniRef50_A5TS63        Transcription antiterminati...   145     8e-34  1  35.4%   1:181    1:193     MSVENVRKWFMIHTYSGYEKKVKTDLEQKMETLGFREVVTNILVPEEELTEIVRGKPKKIYRKLFPAYVMLEMEATRevWYEVRNTNGVTGFVG-VGSDPIPMEEEEVKNIFNIIGVKTPKETIKIDFAEGDYVKILKGSFKDQEGQVAEIDNEHGRVKVMVDIFGRMTPVEIEVDGVLKV    
 85 UniRef50_Q1Q133        Transcription antiterminati...   143     2e-33  1  40.5%   7:179    3:180     ------KEWFVLRVQSNREDKVRDNLVERIRAQGMESLITNVLVPSEKISEVKGGKKRVSDRKIYPGYIMVEIEVDeeVWFTIRETSGTGEFIGGQ-SKPVPMTKYEVEKLLSDLDQKEERPRAKIEFNEGEKVRIKEGPFENYDGIVEEVLPASGRVKVMLTVFGRATPVELEYWQVE--    
 86 UniRef50_C9RQP0        Transcription antiterminati...   142     4e-33  1  36.8%   8:181    4:177     -------QWYAVHTFTGQENNIKKRLEQMIEREGVQDKFGRIIVPTREVVSNVRGKRRISVQNLFPAYIIIEMELDELTQHLVSTINGVTHfmTRASRVPIPLRQSEVDRLLGVDPENSIEGEIQIPYTIGENVCIKEGPFKGFVGVVDEIMEAK--IKVMVSVFGRSTPVELAFNQVESA    
 87 UniRef50_C7NC81        Transcription antiterminati...   142     5e-33  1  33.7%   6:180   15:204     -----EKKWYIIHTYSGYEKKVAADLEKRIESLDLTDKVFRILVPEEEVLEEKRGKQVKVSRKLFPSYVMIEmrVDSDAWYVIRNTNGVTGFVG-VGSDPIPLSDEEASNLLAKIgeGETSPRIDIDFKVGEVVEVKGGSFDGQQGEIAEIDYEHGKVKVMLEVLGRLTPVEVEHTEIAK-    
 88 UniRef50_B9KHV6        Transcription antiterminati...   141     9e-33  1  34.4%   2:181    5:186     -HDDSGHEWYIVQVSSGSEEKVAQMILERSQQLGMSGVFSEVFIPYEEVTKVKYNKKVAMRRKLSPGYVFLYMRLSDDAINFVRRVPKVSNFLLDDAGLPKVIPASEMETMRSSMCrsSEAASEVCSFEVGDEVVINDGLFQDFNGRVEYVNEDKKVAGVSVMIFGRLTKIEFKLSSIQKV    
 89 UniRef50_O83264        Transcription antiterminati...   141     1e-32  1  39.7%   7:180    3:184     ------KEWYILHTFSGREARVERAVRMLVEHARIpnVIFDIKIPEELLTEVKDGKKRVVRRKFFPGYLLVEMDLPEVDWreVRRIPGVSGFLGSSGnkPQAVSADEARRILQKAGegDRTPRIAQTFLVGQQVRIVEGPFATFSGEVEEVMSERNKVRVAVTIFGRATPVELELVQVEA-    
 90 UniRef50_C7PUF8        Transcription antiterminati...   141     1e-32  1  35.2%   5:180   17:194     ----QDTKWYVLRVVSGKEKKVKEYLDIEVRRSDWGNVITQIFLPVEKVYKVQAGKKVMREKNFYPGYVMIEakMTDEVIQSIRNVSGVIHFLGKD--KPIALRKAEVNKMLGKVDesDNGLTMSEPFIVGETIKIIDGPFNDFNGIIEEVIEDKKKLKVTVKIFGRATPVELNFMQVEK-    
 91 UniRef50_Q7UMY8        Transcription antiterminati...   140     2e-32  1  34.6%   1:179   42:223     VDDESPMDWYILKVAFNREDSIAEALRKKVRMEDMGEYFGDIVVPSEDvtFTRDGKRRVSKRKLLPGYIMVYMSINDDTWFLVREVGGISDFTGSAG-KPQPMEPEDVERFINRpdEDETPIKTAIPFKVGDRVRVKEGNFENQEGEVDVVDEANGRVTVIINIFGRSVPMELDHWQVE--    
 92 UniRef50_B3ETZ5        Transcription antiterminati...   140     3e-32  1  33.9%   4:180    2:184     ---KTDPKWYVLKVVSGQEKFVKYHLDSELERRKLQDYVAQILIPSEKIYEMRAGKRQTRERNFFPGYLILHADLSdrVLHTIKDIPNALGFLGVRgsQPIPLREKEINKILGRVDEIAEDDNgeKPFIVGETVKIVDGPFSGFTGNIQEVFEERKKLNVIVKIFERNTPIELTYTQVEK-    
 93 UniRef50_B0A697        Transcription antiterminati...   139     3e-32  1  37.4%   1:179    1:177     MSEIQEAKWYVVHTYSGHENKVKATIENSVKNRGMEDYIKQVIVPTEDVIetKTGKEKVRQRKIYPSYVLIQMIITDESWYIVRNTKGVTGFVG-PGSKPVPLSEEEVKSMGIDLDKIGEK---RTEIEVGEVVNVRDGVFKGQSGVVKELDLKNEKVKISvnGTSGELSLELDLKSIE--    
 94 UniRef50_C0W699        Transcription antiterminati...   139     5e-32  1  35.0%   1:180   57:262     MSSLP-GEWYVLHTYSGYERRVAADIMARAENFELEDYVFDAVVPMETVIEVkaGKKKEVSRVRIPGYVFVRMDlsDRVWRTIKDTPAVTGFVGDRYN-PVPLTFDEAVSQLGPTPEEVAAKqyEVAFEVGESVIVTDGPFESLPATISEIHPETQKLQVLISLFGRDTPAELSFTQVAK-    
 95 UniRef50_C4V5M2        Transcription antiterminati...   138     9e-32  1  32.9%   9:178   18:182     --------WYVIHTYSGYENKVKANLERLMHSASMSEMIFDVVVPVENEIEVKDGKEKVVPRKVFPGYVLVDMIVDEHSWYVVRNTTGVTGFVGSE-KHPIPLTAEEAERILS--GSVGAEPKRRTKVNVGDTVRITSGAFEDYAGKITSIDMSSMGVKVDVD--GKSLDVEIDQVEL---    
 96 UniRef50_Q5GRY4        Transcription antiterminati...   137     2e-31  1  33.7%   3:180   95:275     --EFNKYKWYILRVASNYEEKVCQHVLENSMRLGVNDYFKEVFIPYEELSEVerSKKAAMRRKCFPGYVFLYVDLCDEVLNFVNNIPkvYGFLKN-GSVPKVISDDEIYSMCNALYNAQETKKLSHGYEKGEKVKINDGLFQNFTGKVDMINDEKKIINIEVSILGKPTIIELDLAQVEK-    
 97 UniRef50_B0VGC6        Transcription antiterminati...   135     7e-31  1  32.0%   8:179    2:173     -------KWYVIHTYSGHENKVKTAIEKGLAGTPLEKQVGRLLVPVRKTFVIREGKKIERDKKLFTSYVIMEADMTPELKTYILQIAGVTSFLgkEHKEPIPLSQEEVDRLLGITDPNRDIKVYS--YMPGDMVKVISGPFTDFEGIVQKTTENGTKLIIEVTVFGRRTPVELNASQVE--    
 98 UniRef50_A4WZX9        Transcription antiterminati...   135     9e-31  1  21.9%   4:181    8:173     ---PDTAPWYLVQTKPNAFRIAERNLLR---------QDFSVFSPTQNQTKKHGTRFRHTVQQLFPGYLFVRFNPEFPQWRAINATYGVSRLVTF-GNIPSPVPHALIAGLRQRCANDGTLLPPE-QLSLGDRVRIISGPFADYVATVEQIEPDK-RVWILLDILGGQTKTQIQIAALQKA    
 99 UniRef50_O51355        Transcription antiterminati...   134     1e-30  1  37.8%   9:180    5:183     --------WYVVQTYSQYEKKIEQDIRLLINEGVFGGVVLDVKAPIEKVEEIRNGKKRIRERKIWPGYILIELDLPEVGwaNIIKVQGVINFVgsKGQRPIPINDEEVKsmLTGEIKANKSIFMLYDFEEGERVRIKGGPFDSFEGLISSIDYERKKLKVAVQIFGRSTPVEVDFQHIEK-    
100 UniRef50_A6FV14        Transcription antiterminati...   132     6e-30  1  26.4%   1:178    1:166     MTLEAQIRWYLVQFKPNSHKIAARNLQR---------QSFQTFLPMQDVTRRRAGKFHTAPQPLFPGYMFVSLDTIRGPWRQINATLGVSKLVSVAG-RPQPVPDTLVNALLERCDDDGKLLPPET-FSPGEQVTLRSGPFASFVATVEKMQPDR-RVWVLLEFMGQATRIQVDADIL---    
101 UniRef50_A9ND88        Transcriptional activator R...   132     6e-30  1  21.3%   1:178    1:164     MSTDSD--WYLIYTKPRQERIAEENLER---------QGYRIYLPFIQVNRRRLGCYQLITEPLFPRYLFILLNIDKDNWGPIRSTRGVSALVRF-GGIPAKVPPDFVQ-FLKNNETSASVPPKVSLFQKGQRVQIIDGVMAGYEGVFEMYSGAK-RVTLLLDMVGKVTRVEVPLDSV---    
102 UniRef50_C8WIE4        Transcription antiterminati...   132     7e-30  1  26.6%   9:181    2:169     --------WYVAQVQAGRESSTLEMCRRLVPPSVMED----CFMPEYEVMWKIRGEWRLVKRLLFPGYLFFVTDDPEALNRELSRVPMPIRLLGNEENSFFPLTGKERDWFLSFM-DGNHTVRMSEGYISGDKITVTRGPLMGFEGDIRKIDRHKRRAYIDVSLFGRTVPASVGLEIVRKS    
103 UniRef50_Q4A951        Transcription antiterminati...   131     1e-29  1  27.0%   8:181    5:188     -------KWYMISTISSKEDTAISLLKNRIKYENLEEHFQEItvPYYEENPNKPGEKKLKYRNLYKGYFFIKMNMVDKAWFVVRNTQYVTGLVggRGTKPTPISPRQFERMRkqILNFQQTNDGTINWEIGDWVKVTHGPFSDDFGKIIEMNVTKTLITVELevFGRRTPATFEYKNLKKV    
104 UniRef50_C7RAP1        Transcriptional acivator Rf...   130     2e-29  1  27.1%   1:181    1:167     MSEC-EKSWYLINSKPKQELRALEHLK---------NQEINCVLPVLEVERIIRGKRQKAIEPLFPGYLFVELQTNGQGWSKIRSTRGVRDFVRF-GGVPGRVPDSVLEHLL--ILDTSFTPIETNAPGAGDKVIITDGPFKDLEGVF-KISNGEKRSIVLLTILGKVTEMELENKQLRKA    
105 UniRef50_A3WUF1        Transcriptional antitermina...   130     3e-29  1  26.5%   1:181    1:170     MTASGQ-QWYVVQTHPHAEGKAAAHLRR---------QGFEVYLPRYARRRRHARRVDITASPLFPRYLFVAIDLVHQRWRAIRSTVGVTNLV-YSGDEPAPVPDDVVRRLKQREdkGCVQLDLAPRFSAGDTVRVVDGAFSDCLGLFESMS-DGERVLVLLDLLGRKVRVTMDIDTIEAA    
106 UniRef50_Q2LVW1        Transcription antiterminati...   129     3e-29  1  27.9%   9:180    3:166     --------WYAVHTRSRHEDKVFTGLVQKS---------ITTFLPKIEVWSKRKDRRKRIMTPLFPGYLFVDMplDNQAKLDVLKTFGVVRILGktGSAPIPVPDDKIDAIRRIV-DSRVEVQNLQYPHVGEAARIVDGPFKGIEGTVIKTDYDKDLFVVTIELLQRSVAIKLDSSQIEK-    
107 UniRef50_A0LIY4        NusG antitermination factor...   129     4e-29  1  23.2%   5:181   37:202     ----DTKSWFALYVQVKHEKEVVRRLDQKS---------IDCFLPLMECWSKRLDRRKRITLPLFPGYVFVHTVLDNYTNVNILKTPGALSILKNSEG-PLPIPVYQIENLQTIL-NSSKSLDLHPYLKEGEWVRVIRGPLSGCVGILKRHAPKKGRLVVSVDCIRQSVSVELDVEDVEAT    
108 UniRef50_C4XFX3        Putative uncharacterized pr...   129     4e-29  1  27.4%   1:179    1:200     MEddKNFQWYMISTVSGKEDKVVEALKNRIISEQVEDCffKIftPKELEKQKNGEEYKVKYVNMYSGYIFINMDMTDRAWFIVRNTQYVTGLIGSSGrkPTPVSQHQIDKSFKklQEDFDKGVTHTKFQIGEIVEIIDGPFKGEQGRVLECSEANKKVTVEIEYLGKKTPADFEYKEIK--    
109 UniRef50_A1WZB7        Transcription antiterminati...   127     2e-28  1  23.7%   9:181   15:175     --------WYLVYSKPRQEERA---------WWNLDHQGFRCFLPMARFRRRRQRRYQTVIEPMFPRYLFIRLAAGLEDWSPIRSTTGVSGLVRF-GTWPARVPDGLVDTIRARIEDGHCDLAPE-PLQPGERVRVLDGPFQSYEGIF-RASRSDERVMILLDVAGQHTTLTVSQHQIERA    
110 UniRef50_A6F1J5        Transcriptional activator R...   127     2e-28  1  22.7%   9:180    3:159     --------WYALQHKPSQGDRALTHL---------QNQDIACFYPKITVEKIKAGKRTKQLEPLFPGYLFVNLEQTDPMWAKLRSTRGILRIVSFA-NKPAAIPDDVIQHIK----DSLHTVAEQGGIKPGQAVELDEGPFKGIEAIFQAYDGE-ERAIVLISFMQKQQTVKVPLSTLHR-    
111 UniRef50_B1I6V9        Transcription antiterminati...   127     2e-28  1  27.2%   8:180    4:167     -------QWCAVNTKPKKEDFAARQLEAK---------GLEVFLPRISVTRKRGASKFSLWEPLFPGYLFVKLLPEPVQVQRVNWTPGVRRLLC-AGDTPVPVPDEAIALIRQRVGPGGrtPKPQAEFPAGSRVAVRHGPFAGLLGVVEKPMSGRGRVRVLLELLQRQTAVEIDAVDLDR-    
112 UniRef50_A5CC98        Transcription antiterminati...   127     2e-28  1  35.8%   8:180   10:180     -------QWYIIRT-SGSESSIKQTILEKAAKKGIAHCFEEIIIPGIQVVKMKRGKAINVNKKTMPGYILIKMDMIDQVKDFMQKVVKLNRFPGNE-SKIVQVTEKEVQEMMVQLENKAQDPSFLEKYQIGEEVRVNDGPFETFVGRIEEVDYAKKILKLSISIFQRSTELTVDFSQVEK-    
113 UniRef50_Q2ST07        Transcription antiterminati...   127     3e-28  1  29.0%   4:179   15:209     ---EAKGQWFVISCQTGHEEKVLGDLQQKIKSASIEDEVFSIKISKANQVSKSG---KASIKNKFPGYIFINMIMSEKAWFLIRNTPGVTGFIGSSGrkPSPLTIEETLNMLVPNIEEIQQAhfTADFKIGDIVKVKSGIHENEEGTVKDMDYSKGVAFVAIEMFGRWTTLEVSFKNVE--    
114 UniRef50_C8VZE8        Transcription antiterminati...   126     3e-28  1  29.3%   8:181    2:164     -------HWYVIHCLTGHEEDVRSRVKEK--------DIARAVVPRRLMVERRQGGWQYVERVVFPGYVFVQAHMTPAAYYAMRNLPGVIRVLG--TSRPVPLMGNEVTLFLKLCRDGDPLGLSEV-FVKGGSVKVISGPLMGLEGHIVKLDARRFRAKVNISLMGEPRIVELAVSVIKKT    
115 UniRef50_C6PET8        Transcription antiterminati...   125     5e-28  1  26.0%   4:180    2:174     ---EDGEKWYVIYTRTGDELKVKRLIELLFSKLN--KKPIRVLIPKRAIIERKGKKRVEKIKFLFPGYVFIKTNMCFEIYYEISKLPHFLKFLKDEM-EPAEVRDDEIRIILSLVGDSD-IVGFSTGIKIGGKVKIIDGPLKGFEGLIEKIDKRKGRVKVRLNVSGNANLVDLGIHIVEK-    
116 UniRef50_Q1QVL5        Transcription antiterminati...   125     5e-28  1  22.2%   2:181   12:181     -DTAARPRWYVVQCKGGESFRAGEHL---------TNQGYRVFHPVLEVQKKRRNKLVWIAEPLFPHYLFIHLDRVASNWRPIRSTRGVLKLVGF-GDEPLPVPDALIETLAArhLDEASRTSGNAYFRPGEIVEITEGPFQALQAVF-DTQQGDERAIVLLNMLHHQQRLELPVGHLRRS    
117 UniRef50_O84322        Transcription antiterminati...   125     7e-28  1  39.1%   8:181    3:175     -------KWYVVQVFTAQEKKVKKSLEDFKEASGMSDFIQQIILPSENVMEVKKGEHKIVEKYIWPGYLLVKMHLTDESWSYVKKTQGVVEFLG--GGAPVALSEEEVKNILADLEEKKSGVVQKHKFEVGSQVKINDGVFVNFVGVVSEVFHDKGRLSVMVSIFGRETRvdLEFWQVEEV    
118 UniRef50_Q8R8A2        Transcription antiterminati...   125     8e-28  1  27.5%   3:180   10:177     --TKEKPLWYVVFTYHNAEKRVEEHINSLAKTEKYDGLIIKAEVPVQKRTVSRRGKIKEIEEKIFPGYVFVKAVMTPEVMAAIRRINGVAHFVGG-GNEPVPITPEEVKR-------ARIQDDLSEEFKAGDTVMITDGPFENFIGKIIKI--EGRKINIALSLFDREMGIDFSPEQIMK-    
119 UniRef50_Q82X31        Putative transcriptional ac...   125     9e-28  1  21.8%   8:181    2:164     -------HWYLVHTKPKQEKCAFQNLQQ---------QGYRCYLPMLPVEKLHLGNLTVVDEPLFPRYLFIQLedSAKSWVPIRSTRGVNRLVCF-GSEPARIDDILIDLLR--MQEASFQHKPERLFKPGERVRLTEGAFAGIEG-IYQMAEGERRVMVLIELLSKPVAMRVSPTSLRKT    
120 UniRef50_C8WL22        NusG antitermination factor...   124     1e-27  1  23.8%   9:180    4:170     --------WYVVQTVGGQEKHVLDLINKLVD----EELIQESFIPQYEVKKRIQGVWKMRSEVLLPGYIFVITDQPGKLREALRSVPKFTRLLGNND-VFTPLDDQEVAFINAFTKPDHRVVEFSSGVMEGDEIVILNGPLMNQTGLIKKLDRHKRLAYLEIEILGRVKTVKVGLEIVRK-    
121 UniRef50_B5Y935        Transcription antiterminati...   124     2e-27  1  32.8%   7:180    2:180     ------KKWYIVTTVHGKESAVAEAIKLRAENAG-NTAISDVLVPKEWRLEYRGKKPrrVQRVIYPGYVFVEVeiDPETWSLIRYTPGVRGFISTPDHTPIPVQDNEMEKVL---QKSREQEAVKVDLQTGDEVEVRDGALKGLTGVVVDVDHEKQKVFVKISMFGREVISDLDAVQVRK-    
122 UniRef50_C3RLT4        NusG antitermination factor...   123     2e-27  1  19.0%   8:181    4:172     -------NWYVIQVRTGKEEKIKNTCEKLISRDILE----ECFIPKCIRLKKYQGTWKEVDEVLFKGYVFMISDHIDELFNKLKLIPDLTKVLGNDGEFICPI-LKEEAIFLLKFGKEKHIVDLSQGYIEGDKINIISGPLVGYEGMIKKIDRHKRVAYIEVKLFDQITMVQVGLEIIGKS    
123 UniRef50_D1AXH4        NusG antitermination factor...   123     2e-27  1  28.7%   7:180   10:189     ------KKWYIIHTYSGYEKKVKTDLEKRIMSEDLNDKVFRILVPEEKIFEEKKGKMVPVFRKIFPSYVLVEmrVDSRAWYIIRNTNGVTGFVG-VGSDPLPMDEKEVEEIFSKMSNEDFQEK--LEYEVGDYVK----TLDGIEGTVEHIDYIAKQIKIVIQVGSRPTTLTLGLNEVTK-    
124 UniRef50_B3PLY8        Transcription antiterminati...   123     2e-27  1  25.7%   1:179    3:194     MNNQDKakWYMISTVSGKEDNVVESLKNKISTQDMDECFKEIKIFkeLEKKSKGEEYKVKYLNIYKGYIFINMIMTDEAWYLVRNTQYVTGLIGSSGkkPTPISTRNFEKMVQklAEKFAAGDIETVFKEGVIVKITSGIFKGEMGEIVKNNDITQKAFVNIEQYGRKVPTEIDHADLE--    
125 UniRef50_Q3J8A9        Transcriptional activator R...   123     2e-27  1  17.8%   1:180    1:171     MESSPSSkwYLIYCKPRQERLAQENLER---------QNFETYLPLVRQMRRRAYRRIATVEPLFPRYLFIHLDTEKDNWGSIRSTIGVISLVRF-GAQPAHVPDTLIRELQTHEGSDGIQDLASPDFRKGQQVLVEEGLLAGHEGIWL-TSNGKKRAHILLEIMGKQIKTEVNENWLKR-    
126 UniRef50_Q3KCF2        Transcriptional activator R...   123     3e-27  1  21.3%   3:180    5:169     --SSDQPNWYLLQCKPRQDERAHLNLLQ---------QNYVVFHPQLVSERVIRGKRQRVQESLFPGYLFIQLSR-DDNWAPLRSTRGVSRFVEFNHG-PATVAEHVIEHLRARCLESTLSEPDEA-LKPGENLQIVSGPLAPLEGVFLGL-HGTDRVMILLQFLNREQPVCLPLSVIER-    
127 UniRef50_Q48H23        Transcriptional activator R...   123     3e-27  1  22.9%   3:181    4:166     --SAQEARWYLIQTKPRQEARAEEHLRR---------QHFQCYRPLQVDVKKTA-ARVQADEPLFPGYLFIQMDQVQDNWYPIRSTRGVSRIVTF-GGHPVPVRDHLIEQIRQRLS----TPAPKARFIQGDPVMITTGSWSDVEAIFLSED-GTERAVILLNMLQRQQKMGLPISSLSRV    
128 UniRef50_C1DDG1        RfaH n=1 Tax=Laribacter hon...   123     3e-27  1  24.6%   3:181    5:171     --SEEKMHWYLVHTKPRQEQCALQNLQQ---------QGYQCYLPMLATEKLRQGRLVVSEEALFPRYLFIRLGlsDKSWAPIRSTRGVNQLVRF-GTEPARIDDGLIERLRGH---DAARANPEPLFRTGERVRLTDGPFAGIEGIYQMTDGE-SRVMVLIEFLTRPVVARVAPGSLRKV    
129 UniRef50_Q0ACI7        Transcription antiterminati...   122     4e-27  1  19.3%   1:181    6:177     VTEQQEHrwYLIYTKPRQEEAARDNLGR---------QGFHAWLPRVRVVKRRGTRRVPVVEPMFPRYLFVELDSAYQDWSPISSTLGVTSLVRF-GGVPAKVPGPLVAALQARADEDDidLSARQQPRAGDTVRVAHGAFAGYEAVFQA-RSGRERVLVLLEVAGKQSRVTLPADDIDPV    
130 UniRef50_C2NS75        Transcription antiterminati...   121     9e-27  1  24.1%   9:178    6:173     --------WYALCVRSGYEDLVESLILR-----DLNETLVSVLVPKKTVPEKRKGHFKWVTRKLLPGYILINTSMDAKMYYKLKEIPNCYNFldDDDIYFLEIPDQEITPIIQLLNDRGTIECSEAYFE-GSKVIVKSGPLKGREGIIRRIDKRKKRAKLLLNFLGDTKMIDVGVEFL---    
131 UniRef50_C4FB35        Putative uncharacterized pr...   121     1e-26  1  22.2%  19:180   13:169     ------------------EDRAAALIAKIA-----QGAVDDCFVPKREVTHRKSGQWHRILEKLFPGYVFVRTSAPKQIREALGRVPAFTRMLTSAGDTCLPLTADEVAWINAITNVDTHVMEMSEGVIEGDCVMVIRGPLKGHEARITRIDRHKRLAWVDMDMFGRHKAIRVGLEIVSK-    
132 UniRef50_C8WIA3        NusG antitermination factor...   121     1e-26  1  23.3%   9:180    2:168     --------WYVVQTVAGREFAVCRLIESLVEDDVLQ----ECFVPRYEVQKQFRGQWRTCTATLFPGYLIVVTDRVDELESQLRRVPAFA-WVLSNDGGFVPLERDEVAWIDAFTEKGHRTVGVSEGVIEGDRIIVLKGPLVGREGWIRKINRRKRTAYLEIDMFGRTIQTKIGLGIVRK-    
133 UniRef50_Q1Q029        Similar to transcription an...   121     1e-26  1  23.2%   3:179    2:166     --EKNVAYWFAVHTRSRHEKQVDSFLREKN---------ISSFLPLVKTISRRRDRKKFIDVPLFPGYLFVNITLDN--LYEIKSTRGVVRIIGNEDdiPSPIPDAEINNL-KTLINSNVAIDPYKYLQKGTKVRVVSGPLIGLEGLLVK-RKTNYRVVVSIDILQKSTSAEISIADIE--    
134 UniRef50_Q4K6G2        Transcriptional activator R...   121     1e-26  1  20.3%   9:180   84:238     --------WYLVQCKPRQDLRAEENLRR---------QGFHCYRPQRGCERVVQGRRQSGTESLFPGYLFIALEH-DASWAPLRSTRGVNRLVAFNG-QPLAVPVSLIESLRQRVTDMDTSLPY-----KGTRVCITEGCFADLEAIFESSIGD-ERVVLLLTLLNQQRRIELPLSSIRK-    
135 UniRef50_UPI0001692BF2 putative transcription anti...   120     1e-26  1  20.0%   9:178    3:173     --------WYVLFVTTGKEDVVGKYISNFCNHLSLQ-----CFIPKKVVPECHKGVRRDVIRVLFPGYIFIRTTMSSNLYYLLKEIPNLHYLVNSGDRkySAIPEEEMEWIRDLTGNRDTIEYSEVSI-INKKVKVISGPLKGKEAMIKKVDKRKRRAKIEVTLLNKTNLVDVGINIL---    
136 UniRef50_Q0F316        Transcriptional activator R...   120     2e-26  1  22.2%   5:171    2:160     ----SDKQWFAIRVKPRQESLAAANLER---------QGFEVYLPMINTRISHAGKVSWQPRPFFAGYLFVHLSIDEQRWTTIRSTVGVLAPVAFGTFYP-PLSDQVIALLQARHDENgvSSTPESPFRAGEKVRMLDGAMKGLEGVFIEM-RGQDRALILLDWMKKSMRV----------    
137 UniRef50_C8PLY0        Transcription antiterminati...   120     3e-26  1  23.3%  10:181    4:171     ---------YAVQVKTGKEPE----LLKKIRKLNEENHEIQAYFPRRVLYIKKKGIRQKVDAPVFPGYIFLEIDDLSLPLCWqrKTPNFYHFL-PNNQNPLPLVDNDLSLLHHFLSFGEVTAPSKVYFDANSRICVIDGALKGLEGKIIKVDRRKQRAKVLLDMYTDSFPIDLAFDVIEPA    
138 UniRef50_A0KGQ9        Transcriptional activator R...   119     4e-26  1  21.3%   7:180   19:181     ------KKWYLAYCKPKEEARARAHLEA---------QGIESYYPMVEIEKLRRGKRVPVREPMFPNYLFIYVDLEEVTPVTLKSTRGISRIIHF-GREWTSISSQLVYQLMSRDDSDEARASYASLPTQGDKVLIESGPLAGFEAIYLEPDGDK-RAILLVSLLNQETSSSFDNQSFRR-    
139 UniRef50_C5EKF0        Predicted protein n=1 Tax=C...   119     5e-26  1  24.3%   8:180    3:169     -------RWYAVQVRTGREEAVLQLSKKMIDGSVLK----ECFIPYYERMKRYQGEWHKEQYILFPGYIFLVTEQVDELFWELKKVPGLTKILG-DGMEFVPIKEEE-KVILQKMGGSDHIAEMSKGYVIGDIVTVISGPMKEMKGKIKFIDRHKRLAVIEIEMFGRKTEVRLGLEIVMK-    
140 UniRef50_D2C1D2        NusG antitermination factor...   118     7e-26  1  17.9%   9:181    4:162     --------WYLLYCKRGQLLRAKEHLER---------QDVVCLSPMIALEKIVRGKRTEVSEPLFPNYLFVEFDPEHIHTTTISSTRGVSHFVRF-GNLPALVPQQVIEDLQHHQCTTHVDPETP---QPGDQVTITEGVFSGLEAIYTEPDGEA-RSMLLLNLLNKQVRQSIDNRQFRKV    
141 UniRef50_Q982S4        Transcription antiterminati...   118     7e-26  1  28.1%   3:180    8:180     --DGPEARWYVLRV----EDRADIAVDKLLGEANVERVMLHTECEAKRRGRRKHQSLEPVRVPSFPGYIFVKVVSCAATWAGLRTVSGVLGPIGGCDG-PSPVSEQEILKFQARIENDPEAIAVLTnlKAGDKVSIDSGPFAGFEAVVL-MLGDKHKVHVEVDIFGRKTPIGFALAEVTK-    
142 UniRef50_Q0FE68        Transcription antiterminati...   117     1e-25  1  19.1%   7:179    3:163     ------KEWFILQFKPNSHHQATKNLTR---------QGFETFLPLTDITSRKTSRFINTTRPLFPGYMFITFDRTKPEWHKINNTYGVSRLVTFNSN-LKSIPTTLVENLMVRCDLSSKILPVE-NLKKGDQVKILHGPFANFIATVETYETDQ-RIWVLMDLMSRKTKIQTPLDALE--    
143 UniRef50_B8FH43        NusG antitermination factor...   117     1e-25  1  20.6%   5:179    8:169     ----NTKQWYALYTKSRHEACVNNYLAARS---------IESFYPQMRILSRRKDRRKMIDVPMFPGYLFVRAALRSRQHLSILKAPGAVTLIGNTRGAIA-IPEDTISSLRIVSQK--EALETGPCYHAGDLVLIVSGPFAGVTGVFMR-NKGGGKILVNIDALGQSVAVEMGGADVQ--    
144 UniRef50_C0ZGR2        Transcription antiterminati...   116     3e-25  1  24.9%   8:180    2:175     -------KWYAIFVESGKEEVVQKYLR-----LYFNEQSLKSIVPKRLVPEKKSGIVYNVLKNFFPGYVLIQTEMTNEMFHKIKKIPRSLRLVNneGAYYSSIEEKEITPILQLMGNGEVVDYSKVYLE-NSKVIVESGPLKGLEGIIKKVDKHKNRAKIFLTFMGVEKTIDVGIEILSK-    
145 UniRef50_Q7MMR1        Transcription antiterminato...   116     3e-25  1  23.1%   7:179    2:165     ------KKWYLLYCKRGEQIRAKQHLE---------NQGVECFYPTIEVEKILRGKRQIKSEPLFPSYIFVRFDFegPTFTTVRSTRGVVDFVKF-GAHPKELQGDLIYELKLLEQEGHQSALQGSNlkPGDSIKVKSGQFAGIEAIFQEQDGET-RSIMLVKMISQTVPVSIENSDLE--    
146 UniRef50_A1T084        NusG antitermination factor...   116     3e-25  1  17.8%   8:181    4:167     -------QWFVVYCKSREELRAQRNLE---------NQGVYSFFPKICKEKILRSKKKVVEEPLFPSYLFVNISKNDEKFSAIRSTRGINNFVKF-GLSIATIPDQQIKKIEQLCHVNNKLAVNSEdyQNGDKIEILSGPFKGLTAIF-NIEDGLERSMLLLKILNQDNNISFKNSALKKV    
147 UniRef50_C6LL07        Putative transcription anti...   116     4e-25  1  21.9%   3:180   11:182     --KEETEVWYVMQVQTGMEERICAQCRRKISETVLE----QCFIPRYEVKKHIQGEWKTQKQILFPGYVFVVTSDIQNLHEELKKVIGLTKLIG-TGREIVPISENEKEFLLGFGGE-EQVVQMSEGIITGSQVVIHSGPLKGKEGYIRKIDRHKRKAWLELPLLGGMQNVQVGLEIVCK-    
148 UniRef50_A5IXI2        Transcription antiterminati...   115     5e-25  1  29.8%   9:179    6:195     --------WYMISTVSGKEDKVVESLKNRIVSEQVEECFNqvLTTKEAEKKALGEPYKVKMSNMYGGYIFINMDMTDKAWFVVRNTQYVTGLIGSAGkkPTPVTKKEIDLAfkQLIEDFNAGKIIDKFTVGEIVEIIDGPFKGTIGKVLEANESIHKVTVEVEHFGKKVPTDFDYSVVE--    
149 UniRef50_UPI00016C58F1 transcription antiterminati...   115     5e-25  1  32.6%   4:181   21:223     ---ENKKKWYAIKVQSGREDTIKAAILRKIAIEGLEDVFGQIMVPVEKVIEKKaeRKVERKVKKFQGYIFAELEFNDRLLYLIRETSGVGDFLknDTPVPEPMSDAEVKQMleKVGPEKGPTKVKVDFEKGDRVRIKEGSFKDSEGDVKDVILPKdkVIVTVTFWGRPLDVELEYWQVTKA    
150 UniRef50_Q5QWY1        Transcription antiterminato...   115     5e-25  1  21.2%   1:179    1:163     MNELESDVWYIVRTKPKQEERAILNLE---------NQGFGVFAPELTVKKVRRGVRTSVVERMFPGYVFVKPDDIIEQFYKLRSTYGVAGVLRFGDNIPK-VPQRWIDQMR-----GVDQLTDEQAPQIGDTVEIQQGPFRGFLAKIVKLDGE-SRCFVMLEWMQKEVKANFSYKELQ--    
151 UniRef50_B4D2H1        Transcription antiterminati...   115     5e-25  1  23.5%   2:180   13:180     -AEIPEAKWYCLRAQPKHEHIAAARLRQCEE--------IQVFCPRVRIQRSTRRGLVWFTEALFPNYLFARFEWV-QSHALVRSCQGVSGIVRFGDHVP-EVPAGTLDDLRAYMEDA-ELKTVSFNIDEGDDVEIVEGPFRGQNGVVKQLLPARERVKVLLEVLGGATEVDLCLTSVFK-    
152 UniRef50_Q2WBC3        Transcription antiterminati...   115     8e-25  1  19.2%   9:180    4:165     --------WFVVHTHANAEKIAAGHLQR---------QHFDVYLPQYSKRRSHARKVEWVKAPLFPRYLFLRMDPDLTPWFSIRSTVGVHSLVCR-GGMPVPLGQVIIDEIRGREDDSgvSLGEAMPFASGQRLEIVEGPLAEQLGLFQGLD-DMNRVVLLLDLLGRQVRVRVPLEAVRA-    
153 UniRef50_B6GCE7        Putative uncharacterized pr...   115     8e-25  1  21.9%   4:181   32:204     ---SQEVPWYVVNVPTGRESALCKVIERIAP----EGVVRECFSPLYSTQIKRGGEWLDVEKTLLPGYVIVATEQIGRVKRLLREVPEYTRVL-NMGESFVPLADGERAWIDAFTRKGERCVPMSMGVMEGDHVVVVSGPLLGREACIKSVNRHRSIAYVELEICGRRVTTKVGLGIVSRA    
154 UniRef50_A6GM36        NusG antitermination factor...   115     9e-25  1  21.1%   7:181   14:179     ------AQWYVMYTKPRQETVALENLQR---------QNYNVFFPQARVQKRKTGqtVQVVEPLFPRYMFIQLEVGVSDFSKLRSTKGCVDLVKF-GGKPSVVPIELIELIQHQLDSDSvdLLKLNELEVGGEVRVAEGPFEGMMGKIAARKSDQ-RVIVLLNVLGAERSVELAQSQLDKA    
155 UniRef50_Q1YPV4        Transcriptional activator R...   115     1e-24  1  23.1%   9:181    4:167     --------WFLLQTKSKQEGRAVENLER---------QGVKSFCPMIKVEKLSRGSRVVKEEALFPGYLFVNFDQSSVSSTTVRSTRGVSHFVTSAGL-PVKVPESLINQLMLRTDAGNDETVSSLP-SKGERLQIIDGPFRGLNAVFSQPDGDR-RAIVLINLLNQQVSASLPFASleRV    
156 UniRef50_A4EGG1        Transcriptional antitermina...   114     1e-24  1  21.1%   1:180    1:170     MNDRNEKlwFVLQLKPNGLSLARTHLAR---------QGFLTLMPLREVSQHARYGLRTVRQPLFPGYLFFSVTARQINWPAAANTRGVTRIVVGTDGQPARLPADIAAGLLAITTEDG-MLGDVADLQTGDQVGVVNGPFAGWMAKVVSADTP-DRIQLLVDVMGRETAVNIAGRDLEK-    
157 UniRef50_C7PUS0        NusG antitermination factor...   113     2e-24  1  19.4%   6:180   12:172     -----DTKWYVAYTRANFERKVAKDIV---------DQQIEHYLPLRRETRKWSDRLKQIEVPLFPNYIFVKIKLQHKV--NILGIPGVLSLVSFSG-QPVSVSEREIQHIRK-IEERGQDIALEYYYCVGDRVRITQGIFTGMEGILLR-KSGQMRFVLKLPAISQAVSVEIEGDQLER-    
158 UniRef50_Q2CAE9        Transcriptional antitermina...   113     3e-24  1  19.1%  29:180   10:161     ----------------------------RLATQNLARQGLAVFCPLQQASRRIRGQIRSVTKPVFPGYLFVSLAPAGGEMRAASYTRGVARLVTLDESGPKAVPDALIEELqrCTPEGILGPPEADQLDVGDRVWVTDGPLAGQVSRIIALAPEA-RIWLLLDLMGRQTRVAVKREAVRR-    
159 UniRef50_B9XAW5        NusG antitermination factor...   112     5e-24  1  15.3%   2:178   27:192     -ATDGEPAWYCVRSKPKHEHIAAANLSKL--------QVVETFNPSLRSRKATRRGPVWMTESLFPNYIFARFPF-EQMFDEVKYTRGVSSLVHFGTGYP-EVPADVIEELRRNFPANELKLSSEVP-TAGDQVTITSRALFGLQGVVLRTMPAQRRVQVLLDMLGQTSAVELNLNSV---    
160 UniRef50_B4S8Z4        NusG antitermination factor...   112     6e-24  1  23.6%   1:178    1:166     MDETGNLCWYAVYVRSRFEKKVHLLLQEK---------GIVSFLPLVDTWRQWSDRKKKVSMPLFRGYVFVRIHYRQD-HPFVLDTDGVVKFIG-IGRAASVIRDRDIEWIKILTGEPDVRKEVLPLLPPGKQVKVIAGPFVGLEGVVRK-DGRESKLVVYFESIMQGIEVTINAEYL---    
161 UniRef50_A6DRM3        Putative transcriptional ac...   111     1e-23  1  18.2%   6:181    3:167     -----EGDWYCLYTKPRQENLTAQS---------ALDAGFPTFNPKIEVRKVRRGKATYVHAALFPSYVFIQA--NEGNLDKARYLRGVNRIIGFGRDGESLKIPAVILETLSTFLEDNVYKHDMHELKDGDKVQVLDGPLKGVEAIFKKGLKDGERAVVLFELFSNYQEAKVNIEDLIKS    
162 UniRef50_C6XVK8        NGN domain protein n=1 Tax=...   111     1e-23  1  16.3%   3:180    7:171     --TSDIKKWYPVYTQSRAEKKAYQALLSK---------GIEAYLPLQRQLRQWSDRKKWVEEPLIKSYLFVHIARQQQTEVLM--TTGISRFIYFSG-KIAAMPDRQIEELKLLLASPYELEITEERLLPGEKIEIKAGPLKGIRGEIIEY-RSQKQLLLRLGDISHSIVVNVSASLIER-    
163 UniRef50_Q01XJ6        NusG antitermination factor...   111     1e-23  1  22.3%   4:178   15:175     ---EPALPWFAVKVRSNFEKKSADILREK---------GYQEFAPSYPSRRYWSDRVKVIDQPLFPGYVFCRFHPN--HFLPVLQTAGVVQIVGF-GGKLAPVDEVELASLRTLM-NSSLPISQREFLHVGRKVLIRRGPLAGVEGILEEI-RKGYRIVVSISLLQRSVTAEIDANWV---    
164 UniRef50_B9YBP8        Putative uncharacterized pr...   110     2e-23  1  18.5%   8:180    2:169     -------NWYVLFVRGGMEEKIRD---------FFLSQGLNAFIPKMKVVFRKQGISELVEKIMFPGYLFIESemDEQIKELRMQKTGIVKLLKFD-KEGTPALRSEEKDYLERLLGKNKVLEHSTGLIQGNQVIITEGPLQGFESQIVKIDRHKRRAVLELELCGQPRRVSVSLEIVQK-    
165 UniRef50_P0AFW1        Transcriptional activator r...   110     2e-23  1  16.9%   9:180    4:161     --------WYLLYCKRGQLQRAQEHLERQA---------VNCLAPMITLEKIVRGKRTAVSEPLFPNYLFVEFDPEVIHTTTINATRGVSHFVRF-GASPAIVPSAVIHQLSVYKPKDIVDPATPY---PGDKVIITEGAFEGFQAIFTEPDGEA-RSMLLLNLINKEIKHSVKNTEFRK-    
166 UniRef50_C5CGE4        Transcription antiterminati...   110     2e-23  1  36.9%  51:180  219:352     --------------------------------------------------RKEIKIFKITRTRLYPGYIFIEMIMTDETWNLVKSTPNVVNFV-SNGGQPIELKPKEIKALLRLveEKTRPIKVEVDFEVNEMVRINSGPFEDFVGKITEIDPERQEVKVVVSIFGRETPVMLNLSEIEK-    
167 UniRef50_P29397        Transcription antiterminati...   110     2e-23  1  42.7%  50:180  217:351     -------------------------------------------------TRKEIRIYKTKRRKLFPGYVFVEMIMNDEAYNFVRSVPYVMGFV-SSGGQPVPVKDREMRPILRLaeEKKKPVKVELGFKVGDMVKIISGPFEDFAGVIKEIDPERQELKVNVTIFGRETPVVLHVSEVEK-    
168 UniRef50_B0P702        Putative uncharacterized pr...   110     3e-23  1  21.1%   7:177    2:163     ------AKWYVLQVLAGQETAVRDAL---------HIMGIRAAVPQEERLLRKNGGWTSRIYTLFPGYVFLSLEYSAENYYRVKAVPHVLRFLGFSGLSPSCLTHLEAEWLRLLSNGGEPLKPSRVEELPDGSVRIMEGVLQNFPVRSIHFDRRARRARVGITLCGEPKILTLSMGS----    
169 UniRef50_C7PGB9        NusG antitermination factor...   110     3e-23  1  22.2%   3:178    2:163     --EQKTHTWYAVYTKPRWEKKVADALVRK---------QIETYCPINRVTHQWSDRKKIVEEPLFKSYVFVRIPEDKKT--LVRETSGIVNFV-YWLGKPASIPDHEVELIKRFLREYQDVQVERFPIQEDDLIRITAGPLMHQHGRVVE--AGKNTVKAVLYSMGFSLIATVKTSDL---    
170 UniRef50_C0QI35        Transcriptional antitermina...   110     3e-23  1  21.0%   4:179    2:167     ---SQEKSWYTLLTKSRFENVVFNDIQKKS---------IEVFLPKIKKRSQRKDRKLMIDVPLFPGYLFVNITLDPVTHLSVVKTTGAVRLLGYSSG-PVPVPSAHIESLKIVTGTGLDVVSGTInlQKGERVLVVRGPFSGVKGEFLR-HKGKDRVIIKIETLGQFAGVEIDREDLE--    
171 UniRef50_B5YJ95        Transcription termination f...   110     3e-23  1  22.7%   8:179    7:167     -------NWYCIYVKSRHEFKVFDRLTK---------AGIEAFLPAVERLRRWKDRKKLIKFPLFPGYLFVCIEKSYELMLKVLKTPGVVTFIKTPSGEPEPIPEEEIVPLRKAIENGREIDPY-PYLKEGQRVKIKSGPLAGATGILKK-KEKQHFFIISIHILQRAVSVKIDASEVE--    
172 UniRef50_B8KUX9        Transcription termination f...   109     6e-23  1  18.9%   7:170   21:170     ------RRWYVVASKPRSEGVAKSQLER---------QGFVTCAPRIKLRKRQRGKWQQVIEPLFPGYLFVALRLGVDDPAPIRSTLGCIGLVR-MGREFVPVPEAVMQPLLSI---GESPDASEAVFQPGQAVRFEAGPFEGLSGIF-KMPKGQDRAEVLITLLGSSAR-----------    
173 UniRef50_B6TZG2        Transcription termination f...   108     6e-23  1  26.3%   7:181  103:327     ------PQWWLVRV-SMAPGTDYVDLLTKAISRRYSEVPFKIYNPSIQVKRrkSGAISVKSKPLHAGLVFLHCTLNKELHDFIRDTEGCYGFIGATVgkPKPIPVDEVESIIREEKEEQERVDREFefSPGATVHVLSGPFADFTGSILEVNRKNKKATVQLSLFGKESFVDLDFDQIEVV    
174 UniRef50_C6Y0K9        NGN domain protein n=1 Tax=...   108     8e-23  1  18.5%   4:181    5:167     ---QQEKNWYVVVTYPNLERKALLNLLKNN---------FIAFLPLQKVQRKWSDRKKTIEIPLFPNYLFININEKDR--FEALDIYGVKRYVTF-GGRPAFISETDILNIKRIVESVDLYIEHS--LVKGDAVKIIGGPFKDMIGILFK-KSGQARFGIRVESMNQTLSIEICHTLIRKV    
175 UniRef50_A1VS68        NusG antitermination factor...   108     8e-23  1  20.0%   2:181   16:184     -STDSESLWFLAHTRPRLETVALQNLQQ---------QGFDVYLPLYKRLKKIDAGMQAVFEPMFSRYVFFRTTSLAQSIAPVRSTRGVAQIVSF-GSEFATIRPDMLDAIRQLEqrNAADVAELSTLRPGHLVRFCNSALSGLEGVVKSVSS--CRVAVLLEIMGRQQLVRVDHHQLVAA    
176 UniRef50_B1KMD8        Transcriptional acivator Rf...   108     9e-23  1  20.6%   7:181    4:179     ------KAWYLLYCKPRGEARAVHNL---------TLQNIDTYLPTIGEEKRVKGEVSIKRIPLFPGYLFINIDPQVTSVARIHSTRGVGRIVGcdDSIIHSIRLREHKLLSELLPASELSQksTVEINPGDQVKFTEGPFADLEGIFAEKSGDK-RCHVLFEIMGQKKRVSVPRDSIKPV    
177 UniRef50_Q04WD1        Transcription antiterminato...   108     9e-23  1  19.6%   1:179    1:170     MIENSKVnwYALYTNPRAEKKLKRLLQER---------KIECFLPLISKKKKWSDRWKVVEEPMYPSYIFVKISFFQDR-VKILQLPGAHHFV-FYSGKPYVIPDEDLNLIRIFLepDRIQVEIQERLLPGKKILIQEGPFAGFKAEIIQRKNEKQ-IIVKFPGMNLMTSVTLDIKTLK--    
178 UniRef50_A7Z6E4        Transcription antiterminati...   108     9e-23  1  23.7%   8:180    2:175     -------KWYALFVESGKEETVQKFLR-----LQFDEQALYSIIPKKKVTERKAGIKYEALKKMFPGYVLFKTKMTERTFHKIKELPISCRIVNNGatYFTTIKDEEILPIIRLIGEGDTVDYSKVYIE-NSKVTVASGPLKGMEGIIKKIDKRKRRAKICLSFMGLDKMVNVGIEVLSK-    
179 UniRef50_O67757        Transcription antiterminati...   108     1e-22  1  40.0%  46:180  116:247     ---------------------------------------------KITCKENKTEAKIVLDNKIFPGYILIKAHMNDKLLMAIEKTPHVFRPVM-VGGKPVPLKEEEVQNILNQIKRG--VKPSKVEFEKGDQVRVIEGPFMNFTGTVEEVHPEKRKLTVMISIFGRMTPVELDFDQVEK-    
180 UniRef50_C6QI43        NusG antitermination factor...   108     1e-22  1  23.7%   6:178   12:172     -----KPCWVVVNAQAHREFVAASNLKK---------QGYEIYAPVIRKTTRHARISRESLTPLFPGYLFARWTAPDMRWRPILSTVGIRSIVRN-GNEPSRLDGAIVDALKAREKDG-VIVRAESQREIGQIVRFARGPFDGIAAEIVELC-DKDRLVVLMTLLNRPTKVTVLEDQL---    
181 UniRef50_B8I511        NusG antitermination factor...   108     1e-22  1  17.8%   8:181   16:187     -------HWYVLFVKSGREHRVEQYLKKIV-----GIDMINPFIPLHEFLFKISGTVKRELKPLFPGYVFIESDMarKLYNKIYLLSDIVRILKYSDTEIAVRDSE--KQMLLDLCNNEHCIESSRGVIKGDRIYITNGPLRGRESIIKKVNRHKRQALVEMEFMGDKRLVSVALEIVEKV    
182 UniRef50_Q3AU98        Transcription antiterminati...   107     1e-22  1  22.9%   1:179    1:168     MAEIITPqwYAVYVRSRYEKKVYQALLER---------EVNSFLPLYETIRQWSDRKKKVSEPLFRGYVFVNIAMQQESI-KVLDTEGVVKFIG-IGRKPSVIAEREIEWLKKLVREPEAISRTVASLPAGQKVRVIAGPFKDMEGVVVK-EGRESQIVIYFDSIMQGVEVSIYPDLLQ--    
183 UniRef50_B6GA74        Putative uncharacterized pr...   107     2e-22  1  19.4%   6:180    2:171     -----RVQWYVIQVMKGREDSMASLIGRVVPKSLLQ----EVFSPKYETEIKVRGRWVPVQKTLLPGYLIAVTNDPEGLEAVLRDLPEFARLLA-QGNEFVPLAPAEVEVIGSFTSPGKRVVPMSIGVKDGDRVVVTGGPLVGHEAMVKEIWRRKSIAILEVNMCGRVVTTRVGLGVLSK-    
184 UniRef50_B8IAM8        Transcription antiterminati...   107     2e-22  1  29.8%   4:181   87:255     ---ERGRRWHVMVAKPRFARRAAKDLTKAGIPAVLTDERVE--------LVEESGRRRIVKRPLLRRVLFVGLPRCAAPEVVHRETYFVRDAVRDGCGRAIQVPADQLRRFVRALAD-TLTERDPNAFEPGDEIRIKSGPFASFHGIIEDADYATRRLKVAVEIFGRPSPVGLDFSEVERA    
185 UniRef50_UPI000197AEF0 hypothetical protein BACCOP...   107     2e-22  1  26.0%   5:181    2:168     ----EKENWYAMYVRMHHEKKVAEKLGQ---------MGVEHYLPVQEVVRQWSDRRKKLQVVVIPMMIFIRAS-EQVRLSVMRNIPSVSglIDRCTHRPAVIRDEEMQRFRFMLDYSEEAVHfnTPLAPGQKIRVIKGPLAGLDGELTEID-GKSQVMVRIEQLGYA-SVEMPVGYVEAT    
186 UniRef50_A6FES1        Putative transcriptional ac...   107     2e-22  1  19.0%   1:179    1:167     MAD-DKKDWYLLYCKGKEEPRALINLK---------NQGIESFYPTMTVEKKLRNKLICQEIAIFPNYLFVAIDKNTANFNSIRSTRGVIDFVKC-GANYTKVPAALVTELRATQRCRDKSANEVTVFSEGETVIIQDGAFKGIEA-IYQCKDGLERSMLLINLINHSTTMSVANGEIK--    
187 UniRef50_A3V684        Transcriptional activator R...   106     3e-22  1  24.3%   4:180    5:168     ---DDTAAWHIAQLRPNGLLMALRNLER---------QSVAHFAPTELRTERRGAKFVTRDVPAFPGYVFVQPSAASGGVRAVNSTRGITKLVT-LGQGPAIVPAGLIAALRIRFAPPDITPAPQ--FDQGDWVRILDGPFAEFVAQV-EATPAAERVYLLIDLMGRATRVAVDARSLKR-    
188 UniRef50_Q10BA7        Os03g0825500 protein n=3 Ta...   105     5e-22  1  25.1%   7:181  104:328     ------PQWWLVRV-SMAPGTDYVDLLTKAISRRYPELSFKIYNPSIQVKKrkNGSISTKSKPLHPGLVFLYCTLNKEVHDFIRDTEGCYGFIGATVgkPKPIPVEEVESIIREEKEEQERVDREFefTPGASVHVLSGPFEGFTGSLLEVNRKNKKATLQLTLFGKESFVDLDFDQIEAV    
189 UniRef50_A0XZ39        Transcriptional activator R...   105     6e-22  1  15.8%   9:179    4:159     --------WYLVICKPRQEERAKANL---------NNQGIEAFYPILTTEKLVKSRRTVKQVALFPNYLFVCLDSKNGPFAAVKNTRGIGGFVTY-GANYQVVPLAIIEHLNNHTSNTVE----SQLPKQGDAVSVSNHSFKNIDAIYKEPDGD-MRSILLINLLNKQVEMSVDNTDIE--    
190 UniRef50_A6TKC4        NusG antitermination factor...   105     6e-22  1  22.6%  12:179    1:159     -----------MHVKSNEEMKAKKLVEKEIED-------IKVIVPQRIIPEKRQGETRHVKKILFTGYLFLNVELDVDTYYKLKRIPSIHRFLGLE--KPEAIPLEEMQRVLRLCNQGELIGLSKVIVKEGNKVQVVSGPLLGMEGHIIKVDKRKGRAKVCLSVLGDAKTVDLGIEIIK--    
191 UniRef50_A3XR75        NusG antitermination factor...   105     6e-22  1  25.3%   8:173    2:153     -------NWYVLYVKPQSEKKVASALEK---------LGVKVFCPTLEEVRVWSDRKKKIQVPLFKSYVFVCLPNTERQQVF--AVPGVVRYL-FWLGKPAVVRDEEIAAIQDWLSDEAVADVQVRTYTPGTEVKIAAGHFKGQKGIVQEV--GRKRLKMVIKSLGVIVEARL--------    
192 UniRef50_Q01TC5        NusG antitermination factor...   105     7e-22  1  20.3%   8:179   18:175     -------QWFALSVTPK---------LTQLVLMALEHKGYECFTPLQSSTRKRRDQVADMQVPAFPGYVFARIDVRFRL--PVLVTPGVRGIVGY-GRQPAPVDDGEIFALRRVM-QSQLPAKSAPYLRTGDRVQLVEGPLSGLTGLLIQ-QKGANRVLVQVTLINQALAVDVESAWVR--    
193 UniRef50_Q6MDM6        Transcription antiterminati...   105     1e-21  1  43.1%  64:179    1:115     ---------------------------------------------------------------MWPGYLLIKMNLSDESWQYVKNTNGVIDFLG--GDKPTPLTDFEVGEILKDLEDKKRKITQKHKFEVGDRVKITDGVFVNFIGTVTEVFHDKGRLSVLVSIFGRDTRvdLEFVQVE--    
194 UniRef50_B3DWJ1        Transcriptional activator R...   104     1e-21  1  20.0%   9:178   11:168     --------WYCLSIQPKKEKLAVENLKKEN---------IEVFFPQFQYQKIRSRKTSLVLEPLFPGYLFAKFNLYSK-LTFVRSTKGVRKVVHFGSSYPV-IPDSFIEELRIQFGEEG-IKTIRERIDVGSTINIAEGPFQGYSCIVLGFIPAKERVRVLLEWLGRAVQIEVNLKEI---    
195 UniRef50_C8QDS8        Transcriptional acivator Rf...   104     1e-21  1  21.6%   8:174    3:156     -------NWYVAQTKYAQEKRAQQQLL---------SQGVTCLFPVFSEVrqNGGIRRIAEQPLFPNYIFVRFDPEVVHTTAIKATRGVSSLISF-GGLPSVVPDSVIIRL---NQGWERAPLNTDAPVHGDRVVIRDGAFEGLEAVWYEPDGLK-RAMLLLTLMNREVRVPVE-------    
196 UniRef50_C3MAS1        Putative uncharacterized pr...   104     2e-21  1  20.7%   8:181    3:168     -------HWYVVRTRAGQQQKA---------TREFEDNGVTVYCPMLRRETRHFQSKKwkECPLFTGYVFAYLRISD--FGTLREMRHVLSVLADAGGTPIPVAGNIVEDIRDAQERGDFDvpPVRRLKAGDTVQVKDGPLTGHYAAVTNI-VGRRAIKAFVEIFGSLREVEIGLESIRRV    
197 UniRef50_C7PT75        NusG antitermination factor...   104     2e-21  1  20.0%   9:178    8:165     --------WYLLYTRPRQEARVAK---------EMADKNIQIYLPYTTVTRRWTDRIKVLEVPLFPSYVFVHLTNMHE-FYYGSNLESACSYVRF-GNEVARVSDAAVDAVRTIAKAGNNLEVSSERFTPGQQMMIKEGPLCGLNCEVIQY-KGKDKILVRVHMLQRSIMADMPASVL---    
198 UniRef50_A6EBM5        Putative uncharacterized pr...   104     2e-21  1  15.1%   2:180    4:169     -TERDIKKWYPVCTQSRAEKKAYSELTRKN---------ITSYLPLQRQMKQWSDRKKWVEEPLIRSYLFVHISRQQQAEVLM--TSGIARFIYFSGH-IASMPEQQIEQLKLLTASPYELEITENNLLEGEKITIKAGPLQGMSGEVVAY-RSQKKLLVRMTELNHAILVHIPASLIGR-    
199 UniRef50_Q3SSD1        Transcription antiterminati...   103     2e-21  1  25.1%   5:179   31:209     ----QPKYWFILRTHPGCERKVMREFERRN---------ISAYCpqQRVVRRVHgiKRLVQVPLFPQLVFV-----PDFERVPADIGGVSGWLRFGGWRARIPSERemADIHALVaaNTPQSKRAARFEIGALVRIVDGPFRDFSGRIERLD-SKGRLKVAIEIFGRLSPTEMSEAQIE--    
200 UniRef50_D2QI92        NusG antitermination factor...   103     3e-21  1  21.5%   9:180    3:160     --------WYVLCTKPRKEKFLAKLLAEK---------QIEVYCPLIRRKRRWSDRIKTVEEPLFPCYCFVNVKESERADVFV--TPGIVRYL-YWLGKPAIVKDKEIDLIKLTLNQFDHDLIHLESFNPKDKVVINSGSFMGQGGTV--VNQQGIKVLIHLDSLQLCIRVDTSKTLIAK-    
201 UniRef50_C7PTI0        NusG antitermination factor...   103     4e-21  1  17.9%   2:180    8:172     -TQQRESKWYVLYTYPLFEKKIGRQLAL---------IDIIHYLPVKTEVRKWSDRLKRMEVPLFPNYIFVKTNLLNKT--PILGIPGVVRFVSVEGRAIA-ISEDDINKIRQ-IEQSRQDVEIESVYNTGDKIRILNGVFSGLEGELYK-RSNRLRVLIKLPVIAQAVSVEISNCDIEK-    
202 UniRef50_Q1QKQ8        Transcription antiterminati...   103     4e-21  1  27.2%   9:181    7:194     --------WYVLQTRPAHEDKAARGLVARGFDPYAPVVYRRV--PTGRRDDKGRKLTREIARPMFPGYIFVQFDAGDEKFAEVRIVPGITGYLKDEAGEPQAVPDVAMDLIAVSETEesKRKRGPPEFKAGDDVRVVRGEWKDWIMKVSKAD-DLGRVVLLFHIFGRETKIHADQADLEVA    
203 UniRef50_Q73PT3        Transcription antiterminati...   102     5e-21  1  17.0%  10:180    4:171     ---------YVVQVSTGKE---KNFIEDAEFKNKFDELSYSIVFPQRILKIRKAGKVTEKQLPVFAGYLFIGTdiSKDLYQHLRKCKGFYRFL-PNNQEPKFLEGRDFEILNQFISFGGLAKISQVVFDENDRIKVIEGPLSGLEGYIVRVNKRKGRATVCLDMCQTAFSIDLGFEILNK-    
204 UniRef50_C7PS65        NusG antitermination factor...   101     8e-21  1  19.4%   9:168    8:155     --------WYALYTMPRHEKKLHTRLSELNVTS---------FLPMTRMLRTWHDRKKYVEMPLFPSYIFVYLN-NIEHYYNVLNTNGALYYVK-TGNELSRISEQIIHYIRIVSEQSTGIELSADYFPPGKELLISSGPLAGFSCEVVSYKNS-EKILVRVSLLQRS-------------    
205 UniRef50_Q98R28        TRANSCRIPTION ANTITERMINATI...   101     8e-21  1  20.0%   5:179    2:190     ----NKFNWYMISTIPNKEKEVIEAIKNKVVSENLEAYFSDFKiaKELEKKQAGDSYKTTKKNMYNGYIFIEMVITNETWFLVRNTENVSGLVGShgAWPTPISKLKFKKMIEEETKKEEEFQLSLnfREGLFVKIVDGPFKNDEIviKKTNHEKKYSILEIESLGKSVDTQIDHKHLK--    
206 UniRef50_B8IIP1        Transcription antiterminati...   101     1e-20  1  32.4%   8:180   58:229     -------RWHLVDCRAGKARQFADALAAGA---------IPALRLSEEVVRVRSGRPIRTRMPLFGRLLFVGLdhSEDAHWLRDKYDREIKGVRFRDEKFMLVPGRELDQFTGVLGGDVPPAERRtdFEIGEAVRVADGPFASFSGLVEEIDAESQNLKVSVSIFGRSTPVTLEPTQVEK-    
207 UniRef50_Q1ITB0        Transcription antiterminati...   101     1e-20  1  23.7%   5:181   10:172     ----DELHWFAVQTRHRHEKRVAERLRQ---------SEIETFLPIHrvHRWKNGINAEVNLPLFPGYLFTRLRGSQRI--PLLREPGVI-AIAASSNSPTPIGDNEIAQLR--LVAESVKAEPHPFLAIGQQVKVVAGPLFGMEGILIR-KKSEYRVVVSVKIIMRSVAVDVSELEIEPV    
208 UniRef50_A3I2H8        NusG antitermination factor...   101     2e-20  1  21.7%   5:179    2:163     ----NELKWFVMYTASRSEKKVAKRLR---------ENGKEVYLPIIEEIRQWSDRKKKVEKPLFNGYVFVKTTRNQ--LWECLQVPGAVKFVHFSGQH-ATVRDEELETIERIISTGVAVESDGSVIEAGEKVEVIGGALQHMTGEVIE-KGNKDYFLIRIPSIYQNMLVSIPRKFLQ--    
209 UniRef50_D2LJZ0        NusG antitermination factor...   100     3e-20  1  17.0%   1:176    1:164     MLLPVNSKWVVLTTHPHRENFAVENLAR---------QDFTAYCPMTVKHVRHARRAYDAPRPLFPGYVFVEHQSAFQYLRPILGTYGVRSILR-IGDSPAVLPVGFIESLKAREMDG-VISKPEAPLKAGQTVTISGGPFDGLVGQILEF-RERDRVLLLLDLLNQQTRVQVEAK-----    
210 UniRef50_A4YU22        Transcription antiterminati...   100     3e-20  1  24.3%   9:181   31:199     --------WYILRTHPHCEAKVMKAFRLRNISAYLP-----VMTVSKEFRRMRRGFEWIERRDVVSPLIlvLIPDFEERWQCWRGVDGAVGLLRFGEWTP-RLTPKLFQDIRKIEDIANTPkkRARAFEVGQLVRVLSGPFRYFSARVERID-SRGRLSVGAEIFGRITPIDIDEGEIEAV    
211 UniRef50_B1AJM2        Transcription termination/a...   100     3e-20  1  21.3%   6:179   23:247     -----RHQWYIVTVVSGNEQKVIENIKDKLNGYGYGDKLSDLKIIKEKIKEVkyRCTKIKEGNKFNGYIFLKAEMTDQIWFLIRNTQMVTGLVGSSGkkPIPVPEDKILKLIADNDAKrhEDENFTNFEVDQEVKIIADTFFGEIAKIAKIDQNKKIATVEFEFFGRINTLDLNFNDIQ--    
212 UniRef50_Q1D5E3        NusG-like protein n=2 Tax=M...   100     4e-20  1  22.9%   5:179    7:164     ----AENDWVALLVRVNHEKVAAAQLGKH---------GYEFFLPTYTPPKSSGVKAKL---PLFPGYLFCRYQPLN-PYRIVRA-PGVIRLLGGDAG-PEAVPAQELEAIRR-VADSGVSSNPCDYLRVGQRVRIIEGPLTGLEGSLV-TSKSQLRFIVSVGLLQRSVSVEVSAEQLE--    
213 UniRef50_Q7D1F8        Transcription antiterminati...    99     6e-20  1  26.4%   2:179    8:186     -NQPGKHEWFVVETKHKAEKAVEDALRK---------AGVKVFLPLETIGevRGRIIPAVSRPLLPGYVLVNIVYSPAAVCGIARLEGVAGFVGG-MVHPHRVSDEEMNRFKAFGDDETApvKHCEQFKRGDKVRFVLGPFASFGGNILKLRKDRAvaVVAVDVFGKVSTIEAPLALLE--    
214 UniRef50_B0K4N5        Transcription antiterminati...    99     6e-20  1  25.7%   7:181    2:168     ------KKWYVIFTRSGYENKVRDIIENCFKEE------VKLLIPKRKIIERVKGQPVEKIKLLFPGYVFVNAEMSDDLYYKISEVLK-RGIFLKEGKRPAFVKEEEMKIILSLTKNSD-LIDLSKGIMEGERVKIIEGPLKGYEGLIKKIDKRKKRAKVIFSIAGELKSVDLAIEVMENV    
215 UniRef50_UPI00016C34F5 transcription antiterminati...    99     6e-20  1  19.9%   1:181    1:173     MDEseVGRWAALRTAARWEKAVTEQLAA---------AGVPVFLPLLTRVSRTKSKTQTAQLPVFPGYVFCG---EREYRDSTRVPPSCRKLIAQLLRAPDPDQLKDELRSVADLLANRQLLQERVYGVIGDTVRIVGGPLAGSLGTILRLKPGTRRVLIEVSFLGARMEATVEERLLEKA    
216 UniRef50_UPI0000E0F5F6 transcriptional activator R...    99     6e-20  1  19.6%   2:180   10:174     -SGPQGKVWYLLYCKAKEEGRAVMHLA---------NQGIDAFYPKANITKVLRGKRQTVEEALFPNYVFAQLDHDVHNFTSVRSTRGVIGFVK-QGKDYQKVSQALIDVFVQC---DTVDKLDSALPTKGDNVMLQHPQYQNIPAIYQEPKGEN-RAILLIHLLNKPVELVVDNSQFTK-    
217 UniRef50_Q2GD85        Putative transcription term...    99     7e-20  1  22.9%   1:179    4:173     MSSSSDHTWCVLRVRSGSESKVCDLIKSRC-----SDEVVDLFSPALVKFDASASKR------FLPGYVFVKVVPGSAFLsvMRSLYGIPCRFLNQAGSPKFLSDKDIDEMRNFMLSPEVTPESG-KISVGSRVAILCEYFEACVGEVDEIDERTSKAKVKIVFCGQDVVVSFNLDQLK--    
218 UniRef50_Q4A648        Transcription antiterminati...    98     8e-20  1  21.3%   3:180    2:198     --QNSKFRWYLISTITGKEAVIVEALKNRIKSENIedGPFKVfvPSITKTELNKKQkkVKWKNMFPGYIFVKADMQDLVWYIIRNTLQVtiGSGGGGEKPTPVSQNQIRKSLEKEEEAkeENKNLLNLKVGDLVLITDGNWVGNEAVIEKIIVEDNMAEISFEDFNKKVEFKINLDWLTR-    
219 UniRef50_A9ECY4        Putative uncharacterized pr...    98     9e-20  1  19.8%   4:180   24:187     ---SKNRNWFVLYTAPRAEKKAKLELEYR---------GYEVFLPMTKSLRIwnRQKKLIDSVLFPSYIFVKTD--ERYLAEICRINKIATYIHC-GGKPCKVSPECIEAIKCML-SMDQEISVGNDFIEGESVRIVEGPLAGYNGVLVQ-QKSKTKFGIHLKEINQVASIEICTSALEK-    
220 UniRef50_B5CXQ3        Putative uncharacterized pr...    98     9e-20  1  21.1%   1:180    1:170     MEAKKETHWYAFYVRMHHEKKTAEKLEMLKVVH---------FLPIQEVIRQWSDRKKKIKQVVIPMLIFICTD-EKGRIELLQNLPSLTglIDPATRRPAIIRNEEMEKFKFMLDFSDETIRFQSelAPGEKVEVIKGSLKGLQGELVEL-EDHSQVMIRIEHLGYAT-VEIPVGYVKK-    
221 UniRef50_A6DPM2        Transcription antiterminati...    98     1e-19  1  35.6%   8:111    6:114     -------QWYTLQALSGKENKARQDLERRIEQDSMQDSVLEVLLPTEKVTTVRQGKKITQNRKFYPGYLFVNVdmKEDVWHFVKNTYGIINFLG--GDKPVPLSDDEIQIL----------------------------------------------------------------------    
222 UniRef50_A7AFP3        Putative uncharacterized pr...    98     2e-19  1  21.8%   5:174   21:171     ----DKTSWYVLYTAPRAEKQVRDRINA---------LGVECWLPLHRAPRVWSDRVKIVELPLFNSYLFVRCTDPE--LRNLTRVYGVARIVYYNG-KPAVVRQKEIDAIQDFLDQASE-----HALCPGEEVEILCGAMKHVSGKVKKIK--KNHLVLYLEQLGATVCVKLD-------    
223 UniRef50_A5FN19        Transcription antiterminati...    97     2e-19  1  22.7%   8:161    2:143     -------NWYVVYTKPKWEKKVAEKLTQ---------IGIECYCPLITQVKQWSDRKKKVEMPLFNSYVFIQIEDADR--NSVFEVAGIVRYL-FWLGKPAVVRDEEINVIKNSLKASNIADISVSQIQVGDKIKLETGAFSNQNAIVQEVSKTHYILVLE--------------------    
224 UniRef50_Q1IKV1        Transcription antiterminati...    97     3e-19  1  19.4%   9:178   27:182     --------WSALFTYPRHEKKVAEQLLCR---------GVESFLPLYAEKRTWKNRQTVttLPLFPGYVFARFARRDRVR--VMSLPGVVSIVERAGAV-SSISDHYIEKLRAGIRLGRVRPFREAIL--GDRVQITSGPLSGLEGVLMHFRSE-FRVVVSIGMIGQSVSIEVLRDEI---    
225 UniRef50_A8S2H9        Putative uncharacterized pr...    97     3e-19  1  25.7%   9:175    3:154     --------WYVVQVRTGEEKDIAAKL---------TDMGFQTLAPVENRPVRSGGAWGTKEYVLFPGYVFLQMDYNAGNYYRLKAVPGIVKLLSGT------LTYLEAEWIRLLAGQGGRPLEPTLMRETEEGLEIETGILQNFKSRIIRMDKRSLRATIELSICGEKKEVQLGI------    
226 UniRef50_A6UA20        NusG antitermination factor...    96     4e-19  1  23.9%   5:180   48:218     ----GKAPWFALRVWTGREKTVEKSLDIMA---------VRSLVPMRkdLRRRGRVIEGQMMPVIHGYVLVQMMALSEYLAGLLGVEHVIDVLGGCE-RPMRLSDKEVNRFNGLARNGNFDWERPVDLVvgEPVLITAGPFCDRRATVITpkKGRGDVVVSIDFMGGEVPVTVPLALLKK-    
227 UniRef50_B0UIZ3        NusG antitermination factor...    96     4e-19  1  25.9%   5:178   48:215     ----PDRVWLVARTRPRWAPRVVRDLAA---------LGLCAFEAREEVERvpDGARRRVAVPLLHRLVFLGLRDDADLARA-EAHPGVLRVLFREGRapAPILQAFADALAGRAGEGEDEAVEAVLLALGDAVRVTRGPLAALRGTIEAVDPARRRYRVALGLFGRATRVDLAAEEV---    
228 UniRef50_B9HCH7        Predicted protein n=1 Tax=P...    95     8e-19  1  25.6%   7:178  109:337     ------PQWWIVRV-SRIRGDETSDVLARLLARNFPQMDFKVYAPSVKERRkkNGTYSVKPKPIFPGCVFLWCVLNKEIHDFVRECDGVGGFVgrQINKPRPVSDDDMEAVFQQAKEEQEKADIGFepKTGSTVRVVSGTFADFVGSLKKLNRKTGKATVVVTLFGKESLVELDLSEI---    
229 UniRef50_A9DI26        NusG antitermination factor...    95     8e-19  1  18.5%   9:181    7:169     --------WHVLYVKSRWEKKVHNSLE---------NISIKSFLPKTKTVQQWSDRKKTILTPLFPSYVFVYIE-SPLDFHKALSVDGACCYIRF-GKEYARVTEKEINQilVDSKEIEEIELNPTFPKIGEMKKIEQGPLSGLDCEIIEA-ENYNKIIVRISSLRQNILATIPLNSFKKA    
230 UniRef50_Q5LEP1        Putative LPS-related regula...    94     2e-18  1  16.7%   3:176    9:169     --KENTSCWYAVYTAPRAEKKVKEQLDK---------IGVENYLPLQPVVRLWNNRKKKIFIPVVPGCLFVHISSEEIAHVA--GIHGVA-FLLKEKGQYVSIPEVQMETFKTMIEHSCELVEfpNEFVPGTVVRVISGQLQGLEAELVEC-QGNNKLLLRVEGLG-CALVTVSTD-----    
231 UniRef50_A6L3Q7        Putative transcriptional re...    94     2e-18  1  22.4%   7:180    2:164     ------KKWLVAYVRLHHEKKTAERL---------TAMNIENFLPVQEEIRQWTYRKKKIKRVVIPMMIFVHVDAAERSQVLTLSAIS-RYMVLHGEHTPAVIPDEQMERFKFMLDYSDEAVEMCtpLAPGELIRVVKGPLKGLEGELVEVD-GKAKVVVRLDLLG-CAGVDMPVGFVEK-    
232 UniRef50_B9JXL7        Transcription antiterminati...    94     2e-18  1  18.3%   4:178   47:218     ---DTQARWVVARCKSGLEQVIRDALA---------EQGIDCWCPCERRRLPPRRRKpvVERPLFRGYLFVRVIPDNEAYAGLLLASRLQSLMGQDG-KPYLMPETLMRQLQLSAKAAERRHMDAGDVPpgKQVTIRSGPFADFVVTVRKVLSKRGQVVVDVPMFGGMSEVTVGVEAI---    
233 UniRef50_A4E6I1        Putative uncharacterized pr...    93     3e-18  1  15.0%  26:178    1:152     -------------------------MRERIERMVPASAMQELFYPQYQTEIKVHGEWVSTTKPLFPGYLICDTADPRTVQQYLLRMDDFARVL-SQDGQFVPLAKEETQLIGSFTNRGDRVVPMSEALKDGDQVVVTAGPLLGHEGLIKTINRRKSTAYLELDLCGRRVTTRVGLAVL---    
234 UniRef50_Q94AA3        AT3g09210/F3L24_8 n=6 Tax=r...    93     3e-18  1  23.4%   4:178   93:327     ---ESGPQWWAVRvlRGHET---AQILARALARQFPEMEFTVYAPSVQVKRkkNGSISVKPKPVFPGCIFIRCILNKEIHDSIRDVDGVGGFIGSKVgkPRPVDDSDLEAIFKQAKEAqeTKAKKKKLAAGSTVRVLSGTFAEFVGNLKKLNRKTAKATVGFTLFGKETLVEIDINEL---    
235 UniRef50_Q6AIA2        Related to transcriptional ...    93     3e-18  1  15.2%   2:179   22:191     -DNETEGHWYAIRTKNKKEEVAK---------FNYQRQGYTVYLPLLRKTVHHARSTTEKLVAFFPGYLFLNLAPAEQNWTAIASTRGSLGALCF-GDSYIEIPGWVISDLKAREDKGLSILAkkENLTPGSVVTVNIPGLESVEAVVYSI-RGSENVDVLLNILSRQVKTTVSLDRIK--    
236 UniRef50_Q1NMQ2        NGN n=3 Tax=delta proteobac...    93     4e-18  1  18.8%   9:178   10:171     --------WYAIRTKPHKEEMARQH---------YLNQQYTVYLPLMRVVRSHARRRQVVFRPVFPGYLFLRLNPETCDWAAIHATRGSIGPLRF-GEHYVPVPDWVIEGLQAREDEEGVIApqKEKLVPGCEVEVtkGFFCSFRG--------KENVEILMDILKRQVRTTVPLDRV---    
237 UniRef50_UPI0001972DAA NusG antitermination factor...    92     6e-18  1  17.4%   9:180    2:175     --------WYVIQTTTGKEEELAGIVRRNVSHALYGS----CFSMKRELLKRLGGRWTAVTETMFPSYVFLETEQPERLFYELKRLPEYTRLLGDNEGCFIPIEKEEENflRRNEKETCVAGLTTLDLDEDGGIRKADGPLQFFLDKIVKLNLRKRFAVVELKVAGKEWRAMMGikDVER-    
238 UniRef50_A3J1W0        Putative transcriptional re...    92     6e-18  1  17.0%   8:172    2:153     -------NWYALYTKPRNEQKVAQKLQA---------LGIIAYCPLVLSSKQWSDRKKKVLVPLLPSYVFVQIE--EQNRKDVFQVGGVVQYV-FWLGKPAIIKPNEIEALKQQLDSSIPVVHFetTWRSNETIQITEGVFKGQDAIVDKI--STNKVRLLLKSLNMYITIE---------    
239 UniRef50_C8WIA4        NusG antitermination factor...    92     8e-18  1  16.0%   1:181    1:173     MPSRGRAR-YVLQVVPGRERAVAE----RVKALAGPELVRDCFALSYCILKKNQGVWRLLTETMFPGYLFVASDDIEAFEKTIKRSTAFARLLGAERRAFALRP--EEASFVHDFGGPSHVVGFSRGTIDNGRTIIDEGPLRGHVDRIKKIDRHKRIAYLDIGLLDQKQ-VRVGLEIVRKT    
240 UniRef50_D1PRH1        Putative transcription term...    92     8e-18  1  19.6%  10:177    4:163     ---------YVLQVITGREKDICGRLRK---------AGIPAYCPRAVRQIRRGGRWQEQTYTLYPAYIFVQCERVVDVYYAVRREDGVLYWLGATRGTPEPLSADEEANILWLAGDGPQPVSKAVCRADGS-LDFTSGPLkeLEA-LRSVFRRERRATAVLPLHGKEHKINLSFEI----    
241 UniRef50_UPI0001B49F58 putative LPS-related regula...    92     1e-17  1  15.9%   3:166    9:160     --KENASCWYAVYTAPRAEKKVKEQLDK---------IGIDNYLPLQPVIRMWNNRKKKIFIPVVPGCLFVYISSEEIA--QITSIHGVA-FLLKEKGQYVSIPEVQMETFRTMIERSHELVEfpTDFVPGSTVQVIRGQLQGLVAELVEC-QGNNKLLLRIEGLG---------------    
242 UniRef50_B8IE36        NusG antitermination factor...    92     1e-17  1  20.7%  10:178   37:193     ---------YAASVAGHGEYRACEWLQQ---------AGFATLAprTAVVRQASSGKRLVRRPVFPGYAFVG-KRPEQSWRDILRVPGVRALVT-TGEAPTELPPW-MMKMLIAADEMGAYDRPRPQLAVGDKVRIRDELWQGLIGEVMRA-PEGRRIAVLLKAFGKKHVLSVDVDRL---    
243 UniRef50_B7AH17        Putative uncharacterized pr...    91     1e-17  1  20.7%   7:180    8:170     ------RHWYAVYVRHNTEFRVESWLR---------EQGIEIYLPVQDVYREHAGKRIKVTKPVISGMLFVCLSRPE--LTIVEHAPNVHHFFSKRgnAPLIIPDQQMADFRFMVDLSDTSILMVNeiAPGTMVTVAKGSMQGIRGEMVKY-ESKYYIAVRLQELG-CALVSVPVSYVRR-    
244 UniRef50_UPI000174528A NusG antitermination factor...    91     1e-17  1  26.1%  40:181    7:147     ---------------------------------------VETFCPRIRFQRSTPRGKVWFVEALFPSYFFARFVYSEA-HRAVKHTHNVIRIVGFGGD-PAPIPDLTIENLREEM-QGAELREVKYGVEVGDTVEVAEGPMRGLKGVVESLASGEQRVKLLLEFLGRQSLVEVQASKleKA    
245 UniRef50_A9BF38        Transcription antiterminati...    90     3e-17  1  32.2%  63:180  231:351     --------------------------------------------------------------NLFPGYVFVEMMYIKETEELVSNLPYVSTIL-NIGGKPVKLNKNEVRFVLRVMGEerQVKEVRTDFELGEHVKIINGPFEYFTGKIKDFDLEKQEVQVVVTMFGRETTVTLSLGEIEK-    
246 UniRef50_A4E6Y7        Putative uncharacterized pr...    89     7e-17  1  19.4%   2:176   22:195     -SQHGRVRWYLVHTPNGKERETCEKVRCIIPHNLMQD----AFVMQKEFWFKRDGAWSLQTKPMYKEYFFVATHDAAALDRALAQLSFGCRIAGSRERAYMPMPDDAQDWYRSVLDEDGVVRNSVARIEDG-VLHIEQGPLVGQEARVHKIDRRKRWCLVDvsSFREVLPLDVPIK-----    
247 UniRef50_Q2RYZ3        Putative uncharacterized pr...    89     7e-17  1  18.4%   1:179  106:275     MSTSPDDnwRVFYTRARAEKKCETRLDER---------RIDVMVPKKTEVRQWSDRTKEITEPLFRNYLFARVDEKDRLR--VLRTNGIVRCVHFDG-EPARLREETVDRLQKAQAVPERLSTADLRPAVGETVTITGGplQGLTGKVLQ-HRGQTYLLVQVRAVRQAVKIEVAADWVQ--    
248 UniRef50_Q1VSS9        Transcription activator or ...    88     8e-17  1  18.2%   1:170    1:156     MQKDAKKKWFVLYTKPRGEKKLSEQLNR---------SGIEAYCPTRTEVRVWSDRKKKVEMPVLPSMLLVKIE--NKQRAKALESPLAIRYL-FWNGKPSVVTQVEVDTLRSILGDSKFESHELDQLRPGQKLDMTELGFENIEGTVQYVN--KKECWVVLQGIGYVVK-----------    
249 UniRef50_A9A583        NusG antitermination factor...    88     9e-17  1  15.1%   1:179    1:147     MSEEVKSHLFAIRTTGGQEKVVMRLLEAKANANQINIQ-------------------SVFWVNDLKGYVVIEAINPSDAYMAVEGVRHIRGQLRGE------LEFKDIEGYL-------VKKSTVSTLAVDNVVEITGGPFKGMKATITRIDSDKEEATVVLLDASYQLPVTVDANYLK--    
250 UniRef50_Q7NAK3        NusG n=2 Tax=Mycoplasma gal...    88     1e-16  1  21.8%   1:179    2:265     MSKKSTAQWYIATTTNGNEDSVIKTLKAKVRALHFEDQILDCKVIKFRSVEevYKKYKITDTNKYPGYIYIKMEMNEAAWFAVRNTVNITGIVggKGAKpiVITPNAIIEMDRNLFNEreQVDEAIELKVGHMVDINSGDYSGLSGQISRII-DNDEYIVDVQILGKLVSVKLNKKQLK--    
251 UniRef50_B8INV2        NusG antitermination factor...    88     1e-16  1  26.4%   4:181    3:178     ---DQAKTWFVVQTGPARERRVVELLAR---------EGADTWLPLFRVTTVRRGRKVDDFEKVFASYVFAGLdmRRRGTSVLFDCDHVLDVLGVD--RPLPFPADALQVlnRDETEEGRRRTEAAKIQVGEMRRIINGPFMSFFAEVEEVL-SNGIIKAGVRIFGRITPVEFTPDQLDAA    
252 UniRef50_B7KSX1        Putative uncharacterized pr...    88     1e-16  1  19.0%   8:181   46:237     -------KWYVCTTAPSRELSAAASVRQalRGRREGETPFAAYVPCEFFWHRAIRsrREIQRPILRHYILVglAALRDRDREGRNVHGLAGILGAPGIGPLAMNGEGLRWLRAQGEdgATNRSASGTIQPGEDVRAGSGVFSGFLGKFIGTAEGGTVGVIALDMRSTSCEVRLPIEDVHRA    
253 UniRef50_D1N7B2        Putative uncharacterized pr...    88     2e-16  1  15.2%  30:180    1:151     -----------------------------MVAQKLRNAGIACYLPVVPRAYMMHSTKVITEVPMFPGYLFLCLGRFEAADLKIREKKIVKIDLQFDEGREALLIDELHTLQRCEALAKTEPILINPGIRHGDKVLITSGSLAGLVTEVVRRDDAHDAIIVNVTLLGQHIEYRLPAEKLKK-    
254 UniRef50_B0SHW0        Transcription antiterminato...    87     2e-16  1  20.1%   1:169    1:161     MSesEESAWYIVYTKPRAEKKLSELLRK---------YHIENYLPIRKERKKWTDRFKWIHVPVLPSYIFVRIVFWRD-KNKVLQLPGSVQFV-FHKGQPAIVEQNDLDVLEKGLQEYAESLKMNPelQKGKLVRIIDGSFVGKTMEIIKV---KNKTLVVCRIPGVET------------    
255 UniRef50_A6X1C2        NusG antitermination factor...    87     2e-16  1  21.7%   5:179   47:215     ----DDSPWLVLQVMSGRELSVREALGKEN---------IEVLVPMkpKIRRQGREIPAKKQPVMNGYVLARCMISNECLAGLLSFENVVSILGGYET-PFLVSAEKVFVFRAKAEDGqdYEHFHRKFIGVKWARVADGPFAGCRAevSGGTKGNGLVVIEVSIMGRPVAMTVPIAILE--    
256 UniRef50_Q7UWN7        Probable NusG-like protein-...    87     3e-16  1  22.9%   2:180   19:182     -EESLDSPWWLLYTKSRQEKAVIRKLR---------DAGVPHYAPMVkrFRSPAGRMRESFVPLFSTYVFLRGDDQARYEAIC------TGSVLKASEIVQVPDLIEDLQQIRSLIVMGVPLTIESQLQPGEHVRVKNGTFAGYEGTVIRRENET-RLLVFVRFMEQGVSVKLEDCQLEK-    
257 UniRef50_C6QJC2        Putative uncharacterized pr...    87     3e-16  1  23.5%   9:178    3:183     --------WYAIRTNPQREFLLAGRYDENGEWrvLEKKGYdvFCPTETKFRkkKGRRVSIPvpMFCGYIFVGGRFS---WLELMAENYITAAVGFPdrRPAPISDYEMAKLREmlIPHRRSVNTHRAFRVGEMAAIAAGPFAHQVAQIAGLHGTKARVFLNLFNGTREVEVDLDMLDV---    
258 UniRef50_A1RX84        NusG antitermination factor...    87     4e-16  1  16.8%   1:179    1:149     MAEKPPsrFYALRVTSGQEYNVAQLLYRRAASG-------------------KYKVYSILVVPGLKGMVFVESDALYEAQRLAYGLKHVRGVVRGA------VSLQEMEGLL-------KPKPLVDQLNVGDFVEIIRGPFTGMRGRIVGIDKSRNEVKVELAEAVFVLPVTINADDIK--    
259 UniRef50_B8IEU5        Putative uncharacterized pr...    87     4e-16  1  26.3%   1:179    1:168     MDESRT--WHLVRTAPSMMGRALDTLK---------EQGIPTVVPRTVAVGHREGRPYLRRAQMFHRTVFVGVEGAADLDGKVPTARGVTRVLRNPTraPMTISGPDMAAFVAAIGITEKRKP--AGIAAGDRVVVQAGPFASFPAMVEEVLP-NERLKVAVQIFGRATPFECGHADVR--    
260 UniRef50_C3RM78        NusG antitermination factor...    87     4e-16  1  15.7%   6:177    2:164     -----KDNWYVLFALVAKENKLCSVLRRK---------GLDAFIPKIEYYRR--DIKGNTLKMLFPGYIFVRSEmdNLLYELGEQRDGLIKQLKDDG--VTALRDEEIE-MFNKLLNSEGILEMSQAFIEDNKAKVIYGPLIHYQDHIVKIDKHNRIAILDIEFLNRHILAGLEIKS----    
261 UniRef50_B1C1D4        Putative uncharacterized pr...    86     5e-16  1  15.6%   8:180    2:164     -------NWYVLYTLSHRTQRILGNLNKKKE--------LEAFIPSYEVC--HRYTKEITIKPMFNNYIFIKTMLNQelFNMKEDNNGLIRQLKNADT--SALTKKEIE-FFNLVLDSKHVVRLSHGYQENGITRVISGPLVAYENHIVKVDKHNCCAFLDLIFFDR--RIKLGIDILGK-    
262 UniRef50_A6E8J5        Transcription antiterminato...    86     5e-16  1  18.8%   8:161   13:155     -------KWFAVYTRPRWEKKVEQQLKM---------QGITCYCPLRKVQSQWADRIKVVELPLFSSYVFVCIHPREEL--NVRLNIGVVNFVYYMGH-LAEIRHSVIEEIKSNLEkpDAEIVSMRDLEVGDRVRIKAGLMGEQEGKVLQVRGKNVLLVID--------------------    
263 UniRef50_Q5LG31        Putative transcriptional re...    86     5e-16  1  18.9%   1:180    9:173     MTEKQSCHWYLAFTASRAEQRVKQELDQR---------KVRNYLPLRKITYQWQGRSREALCPQIARCVLIWTSLSDI-----RQLSGISGLIIPQNIWDYRVPEWQVESYQLLFSQMDTAVEWIPdlESATMVRVTGGPLTGLVGELDTSDTG-FRIRIRFHSMG-CFRVAVPEEWIEK-    
264 UniRef50_B9YBN1        Putative uncharacterized pr...    86     6e-16  1  16.9%   9:180    3:169     --------WYFIETERFQEEQVKETLL---------NSQFDAFAPKKEMYFKKGDLTTLTLRFLFPGTVLIHDPASPPQFAkdRNQPGSEGIHREADAYFSLASDE--KETLEQLLNEKKILQFSTGIIRNKELHVLKGPLQGHEKEIQKIKRHQRLATLPIKLCGQTIPLILGLEVIEK-    
265 UniRef50_UPI0001C34E8E NusG antitermination factor...    85     8e-16  1  14.7%   9:171    3:160     --------WYVLYCRPGQETEIIESLKQRLPKDALSEAffQC----ERLWRAGGGNWKLIRKEMFPGYVFLESEDSEYLSEKLEAYRGIVR-VMEEPGYLIPVYREEEERLRRLCGP-EHILRLSYGYRENGVNHVVEGPLKGMERQIVKADWHRRFAQIETAVGGKRTVI----------    
266 UniRef50_A6L134        Putative transcriptional re...    85     8e-16  1  14.0%   1:179    1:174     MYSSEKMQWFAMRATYRRGMQIKGLLDQK---------GINSFIPMRYEIHLKNGHRRRELVPVIRDIVFVHTTQS-ELQRIKYGIPYFQYMMDIRNGEKIIVPDEQMRRFIAVAGTYDEQipDEVNLRKGTKVRITGGQFEGYEGVFVKVKGSrrRVVISLQGILALAMATLSPDLIE--    
267 UniRef50_A6LGY4        Putative transcriptional re...    85     9e-16  1  16.3%   1:178    8:184     VEEKKQVRWFVMRAYKN-EKMAEDRLKDK-------EYGLEYFIPKHYAVKTYHGVKSTRLVPVIPSLVFVHASHSQITEFKKrnFLQFAMWKKSTGMEYITVPDDQMDSFIqyEKDTAYYKPDEIDVRKGTRVCIHGGKLDGVKGVFMRVKGKrrRVVVMLeiMGISAEVHPDLIEV---    
268 UniRef50_D0I9V3        Putative uncharacterized pr...    85     1e-15  1  18.4%   8:181    5:165     -------RWYAVYTHFNEEKVLRDELLAK---------GYEVYLPERKLWETLGNRRRVTYEPLFKCHLFVRT--TPEGLKNVKQAQGFSHLVRY-GKYVATISESHIIKIKTILYYYEDATSVSNSNVEGLAVAVVNGPLKGMIGVLPAGEGERPIAM-EIGQLGYSVNVTVPMDTIFRT    
269 UniRef50_B1ZWG3        NusG antitermination factor...    85     1e-15  1  17.0%   4:179   18:177     ---PANAVWLVCHTKPRCEKKFAAL---------MAAERFEHYLPLVDSVRKYRQQTKRFTKPLFPGYVFACVPNEKRARIFQQDL--LARAIDVDDERRFLRQLDDVRAIVASGYELTVLPL----LTRGRRVKIVGGPLHGLEGFVDDPSNPRG-VVLSVDVLQQGLLVKLPAENLQ--    
270 UniRef50_C3RR25        NusG antitermination factor...    84     2e-15  1  15.0%   9:175    3:163     --------WYVARCKTGRTKKLVSTLNKQVNM--------NAFIPKSERCFGRGETAEFIVKEIYPDYVFIKSDLDQEAFDEqkTINGLVDLLEYKDTYPLT---SEEQSLLEKLLDNTDTIKHTKGVIVDRRFVPTDGPLVGLEDMIKKVDKYRRFATLDTEIFTGKLLVAIDY------    
271 UniRef50_A7V9P1        Putative uncharacterized pr...    84     2e-15  1  17.5%   4:180   25:197     ---ETQKYWFAARTLSKQEFAVKKRIENLNLEEGID---VECYLPTRTVISQLKYRRKRSVVPVARGLIFIHA--TKQSACDIHNVYGVQVFYmfSTHSMLVVPDKQMQDFMFVMDLNPEGVCFDNelTVGKKVTVVKGEFSGIEG---EIATEANKTYVVIRITGVLvsIKVPKSYLKA-    
272 UniRef50_A9SPI1        Predicted protein n=1 Tax=P...    84     2e-15  1  26.6%   9:177  119:326     --------WYMVSTPKKAEHEAAEQLHIQFAQM-FPGMKYEVLTPSIPSFRkkSGRYSDSRVRLYPGCLLIRCVMNRDVYNMIRSNLRIYNFFgsDMIIPSAVSIIEIEELFRKMEEAEAepPPPPTIEKGALIRINVGPFINHTGIVNYVDHENETVQLSVVIFGQSTDAELRIDE----    
273 UniRef50_Q6L1X2        Hypothetical transcription ...    83     3e-15  1  16.6%  11:179  133:280     ----------IAKCTIGKELDTAVDLSAKAETDLKERLISN--------KNARNEILSIMSPYEIKGYIFIETMHVDRVEYLARTLRNFKGIISGT------VSMDEIEHYL-------TPKPAVSGLSLGDLVEIVGGPFKGERAKIMSIDASKEEVTVQLTESMVPIPVTVKAESIR--    
274 UniRef50_B0MWZ3        Putative uncharacterized pr...    83     3e-15  1  16.7%   1:180    1:177     MSDKneECWYALKVFYNRVFELEKQLSQ---------EGVRSYIPLLHEDTVAGDKKIRKRKPAVSSLMFIRQslLELQDRMKASCPFMAYF-DRETKKPAVIPDREMELFMQITSADTSDLEyaIDYRSGDKVRVTGGPFKGAEGYIKRI-RGNRRLVVALEGIIAVATTYIPGRFLEK-    
275 UniRef50_A7V7E7        Putative uncharacterized pr...    83     4e-15  1  18.9%   3:150   62:212     --EEDSPHWYALRTTYGREKKAYD---------YMTAKGITAFYPTTDTVKLIKGKRKIVTESRLPNIFFAyfVYDNVNLPFLRFYYRHVHVGRRIEKIPMIVPDYQMESLKIIcdNTIVSLIEVPKFEKGQLVRVIDGAFKGVIGRVAR-------------------------------    
276 UniRef50_B8D5Q0        Putative transcription anti...    82     7e-15  1  16.7%   1:180    1:158     MSESQeaKIYAVKTTLGRELDTALIIGMRirARGEETSIGSIIIP-----------------PNVRGYVFIEVERLGELYKVISDIRYI------KAGRPIKVSYEEFEKLL-------KPKPVIEELNVGDEVEITRGPFRGMRARIAGIDRNKNMLTVNILEAAFTIPITIPGDYVKK-    
277 UniRef50_A6L935        Putative transcriptional re...    82     8e-15  1  18.1%   3:179   35:218     --KSDQKHWYIAIVNNKSEKLCRDKLEKRIASQPEGEKDYEVYIASQKEMclPSGKRKQVDRIVFRSIVFIRCTDVLRRKEIVH-LPYIKRFmrSGGIRPVaiPDEQMVKLRRMLDDSEEPVIIDPRPLpgARVRINGGKLHGLEGNVLEVEDGNLNFVIRVDLLG-CAKVNITRDLLE--    
278 UniRef50_A9NQH7        Putative uncharacterized pr...    82     9e-15  1  16.8%   8:156   80:242     -------QWWMLLVPRNSERLVAEDLSKAFPSE-FPDIEFQAYLPEIPSRRkkNGSYSESKKRMFPGYLFIRCPLNKEIHDFIRNTPRVRGFVgrQMIKPKPVPIAEMEETFRKVKEEQEAYDIEIQEekTDDDSIGQDLLEDLEGTDVRMKKDAN-------------------------    
279 UniRef50_Q8VSS9        UpdY n=24 Tax=Bacteroides R...    82     1e-14  1  14.7%   1:163    1:159     MNNSINKSWYALRITYSRELAFKEYLDSR---------GVRNFLPMRYEYVFRGERKIRKLVPVVHNLVFVYATRSEV--DEMKSTVgiRYIMDRETRQPITIPEVQMRSFIAVAGNYDEQvpSVVSMKRGDRVRVTGGIFEGVEGEFVRIKGDR-RVVVSIQ------------------    
280 UniRef50_B9Y881        Putative uncharacterized pr...    82     1e-14  1  17.3%   8:175    2:164     -------RWYFVEVEKHHEEDVLEL---------MKSSPFEAFLPKKQRYFKKQVLVTWVERLLFPGTIMITSDFPQAEFTKQFnhSDISQWIHLEEKEYFSLQEDE-RLFLNSLMNEQHVIPISTGFLNEKQLIVESGPLQGLESRIKKIDRHQRTAQVRFQICGQMMLLNLGL------    
281 UniRef50_D1CTG7        Transcription antiterminato...    82     1e-14  1  22.8%  54:176    4:123     -----------------------------------------------------RAQHRTVCSAYFDCYLFVSLDIRQQRWPPINSTVGVRRLVMSE-HAPLPVPHGVVESLLAATDDEGFLHPKEL-LEPGQKIRVTNGPFTDQLGTLDYV-GRSGAVRILIDIMNRAVPIYIDRD-----    
282 UniRef50_Q48MX6        Transcriptional activator R...    81     2e-14  1  18.6%   2:168   37:187     -EEEPKKEWYLVQCKSGQDSRAEENL---------TAQGYANFRPTINASSESRSVNTKHNSPLFPGYLFIHLSASD-NWAPVRSTKGILTIVKF-GGRAHAVRNEIIQDIKTRAE--------SLNYSHSSHSEKDSAPLDNRGSEISDILSAkeRTLLLVGFLQRE-------------    
283 UniRef50_D0XNC5        NusG antitermination factor...    81     2e-14  1  21.0%   2:177    8:188     -DTKPAAPWFVVITHVNQEKLAKYQLERQGHAVYMP------MVPPSPRARMRNGVPPSV-RPMIPRYLFVQVDLDQPGWPAIYSTFGVSEVitGEGRRPRAIPTRFIEEIRAREVNGLVILPEARkfKKGDKLR-WHGPTADYEVVFQQM-VDGNRAEVVFTLMGVDSriSLPSDD----    
284 UniRef50_C3RR26        Predicted protein n=2 Tax=B...    80     2e-14  1  14.3%   8:175    2:161     -------NWYVLYVFSNKTNKILSNLNQRKE--------LTAFIPKTEVF--HRQAKKKTTKDMFDNYIFVKSDLKQNDFNDLlkNDGLIKQL--ENAEVSALREKEIEFFNNILDKDNVARVSVGYQEEGKTI-ITEGPLLHYQDHIVRVMKHHCTAQLDLPFFDRKIILGVEL------    
285 UniRef50_O27714        Transcription termination f...    80     2e-14  1  18.1%   3:179   12:162     --EDSKNSIYALKTSVGQEKNVARMLARKVRDSGIE--INAILVPE-----------------SLRGYILVESSSKIDMRNPAIRVPHLRGVVESKTEGEAEIDFEEVKRFL-------KPEPIISSIKKGSIVELISGPFKGERAKVIRIDESREEVVLELIEAAVPIPVTVKGDQIR--    
286 UniRef50_D0D588        Putative NusG antiterminati...    80     2e-14  1  18.8%   3:172   39:207     --DRGEIAWYALLCRPQQERHAESWLAAR---------GVYAFHPVTSRRTRVRGKLREYERRYLPGYVFARFDGIPIPHRVLTS-PFLTGALCRSDGQWGVLGPKRLAALHEMRARDLRQEDERQEQkaGERAMFRAGPFEGMSCEVVEIDAAGG-VKVRFDLFGRENSVT---------    
287 UniRef50_C5B0S5        Putative uncharacterized pr...    80     3e-14  1  22.0%   9:181    7:187     --------WLIVRAQLGRFSQVVEGLK---------SAGCPVFEARREIRVQTDGKPKVTNAPMMGRTLFVGVEEPEYA-CLLAGLDYVHGILCRggARPAMIPPKMMTEFADHITGHKKAGKGVQDfsVGDEVRISNGAFATFMAKIEGVDVKRGRYTVAVDVFGRPVPFEIAEESLEAA    
288 UniRef50_C6I4Z2        UpcY n=5 Tax=Bacteroides Re...    80     4e-14  1  23.1%  38:180    2:142     -------------------------------------QEVDTFLPVQNRVIEREGKRIERERLLLPRMVFVHISRQE--MAAVRSTLNVYDFLrrSTGAPTCIPDAQMADFRYMLDYSQDQVILTGeiPKGTRVVVAKGDLQGLRGELVRYNN-KYHILVRIDMFG-SAMVTIPASYVRK-    
289 UniRef50_C6ICX6        UpaY n=18 Tax=Bacteroides R...    80     4e-14  1  17.3%   1:179    1:168     MSQQQE-YWFAARTRKDQELTTRDALEK---------IGVEYFLPTQFVIRQLKYRRRRVEVPVIRNLIFVHA--TKEFACAIANEYGVRLFYmfDTKSMLIVPDKQMKDFMFVMndPAAVILNDDCFAVGTKVQVIKGDFCGVEGELASLS---NRTYVTIRIRGvsASVKVPKSYLR--    
290 UniRef50_B6W2H1        Putative uncharacterized pr...    80     5e-14  1  17.6%   3:178    6:188     --DKDKILWYVMRVYKN-ENTAEDRLSN-------ETYGLEYFIPKQKVLRTVKGKKVFFMVPVIHSLVFVHASHQKIVDFKHNYYYdfVTWKSGGELVYLTVPDEDMTNFIKVCKQADEEvkDKINIEKGKRVRVHGGPFDQVEGYFIKVAKKRGRQLVVidLLAVSAEVKPEYIQI---    
291 UniRef50_C6A1F2        NusG transcription antiterm...    79     5e-14  1  19.0%   1:179    1:147     MVKMSESKIFAVRVTVGQEENTAKLIYSKAKTYSLP--IMAILSPSKVR-----------------GYIFVEATEKAAVDEVIRGIRHAKGTL------PGPISFIEIEHFL-------EEKPAVSGFEPGDIVELIAGPFKGEKAKVVRVDESKDEIVVELIGAIVPIPVTVRGEYVR--    
292 UniRef50_Q8EUN7        Transcription antiterminati...    79     5e-14  1  22.7%   3:134   14:175     --KKDEAKWYIVTSINGNEDTVYKNIEDKVRAYDLGNVVQEMRLLKTREITirYKKTRIREINRFPGYIYIKMIMEDDAWYVIRNTFGVTGFVGSSGkkPIPMSDIEVANLFNPEMNQDIIINKTSDVFVEQTV-----------------------------------------------    
293 UniRef50_UPI00003C8438 transcription antiterminati...    79     7e-14  1  17.2%  11:179  146:293     ----------IAKCTIGKELDIAIDLSNHAERDREERMAMN--------KNARNEVMAVMSPYEIKGYFFIETMHADRVDVLSKSIRGFRGFVSGD------IDISEIEKYL-------TPKPAVTGLEMGSLVEIVEGPFKGERAKITAIDAAKEEVTVQLIESMVPIPVTVKAEAIR--    
294 UniRef50_A7UZ21        Putative uncharacterized pr...    79     7e-14  1  15.8%   9:179   10:175     --------WYAMRATYRREPDAMHLLKKENLG---------CFIPMQYKICIKKGKKVRALVPVVHNLLFVHARPSDVQ-RVKSQVTYLQYITDTRSGQKIIVPDGQMQRFIAVSGTYDDHlpDELNLSKGTKVRITGGEFEGQEGVFLKVKGARDR-RVVIEIQGvvAMATIHPDLIE--    
295 UniRef50_B7QPX7        Putative uncharacterized pr...    79     7e-14  1  20.4%  20:181   49:217     -------------------RKVKGSGQrfVPELVLQKAGFEVFLPIKKEWSRVNreQKLKCRPAMEGWLFVGWAAGQARFHELMALDVVSG-VMGAGGQPVRISDAKVRFLMRKFGGGRLRRkePVRFSVGDLVRVDAGPFEGQTVSLLDVSGGSARAV--MTLLGKDVEVDLEQEFLTAA    
296 UniRef50_B7C7N9        Putative uncharacterized pr...    79     7e-14  1  17.8%   5:173    2:162     ----NNEHWYVLLTIRSKEEEVCKYLN--------ENDGIYAFSPKMEFY--HRVSKQIQQRSLFGGYVFVVSKLSqeVDAIFKKFPLQSVFIhkYEEEVSALTDEEI-RILNMLLDDEKVLRMSYGELVNNKIHVTQGPLKNMDDYIVKYDKHNRLATLNLSFLNQIWKVGV--------    
297 UniRef50_A3DNH9        LSU ribosomal protein L24A ...    78     9e-14  1  17.3%   1:179    1:152     MSIRRKTSFYAIRTTMGREIDVALVIESRIMDLVKQN--------------RDPGVKAVFVPPGVRGYVFLETSRLASIYRLISELKYV------KSGQPIKVSLDEVGRLV-------KPKPVIEMIKEGDIVEIVRGPFRGMKAQVISIDRNKNMVVLSILEAAFNVPITVPGDYVK--    
298 UniRef50_A2BN62        Transcription antiterminato...    78     1e-13  1  17.2%   6:179   22:163     -----QPRLYAVRTVAGREIDVALIMEQRARDQNMP--IYAIIVP-----------------PQIKGYVIVETPAAFYATNAIQGIRYAKGVV------PGVLRYEDVERLL-------KPKAVIETLKPGDIVEIISGPFRGMKGQVVRVSPSKNEVVLNVLEVEYPLQITVPGDSVR--    
299 UniRef50_B9QSZ2        Putative uncharacterized pr...    78     1e-13  1  18.5%   9:181   31:200     --------WIVVRSNPNCESRAAESL---------SAAGLIAWLPMLPVLRKNSRTRNekSRPLCTRYLFVALDRYkqSTSEVVVCDGVEKVLSfeENRPHIVPKAQMRViqCWNAITEGNLSKVKHFDIGAVFGLLADEFDGVTGTVTGYDEAKGIVEGLVPMFGREMAVKVAVDKVKAV    
300 UniRef50_C7XGA2        Putative uncharacterized pr...    78     1e-13  1  20.9%   3:165   26:198     --DQEAVRWYVLttAGGGRDRikGLDAELSRRERRGEALFEYFSPSYVEARKVGGKMVNTKRPLLYNYVFVHAS-EDEIFRLKRTLpnFLPRVSSGGRSYFplSDREMDTLRWVAASYsvYVPDSGRLLKGDRVRITSGPFTDMEAEVV-VQPGGGHKDVMVRIL----------------    
301 UniRef50_Q8AAK2        Putative transcriptional re...    78     1e-13  1  16.3%   3:180   10:182     --TEGRKAWYAVQTFYCKEEHLGKYLEKK---------GVNYFIPMRYIeeTLDGKKHRKLTPAVHNLLFIEKEFTeeLLERVKDCTIPFLLVrrSTRRCYEIPDCEMLEFRAVCDPNYkvDTVTAEARPGQAVRVIRGPFAGLEGKLTQYKKSY---YVVVTLATIGVMLHIPKWYCEK-    
302 UniRef50_B0NP97        Putative uncharacterized pr...    78     1e-13  1  19.5%   6:179   13:180     -----KNPWYAVRTFNCQELKISDFLKERKKVH---------FVPMTYVEKEKEGKTRKMLVPVVHNLVFLQKNESRKATLAMLKECNvsVLCDKETKHPCEIPDKQMTEFRILCDPDFKDthEEAEAKPGKNVRIIHGPFAGITGKLHRARGGYYLIK---TLAGVGVMMRISRWYCE--    
303 UniRef50_Q978E9        Transcription termination-a...    78     1e-13  1  17.8%  11:179  138:285     ----------ALKTTVGSEVQVATDLNNKAERDRDERSQGGEKQPSEVFA--------IMAPYEIKGYIFVETMHPDRISYLAKDIRGYKGMVSGK------IDLEEIAHYL-------TPKPAVSGLELGSLVELVEGPFKGEKAKIISIDSVKEEVTVQLVESMVPIPVTVKAESIR--    
304 UniRef50_C3RM77        NusG antitermination factor...    77     2e-13  1  15.9%   8:177    3:167     -------NWYLIFAN---DNKINDLLLYFNNHPEMT-----AFVPKIEKLMKKDGKKVFAEVPMFPNYIFIESEFNSQEFylEKDMDSTMRIMQSDEQKVLSLANNE-KELLESLFNDDHLIIRSIGVIVDSKLIVQDGPLVGKEEMIKKIDRHKRVAFIG-DVFGKTMKVPLEVTS----    
305 UniRef50_Q9Y9W3        Putative transcription anti...    77     3e-13  1  17.1%   1:181    1:149     MEGGVDARFYAILVTSGAEVNVATIIAERARALGL-------------------DIRSIIVPPRIKGYVILEAHDPGDVYDATRGLRHVKR------RRPLILKFEEVMKLVKPEVE-------IPALKPGQVVEIVAGAFKGMKARVIDVNQSKGQVTVSLLEPLFRATATIPIDEVRPV    
306 UniRef50_Q5LF44        Putative transcriptional re...    77     3e-13  1  15.6%   8:148   27:164     -------NWYALRITYGRELALQEYL---------NSEGIENFIPMHYEYTIKNERRVRKLVPAVHNLVFVRSSRsdAIKESKGTTLPIRYIMDREYHRPIIVPDSQMRNFMAVSANYDESlpSELNIRKGTRVRITGGLFEGVEGEF---------------------------------    
307 UniRef50_P96036        Putative transcription anti...    76     6e-13  1  17.9%   1:179    1:148     MEKPNMRNYYAIKVVGGQEINVALMLEERIKTNNI------------------KGIYAIIVPPNLKGYVVLEAEGLHIVKPLIAGIRNARGLAQG------LLPRDEILKIVS-------RKTVGPTVKPGDVVEVISGPFRGTQAQVIRVEEAKGEVVLNILESAFPLQVTVPLDQIK--    
308 UniRef50_B9NP65        Putative uncharacterized pr...    76     6e-13  1  16.9%   3:179    6:213     --ESKELQWFACRVkvGGEFKAYRdcKRRVNGTglRRAGFEVFLPIKKVLRRKNreKALISQPLLVDWLFVGWPVGESRWHDLMELDVISG-VMGTGGHPIEFPAARVMSLMRqsSECRRYLKTGSEFAVGDTARVIAGPLDGVHVRV--VDVSGPTVKAALGMLGSEVVTEIRGDLLE--    
309 UniRef50_Q8TX53        Transcription antiterminato...    76     7e-13  1  16.8%   1:179    1:154     MAETDSTKLYAVRVQAGREEATADMLVMRARRKVKEEGI-------------ETGLKAVIAPEELRGYVIIEVelTDELRDLIHDLPDTRGIVEK------PMDFEEIEHYFA-------PKPEAVEISEGDVVEILSGPFKGEKARVVSVDESRREITVELLEAPVPIPVTVKMDALR--    
310 UniRef50_Q2NEV9        Putative transcription anti...    76     7e-13  1  17.6%  10:179    3:140     ---------YAMRVLIGQEKNVASLLAQSVKHED-------------------TGISAILSPESMKGYIFVESDKTLDMRHPALKVPNLRGLVEGD------VDFDELKSFLS-------PDQSIVNIEKGSIVELTSGPFKDEKAKVVRIDEAKEDVVLELIEAAVPIPVTVKGDQIR--    
311 UniRef50_A6L7Z6        Putative transcriptional re...    75     8e-13  1  19.5%   5:163    7:161     ----DGNHWFALKVFYNKVFEIEESLKK---------DDIDCYFPCEDAVVMRNGVRKIIRKPIISSILFFHSTTLRAMEIQRQFTDKVILYTRDKELkpLIIPDREMNIFMLVTSSGEKGMEysTKFCRGERVRVIDGKFKGAEGYICRIKK-NSRLVVAIQ------------------    
312 UniRef50_A6LD20        Putative transcriptional re...    75     8e-13  1  14.5%   1:179    1:176     MEYPLTDDWFVLrtRPN---------AKRPAYRLLEEKGIEIFTPMRWRLVERKGKRIREEVPLLHDLLFAHTTRTCMDPIVEEISTLQYRYLRGGYRKPMTVGHAEMNRFICAVHSDDSpvEELTPAMYGRMIRIEGGPLDGYEGRLLSIRGTrkRLIVEIPGL-LVAAVEVDPKYIR--    
313 UniRef50_D1PI13        Putative transcription term...    75     1e-12  1  17.2%   2:181   43:220     -EKPTDAGWYVAVVRVNCETRIADSIR---INLNHNHVWFDYWIPKVKVVYikRSNKRKVKEKLFLS-TFIFCNVSPRQLDKIRFRSDVYKMLTMPgrKIYQIPDQVVANYRYFVENDEEPVTapVPLKKGIKVRVVAGSMKGVEAYVQSYNGKKAVIGSEIKYISGAT-LTISRNLLEVV    
314 UniRef50_Q57818        Putative transcription anti...    75     1e-12  1  17.6%  10:179    3:140     ---------FAVRTMVGQEKNIAGLMASRAEKEQL-------------------DVYSILASESLKGYVLVEAETKGDVEELIKGMPRVRGIV------PGTIAIEEIEPLL-------TPKKIIENIEKGDVVEIIAGPFKGERAKVIRVDKHKEEVTLELENAAVPIPITLPVEGVK--    
315 UniRef50_B0VET3        Putative uncharacterized pr...    75     1e-12  1  16.6%   5:179   21:179     ----DDRKWVVVHTKPRCEKKLADYAKQH---------QITYYLPQYTSKRVYQRRKVDVNKVLFPSYVFVGIDFKGKQELLISGYT--VNFLKVNAQKELIDELQAI----YYGRQKNVQMEPGLWLEKGLEVEIVNGPLKGIRGVVEDQSKLTE-VRLQVNILKQAVLVKVRTQDIK--    
316 UniRef50_A7FC44        Transcriptional activator n...    75     1e-12  1  19.7%   7:128    2:115     ------KNWYLLSYKYGQVNRVQ---------FGLDRLGVNSFSPSIQVKKVRsgTIRLVNEPMFPTYLFVEFDIESIHTTTISSTLGVNYFVKF-GTEPKPIPLSLIHQLMNRSECSSQRNEEIDEI-----------------------------------------------------    
317 UniRef50_B5IAH1        NusG antitermination factor...    75     2e-12  1  17.8%  11:179  133:270     ----------AVKTTIGQEVKVARDIGMKAKIHGWKE-IFSVLAP-----------------YNLKGYVFVETSRPDKVLSLIRGIKDAKGVVRGE------MHLEEIKHYLTPT-------PTIHRISVGDIVELVEGPFKGEHAKVIQIDEAKDEITVELFEAMVPIPITVKAEAVR--    
318 UniRef50_D1JE94        Putative transcription anti...    74     2e-12  1  19.4%  10:179    5:145     ---------YAVKTTVNQELAVATMVEGALGEEGVKDHGIkiMVPEE-----------------LKGYLLVEASFPEALEQIIQSIPHARGLVKG------VMGLEEVEHFL-------TPKPSVTGILEGSIIEIVSGPFKGERARVKKVDEAHEEITIELFEAMVPIPVTVRGDSVR--    
319 UniRef50_B3T614        Putative KOW motif protein ...    74     2e-12  1  15.7%   2:179   79:224     -EDEGISHLFAVRTTGGQEKIVMRLLEARIKMEKINIQ-------------------SVLLLSDLKGYVVVEARDVSAMFDAIQGIRHIRGQLRGE------LTYKEIDKYLI-------KKSTVSELAVENTVEIIGGPFKGMKATITRLELEKEEATVILLDATYELPVTVDANYLK--    
320 UniRef50_B7UF78        Similar to transcriptional ...    74     2e-12  1  14.6%   8:165    3:141     -------NWYLACHQPGKETLYKAQLE-------LSRLHIDSFCPLIRLSRPRPDRprLIIEPLFSGYIFIQFDPEITHTTKLTALSSVSHFVKFGCD-IRPIPKTVIESLMKLPLCPTEQD-------------VIAGRFKEKIVAITRVSNKHERTVMFLALM----------------    
321 UniRef50_B1C0R1        Putative uncharacterized pr...    74     2e-12  1  13.2%   9:175    7:167     --------WYVIH--------AKVDRGSKIVKFFNSQKGVDAFIPKIEKWHNVKSVKDYVIKDLYPDYVFVKSDMDNEAFNkfESIEGFGELLEYEGVYALKDTE---QDLMEKLFNGGHIIKRSIGNIVDKKLIVDTGPLLGLDDLVVKINRHHRVATLQTEFFDKKIMVPLEV------    
322 UniRef50_C6IMS6        Putative uncharacterized pr...    73     3e-12  1  15.4%   4:159   40:190     ---KGGANWCYLFIHHTKVNAVNEKLKER----------YCTFIHKSVVYKRKNKRIAKDEKPTISGLVFVQGESDDIQSFLCENFFGLYLVKDCSTGKIAVIHNNVMQSFMQVSQVerFMPHTFDYYSSGNtvRITSGPLTGLEGYRIRISRDKCLVT----------------------    
323 UniRef50_B5CYV1        Putative uncharacterized pr...    73     3e-12  1  16.0%   5:179    4:173     ----DKAKWFVMrtRSN---------AKIPAYQMLDDMGIENFTPKVTKIVTRNGKRERKELPFIHDLIFVHSSRTVIDPIVERVHTFQYRFLK--GREPMIVRDKDMASFKQAVESSRFppQDITPCMFKRKIRIIGGRLDGCEGYLLTVRGSKrrLLVELPML-ITAAVEVEPEYIQ--    
324 UniRef50_A4EPJ2        Transcription antiterminati...    73     3e-12  1  20.9%   9:180   33:201     --------WFVLKVQPMKEFEVEMWL-------GQQEGVLEAWLPTNKAWrrGHRRKVQYRQKIAPGYVFACVERRIAWDLLQRRSNgvLGVVGYNG-RPLPVPEEQMRAMKKLPKIVQKIYAEAQSVkpGDKARIldGPMCDWVVDVTEVNG--GIAKILVPLLG-EREAQISMEQLER-    
325 UniRef50_Q74M56        NEQ540 n=1 Tax=Nanoarchaeum...    72     8e-12  1  15.9%  10:179   18:155     ---------WIVKTAGGKEEIVADLIEAKAKKLG-------------------ANVYSIVIAPGIKGYIFVEADKYDTVNELVHDIKHVRKVL------PKPIEVKDIEKFI-------KAEPLVTKVNVGDIVEVIAGPLKGSRGKVVAFNENTGEVTIETLDSVIPLPVTVSIHDIK--    
326 UniRef50_A0RUG2        Ribosomal protein L24A n=1 ...    72     9e-12  1  18.1%  53:179   14:127     ----------------------------------------------------KIDIQSVFVVDNLKGYVVVEANDPNAAYQATDGVRHIKGQLRGE------LDFKDIEGYL-------VKKSTVTSLEKDQTVEITGGPFKGMKASITRIDHEKEEATVVLLDASYQLPVTVDANYLQ--    
327 UniRef50_A8Q761        Putative uncharacterized pr...    71     1e-11  1  11.7%   1:162  229:365     MPSVNDPGLWRIRCKRGRERTLVATVLRRALTRETSGRPLRIY--------------SAFCRDSLDGQIFVEARRADDVLDAFDGLAGAY----TTNTKPFLVPILEMADLLKLQKKNTEVP-------VGGWVRIKRGKYAGDLAQVLDVAENGEEVGVKL-------------------    
328 UniRef50_D2EF56        NusG antitermination factor...    71     2e-11  1  14.7%   2:178    5:148     -ENNEESHFFIIRVTIGREMQALERLQSQLA--------------------RVNGIYSIVKPYSLKGYIIVEADSRESISNLIYNIKHIRGIMNKELSKDEALKTIE-------------KKKQNIDINIGDVVKVLSGPFKGETATVKAVNKEKEELTVMFLESAVPINVNIKISDV---    
329 UniRef50_A8HQJ4        Global transcription factor...    71     2e-11  1  14.9%   2:162  164:299     -PTPNDPKLWLVTCKVGHEREAVVQLLQKCYTMAERGTPLRIM--------------SAVALDHLPGFIYVEAAKESHVMDAIRGLRTVY-----IGRGAKLVPLNEM------VDAVTVNKKAKDDMARDTWVRVRSGLYKDDLARVVEVDSVAGRAVVKL-------------------    
330 UniRef50_Q4WP96        Transcription elongation fa...    70     2e-11  1  13.9%   5:162  239:371     ----DDPSIWGVRCKAGKEREVVFAIQKRIEERPPGSRK-----PIRIISAFERGG-------AMSGYIYVEARRQADVMEALEDMSNVY-----PRTKMILVPVREMPDLLR--------VQKSEELNPGGWVRIKRGKYQGDLAQIEEVDTNGLDVTVRL-------------------    
331 UniRef50_A6UAQ8        Putative uncharacterized pr...    70     3e-11  1  13.9%   5:162    2:163     ----SRSRWYAIRTAPGYQRMAAVD-ERLPESRRMESigFDIFMPSFYKELKHHRTNEIIEkpFLVGYAFVNLPRLN--FEELRRVDGAVCFLRGANYGPLEFPSATIEALYFAEHERRQAFLYEQHCRKENE---RHEQIQHLRGQLRKILPKGRKARVSM-------------------    
332 UniRef50_Q4PIC4        Transcription elongation fa...    70     3e-11  1  14.8%   1:162  299:436     MPSVEDPSLWGVPCKPGRERDIVMTLVRKAMAENFTSS------PM--------RIISAFCRDSIPGRVYVEARRADD---VVKACNGLAGAYARQTTSLHLIPISEMADLLKLQ-------KVQNEIQVGGWVRIKRGKYAGDLAQVLDVSENGEEVGLKM-------------------    
333 UniRef50_Q984H9        Mlr7998 protein n=1 Tax=Mes...    70     4e-11  1  19.1%  28:179   20:194     ---------------------------EIVAERSIRDAGFECYYPRMRKEIIHHRTNVRIVrpLFTGYIFVALPSANGEY--LKDCDGLGRLLSYDggKPWQVPTGAVerIKRKLEGKTRRETIAMTFPEGQAIRVKQdmLAGFHGEVVSV-TGRGTVKSMIELFGRLVAAEFDADDIE--    
334 UniRef50_P75049        Protein MG054 homolog n=2 T...    70     4e-11  1  18.8%   7:166    8:196     ------PQWYVAPVSVKDE-AVVRNLKAKVKALGFDNEILDVRVLKEREveDRYLKVKISEKNLLGRYIYIKMIYSEDAWRIIRNFPGITGIVGSSGRgpTPLDQADADNLEQMLKGISVNPKKRVLVTNTAIVEMDADKFDEKCQYILKHKQVKPEAIAQVNESG---------------    
335 UniRef50_UPI00016B21AA transcription antiterminati...    70     5e-11  1  50.8% 118:180    12:74     ---------------------------------------------------------------------------------------------------------------------GVEEPKHQIDFEEGEVVSVIDGPFKGFDGTISEIDTVKGKIKVMVSMFGRDTPVELDALQVKK-    
336 UniRef50_C9LF34        Putative transcriptional re...    69     5e-11  1  14.4%  27:158   48:183     --------------------------LKHIAQKLKADNCFPTFVHQSCKYIRNHDKVCKQLRPTISGLIFIQGEVKAVEAYFKERLPELHLACDYATRCVARIPHAVMQPFMKIAerIRFLLHPFEHYAGSQLVRITSGPMTGLEGYIIRIDRDRKLV-----------------------    
337 UniRef50_C3Q0J2        Putative uncharacterized pr...    69     6e-11  1  15.7%   1:178    1:181     MDeeDKLHWYAMR-------DLKRRHAKLPAYKMFENLKVQCFTPMVHRLVVVGGKRVDQEVPFMQDLLFVK-DTREHLDAIVESTPKlyRYKLGVQHTPIIVPVADMERFIKAVEASDNppDEVTPEMRNRKIRIIGGQLDGYTGTLVTTRGSkkRLLVEltLLAASIEVEAEYIQL---    
338 UniRef50_Q12UQ1        LSU ribosomal protein L26e ...    69     7e-11  1  17.7%   5:179    3:145     ----EDAAIFVVKTTANQERSVAAMLAQVAKKENL-------------------DIRSIIAPDELKGYVLLESSDSGAVEQAIQTVPHARTVVKGQS------TIAEIEHFL-------TPKPTVTGIVEGAIIEVTSGPFKGEKARVKRVDEGHEEITVELFDAVVPIPITIRGDTVR--    
339 UniRef50_C9Y5P4        Transcriptional activator r...    69     7e-11  1  17.6%   8:138   10:135     -------KWYVLYCNS-------QDIQR--ISRRAEDIGVEVFCPRYIKVTPRTDCrrQEEKPLFPSYLFLRFDVNVVHTSTITSIPGAHGFVSF-GAAPCTVPESVITAirLLALNPDEDVFECRNISPDLLLKIQE-------------------------------------------    
340 UniRef50_O80770        Putative transcription elon...    68     1e-10  1  14.6%   6:162  168:295     -----DPKLWLVKCAIGREREVAVCLMQKIVDRGSEFKI-----------------RSAIALDHLQNYVYIEADMEAHVKEAIKGMRNIY-----ANQKILLVPIKEMTAVLSVESKA-------IDLSRDSWVRMKLGIYKGDLAQVVDVDNVRKRVTVKL-------------------    
341 UniRef50_B3JI43        Putative uncharacterized pr...    68     1e-10  1  16.9%   2:178    9:183     -EDLTRIQWFAMSAYKN-EKKAEEMLKGK--------DGLEYFIPKHYAVRVYHGVKSKRLVPVIPNLVFVHASRKQITDFKKknFLQFMMWEKSTGLKYIVVPDKQMESFIKIASQYEEnkPEEIDIRKGTHICIYGGKFNGVKGVFMRVKGKRRRRVVVmgIMGISVEVHPDLIEV---    
342 UniRef50_C6JAQ8        Putative uncharacterized pr...    68     2e-10  1  19.6%  84:180    6:100     -----------------------------------------------------------------------------------RKVIGLTKLIG-TGDEIVPLVQEEID-LLMKIGTDKQLVEMSSGIIENDRVQILAGPLMGMEGNIRRIDRHKRTAYLEIEMFGRTVEMKGGLEIIRK-    
343 UniRef50_O13936        Transcription elongation fa...    67     2e-10  1  12.7%   5:162  238:368     ----NDPNIWAVRCKIGKEKDIVFTIMRKAMDLQYTSSPLEII--------------SAFQRDSLVGYIYVEARKQSHVLDALNGVLNVY------TNNMILVPIKEMPDLL-------KVQKQVVELLPGAYVRIRRGKYAGDLAQVDNLSENGLTARVRI-------------------    
344 UniRef50_D2VQ68        Predicted protein n=1 Tax=N...    67     3e-10  1  16.1%   2:162  117:257     -PTPEDPKLFLVKCKQGKEKevMTLLQKHFSVKHSPNKKDRLLITSALFIE------------GFKGKIYIEAQKEVHVRHA---IEGLSHLIYESGIKLVPL--KEMPDVLNVNQLSTKI----QDISVGKWVRVKRGTYKGDIGKVHDVDKARGYCVVVL-------------------    
345 UniRef50_D1VYC4        Transcription termination/a...    67     4e-10  1  15.4%   4:172   28:194     ---DDDLPWYALRLFTLKTQQVIDYLEEH---------HLDYFIPMEYvvEDRKHRVQQKLRPVVRNLIFIKRTMSELSIRKILTEAPFKGSvsREDSQYYEIPSRQMFEFQAMCNPEIVMRQYLSelKVGTPVYVKYGPLKGLSGRLVRSNKKYFLLK-EIPGLGVMLKVS---------    
346 UniRef50_B9XD13        NusG antitermination factor...    67     4e-10  1  17.4%   5:125    4:114     ----NSPAWYCARTKPKHEHIAAANLLRHAN--------VEVFNPRLRVEKATRRGVIRVSEPLFPCYIFVRCVI-EEKLNDIRYANGISTIVHFANRIPH-ISDSVVVELQEHFKEMREAIVDQ--------------------------------------------------------    
347 UniRef50_Q5KNK1        Transcription elongation fa...    66     6e-10  1  15.7%   1:153  198:324     MPGVNDPSLWKVVVKSGREHAICASIFRKVFAQQYSANPIDVI--------------SVFCRDSIPGMIFIEARQSA---SVSAAVNGIVGIFMSRGVNLVPI--EEMAPLLKM-------KKKDVNLTPGMWVRMKRGKHAGDLAQVVDVDQ----------------------------    
348 UniRef50_B9QXN0        Transcription termination f...    66     6e-10  1  17.8%   5:178   25:205     ----AKAEWVVIHTNPKCETRARDGLLGAGLLAFL---------PMEQIERRHGRGRKvvIRPMFPRYLFAGMDVKkqSVDQIRACDGVKGVLSFdtGAVARVAVSDLIKILELSHGTFEGRPVADglKEGAVVKLVKGSWCGQDLTVTGYDAAKERVIGELTGSAMRLAVTAPLDAV---    
349 UniRef50_UPI0001BCE1C5 transcription antiterminati...    66     6e-10  1  34.4%    7:70     3:66     ------HKWYAIQTYAGSEMSVKRAIENLVVDHGIEEQLLEVVVPTEDVIEIKNGKQKINEESLYPGYAF---------------------------------------------------------------------------------------------------------------    
350 UniRef50_Q9STN3        Putative transcription elon...    66     6e-10  1  10.8%   6:162  181:308     -----DPKLWMVKCAIGREREVAVCLMQKFIDRGADLQI-----------------RSVVALDHLKNFIYVEADKEAHVKEAIKGMRNIY-----ANQKILLVPIREMTDVLSVESKA-------IDLSRDTWVRMKIGTYKGDLAKVVDVDNVRQRVTVKL-------------------    
351 UniRef50_Q6BZG0        Transcription elongation fa...    66     7e-10  1  13.2%   1:159  240:371     MPSINDPAIYAIRCTPGREKDLVRKLYEKKRTLARSN-------PLE--------ILTVFQRDSFKGYIYIEAKKPEAIERA------LTGMVNIYAKQRLLVPVREYPDLLKQVKSSDV------EIVPGIYVRITRGKYKNDLAIVDNLSENGLDVR----------------------    
352 UniRef50_A4RZ64        Predicted protein n=2 Tax=O...    65     8e-10  1  12.1%   6:162   59:191     -----DPKLWLVTVKLGKERETVVCLMQKTINLAKQGKP-----PMQ--------ILSCIAQDHLKGYIYVEAEREDHVRKALQGMRHVYH------GKPVRLVP-----INEMVDSISVTTKEVSVVKVDSWVRMRTGVYKGDLAQVVDVNYADNQCTVKL-------------------    
353 UniRef50_D1W4R5        Transcription termination/a...    65     9e-10  1  15.9%   2:171   23:190     -HEEDTLPWFAVRLFMAKPQLVMDYL---------TEQQLHYFIPMEYvvEDKDHHIRQQLRPVVRNLVFIKKSKPEKAIrlLMDAPFKSSVIRkdDSKYYEIPAKQMFEFQAMCNPEIAMRKFLSelKPGTPVYVKYGPLKGLSGRLVRSNKKYFLLK-EIPCMGVMLKV----------    
354 UniRef50_Q1GG09        Putative uncharacterized pr...    65     9e-10  1  18.5%   9:181    3:188     --------WYLGRTTTRhePGAEKERGEFAVERQLRALGIEAHAPRRIEFKRVGKKRHaiTSAYLPGYIFAEIPAS----MFTRAIQ-CRGLSASLMAVPAQEVLHHVKPFIAKVKSENADAERIIefQPGEALDVLAGPFAERLVKFTRmhDSYPMIEAQIEILGRLTRVKIDPLDVRAA    
355 UniRef50_C5VMP2        Transcription termination f...    65     9e-10  1  16.0%   4:172   13:179     ---DDGTPWYAVRLFT---------LKLEEVRTYFTSHGLECFVPEQYviEGHDGKPHSILRPVVRNLIFVKKPGEDISFQKiqEANYKISVVKkdSQEYALIPHDQMYEFRLMCNPEITMRKfeAQMKAGDEVLVKFGPLKGMIGRLVRSSKKYYLLK-EIPGIGVMLKVS---------    
356 UniRef50_P36262        Transcription antiterminati...    65     2e-09  1  55.9% 113:180     1:68     ----------------------------------------------------------------------------------------------------------------NQVEAAVQRPVSSVFFEVGERVCVSDGPFASFNGIVKNVDEEKSRVHVEVVIFGRVTPVELAYNQVEK-    
357 UniRef50_Q1QI72        Transcription antiterminati...    65     2e-09  1  20.7%   5:120    2:105     ----AERYWGACRTFTGREHLVRAKIEEMDRG---------AFLPTFVRSWIAGGKLSVAERPAVPGYVFFRA--SQDDWSPVQDIDGVIGVLAN-GGRAMRISNDDMASLVIGHAAGAH-------------------------------------------------------------    
358 UniRef50_Q1GII5        Putative uncharacterized pr...    64     2e-09  1  19.4%  10:179    5:190     ---------YAINTTRGKEFAVRDDLKA---------MGVNPWVPVRLGSRYVKEKRSAVWYdyVPKLMF--AVIPAIIWRDVLEHKHVIgvKKSTGAVVPPVprRAVEAEYADAERARANSEYQCQFKPGQALELLCPPWEGFSATFAKVIKHAhkLRVELEIFGRVTPLDVDPDRVK--    
359 UniRef50_D1XYZ0        Transcription termination/a...    64     2e-09  1  20.7%   4:172   14:180     ---DDGLSWYAVRLFT---------LRLKEVKAYFEALDYECFVPMQYviEKPEGGVKHELRPVTHNFIFVKQTMSEASfnVIRKVDDVTQF--------ALIPSKQMYDFRMMCNPekFLSEREAQMKAGDPVLVKYGAMKGMTGRLVRSNKKYYLLK-EVPGMGVMLKVS---------    
360 UniRef50_Q9EUG2        Actx protein n=1 Tax=Escher...    64     2e-09  1  20.8%   8:108     2:95     -------KWYVLQFTTTRFAAVFKHLERLN---------FSYYCPMATEKYRRPDkyRERLTPLFPGYLFIQADFDEVHTTTITGLPHTQRFIAF-GGEPLAVPDDEV-------------------------------------------------------------------------    
361 UniRef50_B6JZQ2        Transcription elongation fa...    64     2e-09  1  12.0%   5:162  183:313     ----NDPNIWAVRCKIGKEKDIVFSLMRKAMDLQYSGRPLDII--------------SAFQRDSLIGYIYIEARKQAHVLAALQGVVNVY------PQNMILVPIKEMPDLL-------KVQKKTVELLPGAYVRIRRGKYAGDLAQVDNLSENGLNARIRL-------------------    
362 UniRef50_A7IAL6        Ribosomal protein L24 n=17 ...    63     3e-09  1  16.1%   8:181   24:168     -------RIFAIKTTSKQERTVADNILKAIETKATDIKVTSIIVPNE-----------------LQGYVLVETPEERNRIEQLVEMIAHARAVAKGQTTLAEVGHFLI------------PKPVVSGIDEGTIVELIAGPFKGEKAVVKRVDSAKEEITVELYESVVPIPITVRGDNVRVV    
363 UniRef50_B8BT45        Predicted protein n=1 Tax=T...    63     3e-09  1  18.6%   5:165   76:258     ----SEPQWYLINCVAGIELDLLAQ-ARLVTKDFPPTDVEKIVVPVERHLRSHGDKKKVVDVKvyPGYVFCKIRLTEDVYETLQELELARSWMGTVNRkpLPLPDEEVKKFKgrTDSGEDLLAQYAGYEVGQMVKVLSGNFEGEDGTVRRLKDGQ----ICVRMF----------------    
364 UniRef50_C7DH82        NusG antitermination factor...    63     4e-09  1  16.6%  10:172    3:133     ---------FVVKVTSGQENIAANILQSKLSKGDAP-------------------IYSIIVIEGLRGYIIVEAQDELACRNFITKERSIKGII------PKPMDPADVEKLIA-------TKSTAQDISRNDIVEFTSGPFKGYKAKVLKVDELKSDITVELMDVVVPIPIT---------    
365 UniRef50_Q8ABS3        Putative transcriptional re...    62     6e-09  1  15.5%  31:159   54:187     ------------------------------VSKKLQTEQYRIFVHKSIVYKRGNKRIKKEEQATISGLVFIQGDANRIQKFLKENFFNLYLVKDCSTGEIAAIPDSVMQPFMRVSerIRFMPHSFDYYSVGnlVRITSGILSGLEGYRIRISRDKCLVT----------------------    
366 UniRef50_A6LE17        Putative transcriptional re...    62     7e-09  1  14.4%   7:159    3:151     ------KKWYALKVFYNRFSEIKATLSR---------DGIESYIPMKTRSyqPDGEVVIRRVPLVAMLMFLRCD--DDYISSLNSILDEKAMvrPGTQIPASIPDEEMDMFImsMEDGFEQIPYDDNLVKneKYRVTGGEYAGVVGYYRRIKKNKRLVI----------------------    
367 UniRef50_A3AP86        Putative uncharacterized pr...    62     7e-09  1  28.8% 102:181  305:388     -----------------------------------------------------------------------------------------------------PVEDSELMLmrQFKKPISKGGSNHNAFTPGASVHVLSGPFEGFTGSLLEVNRKNKKATLQLTLFGKESFVDLDFDQIEAV    
368 UniRef50_A8T9L1        Putative uncharacterized pr...    62     7e-09  1  17.0%   7:112    2:102     ------KNWYLVYCN-------VKNSRRDVLIRFLNSFGVEVFNpyYKARKDRPGKFRKQTKSLFSNYMFIQFDCTKFSFSKFDNIEGISYFLRSSG-QIATIPEPLIENLR---------------------------------------------------------------------    
369 UniRef50_B2CBC8        Transcription antiterminato...    61     1e-08  1  15.3%   8:138    3:128     -------EWYVLYCN----NQDVERITRRVEGLD-----VEVFCPRYIKVTPRKDCrrQEEKVLFPNYLFLCFDVNITHTSTITSIPGAHGFVSF-GSTPCTVPKSVITAirLMALNPDEDAIECRNIAPDLLAKIQE-------------------------------------------    
370 UniRef50_B1L6L1        NusG antitermination factor...    61     2e-08  1  15.8%   3:179    2:147     --EQRQSLFFPVRVISGKEINIMRLLVSRVSSTG-------------------AKVRSIIFVPKFKNYLFVEAEREYEVRKL------IAGLSKLRLASSSPVPPQEIEDILSSETAG-------MEIEPGDIVKIIKGNFKGYRAVVIATPEGKSklTLKLLDIDRDWEVKMPVINVK--    
371 UniRef50_UPI000197ADA0 hypothetical protein BACCOP...    61     2e-08  1  12.1%   3:159   34:185     --DSPTNSWCYLFVHHAKVETINEKLILK----------FKTFIHKSIAYKRGKSHVRKTERPTISGLIFIQGNSREIQNYLNQIAFDLYLVKDCSTKKTAIIPDRVMQPFMqnPHHIRFMPHSFDYYSPNHtiKITSGVLTGMEGYCIRIARDKCLVT----------------------    
372 UniRef50_C1DYX5        Transcription elongation-nu...    60     3e-08  1   9.6%   6:162  238:370     -----DPKLWLVTVKQGKERETVVCLMQKAINLHKSGKGSMA-------------IKSACVQDHLKSYIYVEAERESDVKKALQGMRHVYH------SKPIKLVP-----ITEMVDSITVTKKKVENIQYQSWVRMRGGVYKGDLARVIDINYADNQCTVQL-------------------    
373 UniRef50_Q2NTN8        Putative uncharacterized pr...    60     3e-08  1  18.0%   9:130   11:125     --------WYLLRFKATLFNMVFNHLAA---------SGVYYFCPMIETQYRRPDSvrKRLSPVFPGYLFVNLDFDHCHPQKLSAHRHIYGLINF-GQGPSPIDDAVIDLLMAKPHIVRKIIDAPRAWKE---------------------------------------------------    
374 UniRef50_B3JEC4        Putative uncharacterized pr...    60     3e-08  1  13.1%   4:179   27:200     ---EKEQVWLPLQTVYNKELTVAAYLK---------EQGIEHYIPMTYELRdrEGECSHVLVPAIHNLIFIHCPY-DANwqFASEAPLPVYFLKKegNDYCTVSERDMQNFMHATNPDIQG----TRFIDSEKLrvRRGPLYGVTGKFLRY---GGRHYIAIEMPQSTALLKVSYTWCE--    
375 UniRef50_D2MG88        Putative uncharacterized pr...    60     4e-08  1  17.1%  36:181   30:186     -----------------------------------DELGLAPYLPMEWKSVAarGRRREVQVPLLIGYLLlaGGLAHGRYGDVLATRGVRGLLHYAGSqpARLSDATVERLRAEERAADNKRQMRleWQPGDEVWAEILPGRSLLARISAEKAPRGRIAILleVLGRRAFA-VEPKQLQRV    
376 UniRef50_A8UUU2        Transcription antiterminati...    59     6e-08  1  21.8%   9:178    2:195     --------WYVLKVRSGKEEALKELLGRDFEVLYPSRKKLNVYVNGKKRyrIRDGEVFTDneSPLRGYLFVKG-RYEDILSKTENLLDVVGFL-IMGGKVRTLTDEEVSDLQKRVEKGERLKTLLP--ERGMRVKVVSGEWTGAEGVIEEVYEDLS-LKLKLRLWDKTFTAILPLERV---    
377 UniRef50_A4RYW5        Predicted protein n=2 Tax=O...    59     6e-08  1  22.0%   1:177   19:258     MSEAATGewYMLEVPETRENQAKAAILALNGTKLTRGQgvVAWVPrfYVAEEDAVGKSELeeMLQPGYVLVRCALTQELMDAFDDLRSVRGFATGGSSrpVVKTEADIEAEKAREQAKEVMRAERGDEADedRVEVHTGPFKGFKGHIVARNDDGS-VEATLAIFGRDTNVSLAADE----    
378 UniRef50_A3TRT6        Putative secreted protein n...    59     8e-08  1  25.3% 100:178  361:434     ---------------------------------------------------------------------------------------------------PVPLP-----KITATPLPSTTVAVDPDPFSPGDTVKITAGQYLGLSAKVLKVDTVKNTVTVEVVVLGIKLPVVLPYSSV---    
379 UniRef50_A8MDC8        Transcription termination a...    58     1e-07  1  14.9%  12:179   11:149     -----------VRVIAGQEYNVAAIIRTRLEL-------------MEKDKRKYYNVPSIVVPPNVQGQVYLETPHSYVAIDLSTGIKQYRGLMMGK------VPLTELMKMI----------KREIKVQINDVVEIITEPFRGFKAKVVDVDEKNNTVKLLLFDTATNIPVTLPIKSIR--    
380 UniRef50_B5JIS7        Putative uncharacterized pr...    58     1e-07  1  26.9% 101:178     1:78     ----------------------------------------------------------------------------------------------------MVVEDEVVDLIKENSEDLMLSPAVDDSFQCGENVEVLEGPFQGMMGTVLQNLNEGSRVAILLTLLTSETKVTISRSHL---    
381 UniRef50_C4QBT8        Suppressor of ty, putative ...    58     2e-07  1  11.4%   5:162  171:303     ----KDPNLWALRCKMGEEKATVLALMRKFIAYQFSDTPLQI--------------KSAFAKEGLKGYIYVEA---FKQTHVKQAIDGIT-ALRLSMYKQQLVPIEEMTEVVRVVKETGQ-------LKPDQWVRIKSGLYRDDLALVEYVEDAQNLVGLKL-------------------    
382 UniRef50_UPI00016C0B0F transcription antiterminati...    57     3e-07  1  33.3%    5:58     2:55     ----SEAKWYVVHTYSGYENKVKVNIEKAIKNRNMQELIQKVEIPMHNEEEEKNGTTR---------------------------------------------------------------------------------------------------------------------------    
383 UniRef50_A8ABQ4        NGN domain protein n=1 Tax=...    57     3e-07  1  18.0%  10:181    6:145     ---------FPVRTVSGREIDVALLIEERARAKNL-------------------DVKSVIVPPRIKGFVIVE---SPAHFVVAEAVRGIKYVRGGPGKK---ISLEEVLKMI-------KPVPIIETVEVGDIVELVAGVFKGVKARVEAKIPEKNELVLSIVEAAYPLQITVPADYVRPV    
384 UniRef50_B8IRQ9        Putative uncharacterized pr...    57     3e-07  1  14.3%   3:128   51:164     --EPNPLRWHAAVTFPGCEVKVRDAMQLR---------RIDTVLPMVRFWRIRSRKRFVAERPLLARTVIFGLDHACQDIA---GIEGLERVVRGASVGWADLPEQDVYDLRLSILRGEFDATLRQDY-----------------------------------------------------    
385 UniRef50_UPI0001743F0E transcription antiterminati...    57     4e-07  1  18.2%    6:82    15:90     -----EKKWYIIHTYSGYEKKVAADLEKRIESLDLTDRAFLELLAAF-FNKSDAGGVFNTNVKLLSAYTVISTGITNPILSC---------------------------------------------------------------------------------------------------    
386 UniRef50_C4UKL3        Transcription antiterminati...    57     4e-07  1  16.4%   2:129    4:126     -EELNGQSWYLAQYITGGKNR-----EKLFGW--LCEQHITPWTPLTVRTIRRTDKINCIRkpLFPGYFFLKANLATQTVDNIRRHSAFCGFVMN-GPQIAPLRPLIVEGLMKCHPDPTLSPEALNELE----------------------------------------------------    
387 UniRef50_B3CAR2        Putative uncharacterized pr...    57     4e-07  1  13.1%   3:124   22:137     --DKDKILWYVMRVYKN-ENTAEDRLSN-------ETYGLEYFIPKQKVLRTVKGKKVFFMVPVIHSLVFVHASHQKIVDFKHNYYYdfVTWKSGGELVYLTVPDEDMTNFIKVCKQADEEVHF---------------------------------------------------------    
388 UniRef50_A7V3C8        Putative uncharacterized pr...    57     4e-07  1  15.2%    1:79     8:77     MTDNDMMCWHALYTAPKSEHKLMQRLNA---------AGYTTYCPMQAVFVKWKGHTRKVITPLFSGCLFVAGNVSEVT------------------------------------------------------------------------------------------------------    
389 UniRef50_C1FFC9        Predicted protein n=1 Tax=M...    56     5e-07  1  19.8%   5:135  315:476     ----NDVGWYMCEVPEGREQQAADKIDAIARTEKTEGEPITTWVPrfCVARSDAEGKTRieTLPFPGYVLVHMKLSQTTLNSLEEIYGVKGFarQTGERPRPVPAMQLETMMKMCDVRVVSDAEHAKITEALKRR----------------------------------------------    
390 UniRef50_B0ZDY9        ActX n=5 Tax=Enterobacteria...    56     5e-07  1  16.8%   4:116    2:106     ---KGQKQFYLLQCSPHFHQSVLLQLSR---------SGIAYYNPVIRTFYKRRDcyRGQIMPMFPGYVFVLLDFEVVHPSCFTRMKNVYGLVSF-GEYPAEVPLSVINEVKEQEK-----------------------------------------------------------------    
391 UniRef50_B5HX00        Putative uncharacterized pr...    56     5e-07  1  37.7% 124:176     2:54     ---------------------------------------------------------------------------------------------------------------------------PAPDIAVGASVTITDGPFATLRATVTEIDTPSQKVKGVIELFGRHAPVELSFT-----    
392 UniRef50_C6J5U5        Predicted protein n=1 Tax=P...    56     6e-07  1  19.6%  10:157    5:168     ---------FAIQVMTGKENNVKKLMeaFARNESAQNWIKAVHTFTTTTRRLLGQGkkEIKRAIMPGYIFIEMnlPADVWHLIKSIPGVIKQFTGSGQVIGAEEFQKMLGLEPEEQQVEVAVPIQEQEAPgeKVQV-DEVEKNMKNALHEVNMAKTK------------------------    
393 UniRef50_C3M8G1        Transcriptional activator a...    56     6e-07  1  10.5%   6:138    2:132     -----EKKWYLTCHKSGCSNLYKAQ-------QALIQIEVHSLSPSIQTWRQRLDRkrAVIEPLFKGYLFTCFDPEKIPTRKIEHCAGISHLVRFA-NTIVPIREAVMQEImcMNDETRTNHKITTSLKESQKEQIKN-------------------------------------------    
394 UniRef50_Q7BQV7        Putative NusG-type transcri...    56     7e-07  1  18.9%   8:113    3:103     -------RWYLACHKAGKDNVFKAQ-------MTLERMNIMAFSPVMRAYRPrpGQLRPVMEQMFPGYLFIFFDTEIHHSSKIELCPGISHLVRFAG-EITPIRDAVVDDVMQ--------------------------------------------------------------------    
395 UniRef50_Q6TFR9        ORF9 n=1 Tax=Erwinia amylov...    55     1e-06  1  22.9%   7:115    2:103     ------KNWYVLAFTSNKFGAVERFLKL---------NKIEFLCPMHEHSYSRPDkiRKSLVPTFPGYLFVYLDFNETHPEKLARFQYIYGLITFS-NAPMAVPEVTIQVIAYTC------------------------------------------------------------------    
396 UniRef50_UPI0000382CEE COG0250: Transcription anti...    54     2e-06  1  38.7% 119:180     1:62     ----------------------------------------------------------------------------------------------------------------------EVQDFVETLFAIGDEVRITDGGFATFMAKVEKVDVKRGRYTVAVDVFGRPVPFEIAEESLEA-    
397 UniRef50_D1PC69        Putative uncharacterized pr...    54     2e-06  1  16.5%   9:166    2:193     --------WFIVKTDVFSEQQSIDFLREK-----YNHIITDFYFPlrKTYKNENGEVKVRFVPVLQGMFFIRVQ-NERRLKKVLSPYGYFMYKGFEMerQSKIPDEDMETFVYFNDrsIVEKRYSDLVKENDTIRILSGPLAGRVGVVKQIKHKGKKDRHLLVRFG---------------    
398 UniRef50_Q54017        AnfA1 n=2 Tax=Serratia ento...    52     1e-05  1  20.2%   6:134    2:130     -----KKKWYLIRCNYGKIDLGQKSLETYGLFEGFpsLEFEGFYLTFQKNFFRKG-----MVYFSPPYLFVRFDIDHIPISKIQHAIGVKGFVRFGGG-IKSIPDIVIGKIMKNDYLSGIDKDVIKLIRCENKV-----------------------------------------------    
399 UniRef50_Q6VE90        Orf37 n=2 Tax=Pseudomonas s...    51     2e-05  1  23.6%   7:129    2:117     ------SNWYLINHNP----KAVQGIIFRIRALGAED----VYSPANLKITKRLDcvRTSETQLFPGYLFVKLNPEVLHTSIVLQVSGVKKFVSF-GGVLATISDCLIEAIKSSLLVRVDKKVTQIECR----------------------------------------------------    
400 UniRef50_B5ZVK1        Putative uncharacterized pr...    51     2e-05  1  18.8%   9:136   29:156     --------WYAIRAAPGTQRMARhrVGESIIERNLRNEGISVYMPAFWYESIHHRTRKVIQrpLLVGYAFVNLE--NMNFEQVRDVDGVICFLRSEFG-PIRFSGDDLSVI------AAEELSRRQEFRRERITRI---------------------------------------------    
401 UniRef50_Q92W20        Putative uncharacterized pr...    49     7e-05  1  15.9%  27:133    1:107     --------------------------MESIIERNCRKDGFDIFMPSFYTELRHHRTKQILQkpFLVGYGFVSLPRLN--FEELRRVDGVVCFLRGANYGPLEFPDGYHRGPVLRRSRATAGLPLQAALPEGDR------------------------------------------------    
402 UniRef50_C7CEQ7        Putative uncharacterized pr...    48     1e-04  1  17.7% 103:181    13:91     ------------------------------------------------------------------------------------------------------LSDALARQSSAHVRPGRTNLTPLAGMQVGEEVRASSGLFSGFIGKFVGTAEGGAVGVISLEVMGSPFDYRLPIEDIQRV    
403 UniRef50_Q6MDM7        Putative transcription anti...    48     1e-04  1  38.3%    8:54     3:49     -------KWYVVQVLSTHEKKVKKALEEHLELKGMSGEIEQILLPTENVSEVKK-------------------------------------------------------------------------------------------------------------------------------    
404 UniRef50_Q48B18        Transcriptional regulator n...    48     1e-04  1  18.9%   3:129   70:195     --DLNMKNWRVLMHNS----SVYQSLITSIERLD-----VEVYSPESITYRKRPDRPSSVETklFPGYLLLRFDPEVTHTTTITALNGARGFVQFggGQACVMQDSTVEELKAVAMVRSNRPLDCIEFR----------------------------------------------------    
405 UniRef50_A6NHU0        Putative uncharacterized pr...    48     2e-04  1  25.0%  93:172  204:274     --------------------------------------------------------------------------------------------LTPTGPSRMPRPDEEQEK---------DKEDQPQGLVPGGAVVVLSGPHRGLYGKVEGLDPDNVRAMVRLAVGSRVVTVS---------    
406 UniRef50_C1N286        Predicted protein n=1 Tax=M...    46     7e-04  1  29.5% 134:177  422:464     -------------------------------------------------------------------------------------------------------------------------------------IEVQEGPFKGFKGYITG-NNTNGSVEARLLIFGRETSVTLAADE----    
407 UniRef50_C7IY85        Os02g0772000 protein n=4 Ta...    60     4e-08  1  13.3%   5:162  180:307     ----KDPKLWMVKCAIGHERETAICLMQK--SIDTPDLQI----------------KSVLALDHLKNYIYVEAYKEAHVKEACKGVRNI-----FASRKVTLVPIREVADVLSVQSKS-------TDISINTWVRMKLGAYKGDLAKVVDVDDVHQKVTVKL-------------------    
408 UniRef50_B9F3G9        Putative uncharacterized pr...    59     7e-08  1  13.3%   5:162  180:307     ----KDPKLWMVKCAIGHERETAICLMQK--SIDTPDLQI----------------KSVLALDHLKNYIYVEAYKEAHVKEACKGVRNI-----FASRKVTLVPIREVADVLSVQSKS-------TDISINTWVRMKLGAYKGDLAKVVDVDDVHQKVTVKL-------------------    
409 UniRef50_A9S5X8        RNA polymerase II transcrip...    59     7e-08  1  12.0%   5:162   62:192     ----KDPKLWMVKCNLGHEREAAICLMQKYIDQDQINQPLLI--------------KSAIALDHLKGYLYIESEKEAYVRQACRGMRMIY------SQKVTLVPIKEMTDVVS-------VEKKLVEIDQDTWVRVKIGIYKGDLAKVVDVDHVRQRAQIKL-------------------    
410 UniRef50_C4R370        Protein that forms a comple...    57     3e-07  1  13.7%   2:162  219:354     -PTVDDPGIWGVKVRLGKEKDVVRQILKKKLAREGTKNPLEIY--------------SAFQRDSFKGHVYIEARKAEAINDALKGNVNV-----FSNNSKFLVGIVEYKDLLRPVKSSDVK------LTRGSYVRVKNGKFKGDLAQVDEVLENGLEARLKL-------------------    
411 UniRef50_A4RGW0        Putative uncharacterized pr...    57     3e-07  1  15.4%   5:160  201:334     ----DDPHIWAVRCKEGKEREVVWSIMKRIEQRMG----------TKEELSITSAFERGGTASVMKGYVYVEANRSTDIMVALDGLLNVY-----PRTKMLLVEIKDMPDLLR--------VQKTPELKVGDHVRLKRPpyAGDLAVVRNVTENGLEVQV---------------------    
412 UniRef50_P27692        Transcription elongation fa...    56     5e-07  1  10.6%  12:162  290:416     -----------VRCRPGKEKELIRKLLKKKFNLD------------RAMGKKKLKILSIFQRDNYTGRIYIEAPKQSVIEKFCNGVPDIYI------SQKLLIPVQELPLLLKPNKSDDVA------LEEGSYVRIKRGIYKGDLAMVDQISENNLEVMLKI-------------------    
413 UniRef50_B9HL78        Putative uncharacterized pr...    55     2e-06  1  12.4%   2:162  134:267     -PSAKDPTIWKVKCMVGRERHSAFCLMQKfkSLGTKLQIISAF-----------------SIDHVKGYIYIEADKQIDIIEACKGLCSIY------SSRMAPVPKNEVSHLLS-------IRKSCNQVSEGMWARVKNGNYKGDLAQIVAVNDVRKKATVKL-------------------    
414 UniRef50_B9T6Z6        Suppressor of ty, putative ...    54     2e-06  1  13.9%  12:162  173:296     -----------VKCMVGRERHSAFCLMQKfkSLGTKLQIISAF-----------------SVDHVKGFVFIEADKQCDINEACKGLCSIY------STRVAPIPKNEVSHVLS-------VRSKSNAVREGMWARVKSGKYKGDLAQIVTVNDARKRATVKL-------------------    
415 UniRef50_Q54K42        Transcription initiation fa...    53     5e-06  1  13.2%  12:162  131:257     -----------LKCRVGEEKLFVASMMQKMLNNRNSNNPNDHVL-----------IKSVMAPHHLSGYVYVEAEREVHVRQAIKGMTSLVSF------TPVITPLKDIIEVISAN-------KKNVDLQKGGWVRIRLGKYKADIGQIISYDPSKSRVTVKL-------------------    
416 UniRef50_UPI00015B6054 PREDICTED: similar to GA204...    53     5e-06  1  10.1%   5:162  239:370     ----KDPNLWLVKCRIGEEMNTVLLLMRKFLTYQYTNSPLVI--------------KSAVAPKGIKGFIYIEAYKQVHVKAAIENVNNLK--LGFWKQQMVPL--NEMVDVLR--------VTSSINIKPNQWVRIKRGIYKDDLAQVDYIELAQNKVHLRL-------------------    
417 UniRef50_O00267        Transcription elongation fa...    53     5e-06  1  15.3%   5:180  175:318     ----KDPNLWTVKCKIGEERATAISLMRKFIAYQFTDTPLQI--------------KSVVAPEHVKGYIYVEA---YKQTHVKQAIEGVGNllGYWNQQMVPI--KEMTDVL-------KVVKEVANLKPKSWVRLKRGIYKDDIAQVDYVEPSQN--TISLKMIPR-----IDYDRIKA-    
418 UniRef50_Q6CC84        Transcription elongation fa...    53     6e-06  1  12.7%   5:162  175:306     ----NEPSIWGIRCKPGKEKELVRQCLRKKLSLQKSRNPLEIM--------------SVFQRDTFTGYIYMEARNQQAVTVALKGLVNVY------PQNMILVPIKEYVDLLRATKSAE------TELVPGAYVRLKRGKYGGDLAIVENLSENGLEVRLKL-------------------    
419 UniRef50_Q4SB75        Chromosome undetermined SCA...    52     1e-05  1  14.2%   5:180  186:329     ----KDPNLWTVKCKIGEERATAIALMRKFIAYQFTDTPLQI--------------KSVVAPDHVKGYIYVEAYKQTHVKSAIEGIGNLR--MGLWNQQMVPI--KEMTDVL-------KVVKEVTNLKPKSWVRLKRGLYKDDIAQVDYVEPSQN--TISLKMIPR-----IDLDRIKA-    
420 UniRef50_C9SF87        Transcription elongation fa...    52     1e-05  1  16.0%   1:162  213:352     MPSVDDPTIWAVRCKEGKEREVVFSIQKRIQERMG----------TKEEMAIISAFERGGTNSVMKGYIYVEAARSGDIMAALDGMLNVY-----PRSKLILVEIKDRPDLLR--------VTKTATLEPGAWVRLKRpkHAGDLGQVVDVTESGLEARVRF-------------------    
421 UniRef50_Q2GQE5        Putative uncharacterized pr...    51     2e-05  1  15.3%   5:161  230:364     ----DDPSIWAVRCKEGKERDVIFSIMRRIEERAGGKDALSI-----TSAFERGGTNS-----VMKGYIYVEARRQNDIMIALDGVLDVY-----PRTKMVLVELKDMPDLLRVMK--------TPNLEPGAWVRLKKPayAGDLAQVLDVTENGLEARVR--------------------    
422 UniRef50_B2WAZ3        Transcription elongation fa...    50     3e-05  1  13.0%   2:162  191:328     -PTVDDPSIWGCKCRPGKEREIIMAIQKRIDEKLRAGMGVQVYS---AFERGPSGPQS--------GFLYVEADSKQAVVELIEGIQNV-----FMGSGQFSIPPKERPDLLR--------KKKRAPLEVGKFVRMQRPpyKGDLAKVVEVSTNGLDCVVQL-------------------    
423 UniRef50_Q9US64        Hypothetical nuclear protei...    50     3e-05  1  13.1%   7:143    1:110     ------PNIWAVRCKIGKEKDIVFTIMRKAMDLQYTSSPLEII--------------SAFQRDSLVGYIYVEARKQSHVLDALNGVLNVY------TNNMILVPIKEMPDLL-------KVQKQVVELLPGAYVRIRRGKYAG--------------------------------------    
424 UniRef50_B7PNC8        Transcription elongation fa...    50     5e-05  1  12.7%   5:162  126:258     ----KDPNLWMVKCKIGEEKSTVLQMMRKFIAYQYSEEPLQI--------------RSVVAPEGLKGYIYIEA---YKHTHVKQVIQGV-GNLRIGLYQQTMVPIKEMTDVLRVTKE-------QAQLRPKQWVRLKRGIYRDDLAQVDYVDTAQSQVNLKL-------------------    
425 UniRef50_B6KJY6        Supt5h protein, putative n=...    49     7e-05  1  13.7%   2:162  188:325     -PDITDPKLWMVKlkTGVEREVCISILNK--SFQMQEKGKDCEI------------YSCYASDDLKGYVYVEAFSQYAIKEALQGLRLIRTY-----GEIKMVPLEEMTAVFNSVRSRAPYIPQRNDF-----VRVKRGLYANDIAQIHQVEEQGMVVTVRL-------------------    
426 UniRef50_B0EU05        Suppressor of ty, putative ...    48     1e-04  1  16.6%  10:166  119:245     ---------FAIRCKQGYEKDICMRIMKIWINQKDRIMhfSVFVPKEKT-----------------GIVYIEAMTERKFADACDGVRDLYI------NTIHALNDKQIEELL--------VSRMPTTIEPNSYVRINAEPYKGDLGVVVETTENKKVIVKLVPRFN---------------    
427 UniRef50_C4LVU5        Transcription initiation fa...    48     1e-04  1  16.6%  10:166  119:245     ---------FAIRCKQGYEKDICMRIMKiiNQKDRTMHLFSVFVPKEKT-----------------GIVYIEAMTERKFADACDGVRDLYI------NTIHALNDKQIEELL--------VSRMPTTIEPNSYVRINAEPYKGDLGVVVETTENKKVIVKLVPRFN---------------    
428 UniRef50_Q9V460        Transcription elongation fa...    48     2e-04  1  12.0%   5:162  212:344     ----KDPNLWMVKCRIGEEKATALLLMRKYLTYLNTDDPLQI--------------KSIIAPEGVKGYIYLEAYKQTHVKTCIDNV----GNLRMGKWKQEMVPIKEMTDVL-------KVVKEQVGLKVKQWVRLKRGLYKDDIAQVDYVDLAQNQVHLKL-------------------    
429 UniRef50_Q5CWL0        5kows transcription initiat...    48     2e-04  1  11.8%   2:162  123:258     -PTSRDPKLWLVKvrAGLEKDICIALVQKAAECQKQGKELPIL--------------SAYVASSYRGYIYVEAEAPNFVNEALQGFTGVR------LSSIKIIPVKEMTRVF------SVDMQEKEQLMRESWVRVRSGIYGGDLAQIYEVDEHEANVILRL-------------------    
430 UniRef50_A2ED41        KOW motif family protein n=...    47     3e-04  1  16.7%  12:179  151:288     -----------VKCKPGKELVVISYLYAKFAHSPSqnLTFAAYTPKIS-----------------SGFIYVEARTLADANTLCSELPFIMNL-----NRMKNLKYSEMAKAM-------TIPRTEVDFHPGNFVEIlsGYfkGDIGQVINININRNKVMVKL------IP-RIDYDRIE--    
431 UniRef50_D1IDV9        Whole genome shotgun sequen...    47     3e-04  1  10.1%   5:162  132:262     ----KDPTIWKVKCMVGRERLSAFCLMQklQSLGTKLQIISAF-----------------SVEHVKGFIYIEADKQCDINEACKGLCSIY------TSRVAPVPKNEVTHLLS-------VRSKCNEISEGTWARMKNGKYKGDLAQIVVVSDAQKKATVKL-------------------    
432 UniRef50_D0T981        Transcriptional regulator U...    47     3e-04  1  21.9%  93:165    14:90     --------------------------------------------------------------------------------------------VSSGGRSYFplSDREMETLRWVAASYsvYVPDSGHLLKGDRVRITSGPFADMEAEVV-VQPGGGHKDVMVRIL----------------    
433 UniRef50_D1HH49        Whole genome shotgun sequen...    46     5e-04  1  14.7%  93:160   79:146     --------------------------------------------------------------------------------------------LAKSTEKPCPIVMRLKRWERKECKPNSLPVLHKMHVKVGDTVKIISGREKGRTGEISKIFRHNSTVVV---------------------    
434 UniRef50_Q92917        G patch domain and KOW moti...    46     6e-04  1  25.0%  93:172  215:285     --------------------------------------------------------------------------------------------LTPTGPSRMPRPDEEQEK---------DKEDQPQGLVPGGAVVVLSGPHRGLYGKVEGLDPDNVRAMVRLAVGSRVVTVS---------    
435 UniRef50_Q21338        Transcription elongation fa...    45     8e-04  1  11.2%   2:162  178:311     -PSTKDPNLWIVKCRMGEEKLVAMHLMRKCLAVEHTNEPFQI--------------KSVVVKEGLKGMIYIEAFKQSHVMSAIEGFSALNQF------TITMVPIKDMVDVL-------RVVKDIPQLKLGSYVRLKRTMYKDDLAVVDLVDIAQNRVNLKL-------------------    
436 UniRef50_A1RRQ9        LSU ribosomal protein L24A ...    45     0.001  1  15.9%  10:179    9:146     ---------YSVSAVSRQEYNIVIVLKMRIESNKIP--IYSIVVPPEPF-----------------GILFIEGESLPAVSRAIYGVKHIKGIMRGVTNVEEVLRV-------------VRPTKPAVEIDINDEVEIIADVLKGSRGRVTFVDREKGIVRVELLDSAFPMPLDLRINEVK--    
437 UniRef50_C5SIV6        Putative uncharacterized pr...    45     0.001  1  16.1%   9:176   23:173     --------WLIVTTYAKKEAVVLSQLK---------GIGYEGYRPMIAKRRKIAGQEAPVLVPlyPNYVFVRA-------LEGRSPLSLFGLQGLACVHERAVLDAVVQAHRAKEADGFLPFKNekAFRRGDRIKTLGGLLE----VVLSDPIDTNRCAALSSFMNGSSRLIVGLD-----    
438 UniRef50_C2HWG3        Transcriptional activator R...    45     0.001  1  25.8% 112:177   62:126     ---------------------------------------------------------------------------------------------------------------LKQLDCEQLKHATKQLPEKGQTVRVARGQFAGIEAIYLEPDGDT-RSIMLVKMISQQVPMSIENTD----    
439 UniRef50_C7J286        Os05g0506200 protein (Fragm...    44     0.002  1  17.3%  46:178   17:156     ---------------------------------------------TVNVLEGPFQGKQGVVKHLYMGILFIHNESESENsaQCSSCENVKKrfGNSDDNPIPMFSYEQNEQRDNERPYRSTREQL--FSIGEMLRIRKGPMKGYLCRVVRIF--RNDVTVKLDSLLKIVTVQAEFLSV---    
440 UniRef50_B3L7U7        Transcription factor, putat...    44     0.002  1  12.9%  23:162  221:348     ----------------------KMWLIKLFKNGVERNIAMGIYYKYMKLKDNDFNIKGVYVSDNLKGYIYVEADSLYMLKRF------LLGFKFINLNEMTIVPVQELTSIFSMCHSKVIIP------KVNEYVRIKRGVYMNDIGQIFEVHEKGIYAIVRL-------------------    
441 UniRef50_A5K1V0        Trancription factor, putati...    44     0.002  1  12.9%  23:162  227:354     ----------------------KMWLIKLFRNGVERNLAMGIYYKYMKLKDNDFNIKGVYVSDNLKGYIYVEADSLYMLKRF------LLGFKFINLNEITIVPVQELTSIFSMCHSKVIIP------KVNEYVRIKRGVYMNDIGQIFEVHEKGIYAIVRL-------------------    
442 UniRef50_A9UZR3        Predicted protein n=1 Tax=M...    44     0.003  1  16.8%  70:170  441:536     ---------------------------------------------------------------------FVVGDRVIAYRGNLKNAFGVIETIREDGTVVLRVENQELRDLDRIPVPKEDLRKH---FRPADHVKVQRGRYEGQTGLVLEVND--QRVTVLIDLTMKQIE-----------    
443 UniRef50_B8I2J4        NusG antitermination factor...    43     0.004  1  23.3%    8:80     3:70     -------NWFVFRVQIGEEYKACEFLNKLYDKEESVE-----FVPQVEVVTKNSQSIRKELTPTFPGYVFTGSILKEKTF-----------------------------------------------------------------------------------------------------    
444 UniRef50_A6L4G6        Putative uncharacterized pr...    43     0.005  1  16.5%  67:181  159:276     ------------------------------------------------------------------GYLFVCAPLDELNLILAHLFPRQYLAKDRNSYSVAVIPHRQMEEFIysMPYNIedKPLEEYIQKKQKIRITGGVFQGKEGCIMRLHRNTKLVFA----FGNMT-VAISYLqfEKV    
445 UniRef50_B0NND0        Putative uncharacterized pr...    43     0.005  1  15.9%    9:77    16:75     --------WCIVLTAPHAELNIQKKLEQ---------QGFITYVPTISVRRSWAGCIKEIHIPTIARCVFVYATKEE--------------------------------------------------------------------------------------------------------    
446 UniRef50_Q8STZ8        Similarity to putative tran...    43     0.005  1  15.1%   1:159   74:194     VPKNTSPRLFIVRVKRGSEREILMRI--------IENDPKNVF--------------SIICKDGLKGYLYVEAFQKQHVVDALESLRGVSR------SRVSVVPQKEMIEAMTYHEQR----------ICGEWGRIRNGKYKNDLAKIIESDGEMVRIR----------------------    
447 UniRef50_B7XII8        Transcription initiation pr...    43     0.006  1  15.7%   2:160   91:213     -PKMSDPLLFLVRVKIGKEKSIASKIAEHAKT-----------IPDITAILQKDG---------LKGYIYIESFKKSAVDEAVSKVKNVYK------NRIAAVPIAEMVDVLN----------SKKEYMINEYGRVKNGKYKGDLAQILENYEDSCQIRI---------------------    
448 UniRef50_C5KNI1        Histidyl-tRNA synthetase, p...    43     0.006  1  13.4%   2:150  230:358     -PEPSDSKLFLVKCfiGHEREIITRLSTKYE--------------QFRKKGVKTGILSAFASDSLKGYIYIE----------GKSVNHIKRFVTgnTNSVKVVPATEMLGVFRSAQEAAKG--RFVPLKMGEWVRIKRHpySNDLAQVVE-------------------------------    
449 UniRef50_Q79JX8        TraB n=17 Tax=root RepID=Q7...    42     0.007  1  15.7%   2:128   49:170     -SELHQRNWYLAQYIPAGKNR--EHL-----FSWLSEQHVLPWTPLILKKVRRTDkyRRHIHAVFPGYFFLKADPERHSFTHLRRHSAFLDFVKMAG-EIKTVREDIVQSLMKVYPDPALNPAAREEL-----------------------------------------------------    
450 UniRef50_Q01WX6        Putative uncharacterized pr...    42     0.007  1  28.3% 126:178    25:76     -----------------------------------------------------------------------------------------------------------------------------VKPRAGQRVRIKGGALAGVEGVVIGFRQS-LRLILSITLLQRSVLLEIDRRLV---    
451 UniRef50_D0N3F8        Transcription elongation fa...    42     0.008  1  19.0%  95:173  431:506     ----------------------------------------------------------------------------------------------NDTVRVMPLHEEIKDTILDF-----QLKQLMKYVKVGDHIKVVSGMYSGETGTVVAVDDSEgvAIVLVDSMAREIQVRV--------    
452 UniRef50_A0D4Q4        Chromosome undetermined sca...    42     0.010  1  17.2%   6:162  138:268     -----DPKFWRVSCNKGKEQEAVTSIMFKHNHLIDTN-------PLEIV--------SVFALKKFPAAIFIEANFEQHVMRAIEGLTIVRQclVESEQCPNMFKPAEVEQI---------------DIEEGQWVRVRQhiYSGDLARVMQVDQERKLIKLKV-------------------    
453 UniRef50_B8ICP2        NusG antitermination factor...    42     0.010  1  23.6%    4:75    35:97     ---DGDRRWYVVRIDPTRERKIREGLET---------AGFATCVPASSAVIEHRGRYRETRRRAVPGYLFVGADR----------------------------------------------------------------------------------------------------------    
454 UniRef50_C3Z963        Putative uncharacterized pr...    41     0.012  1  25.6% 101:178  195:272     ----------------------------------------------------------------------------------------------------AVVRPTEDKNQRPLKPGETRKEEDTTGLVPGAHVLILAGPHRDMYGKVESLNAETARAVVSLALGGQTLDISENALQV---    
455 UniRef50_C6KSV4        Trancription factor, putati...    41     0.012  1  12.9%  23:162  257:384     ----------------------KMWLIKLFKNNVERNLAIGIYHKFMKLKDNDFNIKGIYVSDNLKGYIYIEAD------SLYMLKKFLLGFKFINLNEISIVPIQELTSIFTMCHSKINIP------KVNEYVRIKRGLYINDIGQIYEIHEKGIYAIVRL-------------------    
456 UniRef50_A7AM03        KOW motif family protein n=...    41     0.012  1  16.2%  52:162  188:286     ---------------------------------------------------RKLGIYSCFAPDEIKSFIYVEADTKSAIIDAFSDLRNL------NLSKLKMVPINEVSTIYAMESRQQTVPL------IGEYVRIKTGRYAGDLAQVHESDELNGTVVVKV-------------------    
457 UniRef50_A9GHZ0        Putative uncharacterized pr...    41     0.013  1  32.7% 128:179  400:446     -------------------------------------------------------------------------------------------------------------------------------LEKGSRVRVRRGPFGDKIGVVSELDGRGG-ARVLLGLL----STRLELDDLE--    
458 UniRef50_B7ZCC8        G patch domain and KOW moti...    41     0.014  1  26.5% 124:172     3:51     ---------------------------------------------------------------------------------------------------------------------------QPQGLMHGRAVVVLSGPYRGLYGKVEGLDPDNVRAMVRLAVGNRIVTVS---------    
459 UniRef50_B3LCM7        Ribosomal protein l24, puta...    41     0.014  1  17.4%  70:161     4:89     ---------------------------------------------------------------------YVKYFMQAKQLDKRKRKYGNLDFLELSKELSIPFPLRE------RNQPKHLDLSKYLNIKVGDLVKVIYGPYKDREGLVLNINTKRNTVIVD--------------------    
460 UniRef50_Q4DTT9        Transcription initiation pr...    41     0.016  1  11.8%   2:162  188:327     -PQDTDPRVFAVKCRPRM----ARLLVARIVNKCYAYRIGRNY----EKRKVDLGIISVFCLDHVKEYIYIEAHRKVFVENALNGLDGLFRY------KITLVNPSELMQMM-------ERRPSPEKLRVGSFVRLRQRQYRLDLAQVVEVHPISNQVTVKV-------------------    
461 UniRef50_Q4MYL3        Transcription factor, putat...    41     0.024  1  11.7%   1:162  232:379     MPDLGDPKLWLVRTNR---QTADRNLAISIMNKSL----------RYQSLGKNLGIYSCFVPDGVTGYLYIEADNKTVVTEALSEFRQI------NLNTLKLVPINEMSNVFTTGALRCEVRSHIYYlrVGELVRVKFGRYSGDLGQVYESDENSSTVTLKL-------------------    
462 UniRef50_C5Z0R7        Putative uncharacterized pr...    40     0.029  1  12.6%  60:178  495:620     -----------------------------------------------------------VVKHLYLGILFieSESENCGFFCAQscEKIRKGLGSSTTepTPMFSEPTYEQNEHRDTERprSTREQLFSVGQMLRIRKGPLKGYLCRVVRIF--RNDVTVKLDSLLKTVTVQADLLSV---    
463 UniRef50_Q4FY88        Transcription elongation re...    40     0.029  1  10.5%   4:155  169:299     ---EDDPKVFAVKCRPRMSRVLVTRIVNKCYAYRVGRN--------YERKKVDLGIISVFALDHVKEYIYVEASRKRFVENVLNGLDGVFRF------NIAVVDPKELLQTM-------ETRPSTQKVRVGDYVRLRQRFYRGDLAQVTALHPDG--------------------------    
464 UniRef50_B3C5U6        Putative uncharacterized pr...    40     0.033  1  13.3%    4:78    11:76     ---NETRNWYIVLTSPWKEKKIREDLDNK---------GIISHLPTTYVQYKWKEKIRKIQIPTVNRCIFIYATDSEI-------------------------------------------------------------------------------------------------------    
465 UniRef50_UPI00016E26AA UPI00016E26AA related clust...    40     0.036  1  26.3% 116:172  232:288     -------------------------------------------------------------------------------------------------------------------PGDERVKEEELVMGPGSCVLVESGPHKDKYGKIEGVYPDNARVVVRLAIGGRTVDIS---------    
466 UniRef50_Q11LV0        Putative uncharacterized pr...    40     0.039  1  16.2%   9:138    3:155     --------WYAIRTVPgrEYAVetSLGKDGRPRglSEAGYVHYMPAERRlrKHTDLWKARRFAMLVGYVFVKGPVDFRALEP---VPGVHSIVGICG-RPMEIDLLDILTLRSMEAIAEEKFDRDARVAR-KTIRIKS-------------------------------------------    
467 UniRef50_A5BQJ5        Putative uncharacterized pr...    40     0.041  1   8.9%  62:162  451:538     -------------------------------------------------------------VDHVKGFIYIEADKQCDINEACKGLCSIY------TSRVAPVPKNEVTHLLSVRSKSIES-------SKGTWARMKNGKYKGNLAQIVVMSDAQKKATIKL-------------------    
468 UniRef50_P60663        50S ribosomal protein L24P ...    40     0.044  1  24.4% 119:163    51:95     ----------------------------------------------------------------------------------------------------------------------EKLGIRNVPIKVGDVVRVERGNFRGKEGQVIDIDPKYYRVYLSLD------------------    
469 UniRef50_Q90X38        G patch domain and KOW moti...    40     0.050  1  26.8% 116:171  239:294     -------------------------------------------------------------------------------------------------------------------GDEKGKEEEALVLGPGGCVQVLAGAHKDLYGKIEGVDPDNGRVVVKLAIGGKTVTI----------    
470 UniRef50_A5UL77        50S ribosomal protein L24P ...    39     0.063  1  25.6% 123:161    38:76     --------------------------------------------------------------------------------------------------------------------------KRSLPIRKGDKVQVLRGDFKGHEGAVLGVDYGSYKITIE--------------------    
471 UniRef50_B8BVN2        Predicted protein n=1 Tax=T...    39     0.073  1  10.6%   1:161  271:403     MPSVSDPNLWMFSCPTGKEQELVYQIMNKAVAFA---------------KRGRPLGITSVVAAQTKGKVYVESYSEPAVMEA---LQGVRGLMIYSAVK---VPISDMTTVMTVVPKKVPVKK-------NDWVRMTRGHFKGDLALVKHVRDSGLKCVIQ--------------------    
472 UniRef50_B3RYJ9        Putative uncharacterized pr...    39     0.079  1  27.1% 106:164  224:282     ---------------------------------------------------------------------------------------------------------EEPERTSDVCFAAKMVTTISLGFARGVHVMVVAGPHADLYGKVEGIDGDNGRIFVALAI-----------------    
473 UniRef50_A1RWS4        50S ribosomal protein L24P ...    39     0.081  1  24.3%  92:161     1:81     -------------------------------------------------------------------------------------------MVKGTSSKPGKVRKREVYDAPLHIRSKKIVAPLSAELqkGDRVLIVRGSFKGHEGKVTSVDVKKGRIHVE--------------------    
474 UniRef50_B8L4E2        Putative DNA methylase n=1 ...    39     0.089  1  17.0%  23:163 886:1025     ----------------------AKTITRRGARNTKEEGFSKPEVVEREIKRRGLDPADYEVRKHFGGYVGVLKDAPDIAIKSQTPTAGNEGRGAQPTSKGDGAARTEIHRKIDQEFAENLEAIAEEGIGAGDTVKFRSGD-ETLAAEVMEIDNEQGTLQVRLE------------------    
475 UniRef50_UPI0001926E74 PREDICTED: similar to predi...    39     0.091  1  21.8% 110:164  229:283     -------------------------------------------------------------------------------------------------------------RVRHIKGLSEEVKDNSIGYFPGCYVYIQNGPHKDLSGKIISVDEDTTRISVQLRI-----------------    
    consensus/100%                                                                                       .....................................................................................................................................................................................    
    consensus/90%                                                                                        ................................................................h.thhhh...............................h.......h...................st.h.h..t.h.t..s.h.................................    
    consensus/80%                                                                                         .......hahh.s..t.p..h...l.....................................hh.shlhlph.........h.th.th..hh.........l..t.h..hh...............h..sp.ltlhtG.hts..u.l.th..tt..hhl.h..................     
    consensus/70%                                                                                          ......Wahltsh.t.Etthht.l.t...........hthhhP.......htt.ht.h...hh.uYlhlpht.tpt.h.hhpth.tlhthlt..ttt.h.ls.pphtthh..............tht.GphVplhpGshts..u.l.php.tptphhl.l..ht....hth.......     

MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown